WO2016125622A1 - Benzoxazole compound, and use thereof for noxious arthropod control - Google Patents
Benzoxazole compound, and use thereof for noxious arthropod control Download PDFInfo
- Publication number
- WO2016125622A1 WO2016125622A1 PCT/JP2016/052091 JP2016052091W WO2016125622A1 WO 2016125622 A1 WO2016125622 A1 WO 2016125622A1 JP 2016052091 W JP2016052091 W JP 2016052091W WO 2016125622 A1 WO2016125622 A1 WO 2016125622A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- compound
- hydrogen atom
- atom
- halogen atoms
- Prior art date
Links
- CIVSLKJDTQKJDU-UHFFFAOYSA-N CCSc1c(C(Nc2cc(OC)ccc2O)=O)nccc1 Chemical compound CCSc1c(C(Nc2cc(OC)ccc2O)=O)nccc1 CIVSLKJDTQKJDU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Definitions
- the present invention relates to a benzoxazole compound and its use for controlling harmful arthropods.
- An object of the present invention is to provide a compound having an excellent control effect against harmful arthropods.
- the present inventors have found that the benzoxazole compound represented by the following formula (I) has an excellent control effect against harmful arthropods, leading to the present invention. .
- A represents a nitrogen atom or CR 5
- One of R A and R B represents —OSO 2 CF 3 , the other represents a hydrogen atom
- R 1 represents a C1-C4 alkyl group, a cyclopropyl group or a cyclopropylmethyl group
- R 2 and R 3 each independently represent a hydrogen atom or a halogen atom
- R 4 and R 5 each independently represents a hydrogen atom
- —S (O) m R 6 ⁇ m represents 0, 1, or 2.
- C3-C6 cycloalkyl group optionally having one or more halogen atoms, (C1-C6 alkoxy) optionally having one or more halogen atoms, C1-C6 alkyl group having one or more halogen atoms (C3-C6 cycloalkyl) C1-C6 alkyl group, —R 7 , —OR 7 , —NR 8 R 9 , —C (O) R 10 , —COOR 10 , —C (O) NR 8 R 9 , a phenyl group, a 5- to 6-membered heteroaryl group (provided that the phenyl group and the 5- to 6-membered heteroaryl group may have one or more atoms or substituents selected from group X; When it has two or more atoms or substituents, these atoms and substituents may be the same or different.
- R 10 and R 12 each independently represents a hydrogen atom or a C1-C6 alkyl group which may have one or more halogen atoms. ] (Hereinafter, the compound represented by the formula (I) may be referred to as the present compound).
- R 1 is a C1-C3 alkyl group
- R 4 and R 5 each independently represents one or more selected from a hydrogen atom, —R 6 , —S (O) m R 6 , —OR 6 , —NR 8 R 9 , —COOR 6 , group X
- the benzoxazole compound according to [1], wherein S (O) p R 6 R 11 .
- R A is —OSO 2 CF 3 and R B is a hydrogen atom.
- R 1 is an ethyl group
- R 2 and R 3 are both hydrogen atoms
- R 4 is a hydrogen atom, a halogen atom, a C1-C3 alkyl group that may have one or more halogen atoms, or a C1-C3 alkoxy group that may have one or more halogen atoms
- R 5 is a hydrogen atom or a halogen atom.
- a harmful arthropod control agent comprising the benzoxazole compound according to any one of [1] to [6] and an inert carrier.
- a method for controlling harmful arthropods which comprises applying an effective amount of the benzoxazole compound according to any one of [1] to [6] to harmful arthropods or their habitat.
- the compound of the present invention has excellent control activity against harmful arthropods.
- C1-C4 means that the number of carbon atoms is 1 to 4.
- C1-C6 chain hydrocarbon group means a C1-C6 alkyl group, a C2-C6 alkenyl group, and a C2-C6 alkynyl group.
- a halogen atom is a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
- Examples of the C1-C6 alkyl group optionally having one or more halogen atoms include a methyl group, an ethyl group, a propyl group, an isopropyl group, a hexyl group, a fluoromethyl group, a trifluoromethyl group, a chlorodifluoromethyl group, Examples include 2-bromoethyl group, 1,1-difluoroethyl group, 2,2,2-trifluoroethyl group, and pentafluoroethyl group.
- Examples of the C2-C6 alkenyl group which may have one or more halogen atoms include a vinyl group, an allyl group, a 3-methyl-2-butenyl group, a 2,2-dichlorovinyl group, and a 1,1-difluoroallyl group. Groups and pentafluoroallyl groups.
- Examples of the C2-C6 alkynyl group which may have one or more halogen atoms include ethynyl group, 1-propynyl group, 2-propynyl group, chloroethynyl group, 1-bromo-2-hexynyl group and 1- ( A trifluoro) -2-butynyl group.
- Examples of the C3-C6 cycloalkyl group optionally having one or more halogen atoms include a cyclopropyl group, a 1-fluorocyclopropyl group, a 2,2-dichlorocyclopropyl group, and a 3,3-dibromocyclobutyl group. And a cyclohexyl group.
- the (C1-C6 alkoxy) C1-C6 alkyl group which may have one or more halogen atoms means that the C1-C6 alkoxy group which may have one or more halogen atoms has one or more halogen atoms Means a group bonded to an optionally substituted C1-C6 alkyl group, and examples thereof include a methoxymethyl group, an ethoxymethyl group, a 1- (trifluoromethoxy) ethyl group, and a 3-fluoro-6- (hexyloxy) hexyl group. It is done.
- the (C3-C6 cycloalkyl) C1-C6 alkyl group which may have one or more halogen atoms is a C1-C6 cycloalkyl group which may have one or more halogen atoms.
- Examples of the C2-C6 alkanediyl group which may have one or more halogen atoms include ethane-1,2-diyl group, 2,2,3,3-tetrafluorobutane-1,4-diyl group, Examples include pentane-2,5-diyl group, 3- (trifluoromethyl) pentane-1,5-diyl group, and hexane-1,6-diyl group.
- the 5- to 6-membered heteroaryl group means, for example, a 5- or 6-membered aromatic heterocyclic group containing up to 3 atoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom.
- a compound according to Aspect 3 wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
- R 1 is a C1-C4 alkyl group
- R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X
- a compound that is an aryl group A compound that is an aryl group.
- a compound according to Aspect 6 wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
- R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
- Formula (Ib) [Wherein the symbols have the same meaning as described above. ] The compound shown.
- R 1 is a C1-C4 alkyl group
- R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X
- a compound that is an aryl group
- R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
- R 1 is a C1-C4 alkyl group
- R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X
- group X A compound that is an aryl group.
- R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
- R A is a hydrogen atom
- R B is —OSO 2 CF 3
- A is a nitrogen atom
- R 1 is a C1-C4 alkyl group
- R 2 And R 3 is a hydrogen atom
- R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group.
- R 4 is a hydrogen atom.
- R A is —OSO 2 CF 3
- R B is a hydrogen atom
- A is a nitrogen atom
- R 1 is a C1-C4 alkyl group
- R 2 And R 3 is a hydrogen atom
- R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group.
- R 4 is a hydrogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group in Aspect 16-1.
- R A is —OSO 2 CF 3
- R B is a hydrogen atom
- A is CH
- R 1 is a C1-C4 alkyl group
- R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group.
- R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
- Aspect 18 A compound according to Aspect 2, wherein R 4 is a hydrogen atom.
- Aspect 19 A compound according to Aspect 2, wherein R 4 is a halogen atom.
- Aspect 20 A compound according to Aspect 2, wherein R 4 is a C1-C6 alkyl group optionally having one or more halogen atoms.
- Aspect 21 The compound according to Aspect 9, wherein R 4 is a hydrogen atom.
- Aspect 22 The compound according to Aspect 9, wherein R 4 is a 1,2,4-triazolyl group.
- R 1 is a C1-C4 alkyl group
- R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or 1,2 , 4-triazolyl group.
- R 1 is an ethyl group and R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or 1,2,4- A compound that is a triazolyl group.
- the compound of the present invention and the intermediate compound can be produced, for example, according to the methods described in the following production methods 1 to 5 and reference production methods 1 to 4.
- a compound represented by the formula (Inn1) (hereinafter referred to as the compound (Inn1)) is a compound represented by the formula (Inn0) (hereinafter referred to as the compound (Inn0)). It can be produced by oxidizing. [Wherein the symbols have the same meaning as described above. ]
- the reaction is usually performed in a solvent.
- the solvent include halogenated hydrocarbons such as dichloromethane, chloroform and chlorobenzene (hereinafter referred to as halogenated hydrocarbons), nitriles such as acetonitrile (hereinafter referred to as nitriles), and alcohols such as methanol and ethanol.
- esters such as ethyl acetate and butyl acetate (hereinafter referred to as esters), acetic acid, water, and mixtures thereof.
- the oxidizing agent include peracetic acid, m-chloroperbenzoic acid (hereinafter referred to as mCPBA), and aqueous hydrogen peroxide.
- mCPBA m-chloroperbenzoic acid
- a base or a catalyst may be added as necessary.
- the base used for the reaction include sodium carbonate.
- the catalyst used for the reaction include tungstic acid and sodium tungstate.
- the oxidizing agent is usually used at a ratio of 1 to 1.2 mol.
- a base is usually used in an amount of 0.01 to 1 mol with respect to 1 mol of the compound (In0).
- the catalyst is generally used in an amount of 0.01 to 0.5 mol per 1 mol of the compound (In0).
- the reaction temperature is usually in the range of ⁇ 50 to 50 ° C.
- the reaction time is usually in the range of 0.1 to 12 hours.
- the compound represented by the formula (In2) (hereinafter referred to as the compound (In2)) is the compound represented by the formula (In3) (hereinafter referred to as the compound (In3)). It can be produced by oxidizing. [Wherein, r represents 0 or 1 and other symbols have the same meaning as described above. ] In this reaction, compound (In3) is used in place of compound (In0), and the oxidizing agent is 2 to 10 mol when r is 0 with respect to 1 mol of compound (In3), and r is 1 In this case, compound (In2) can be obtained according to the method described in Production Method 1 using 1 to 10 moles.
- the compound of the present invention can be produced by dehydrating a compound represented by the formula (M1) (hereinafter referred to as compound (M1)). [Wherein the symbols have the same meaning as described above. ]
- the reaction is usually performed in the presence of a solvent.
- the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran (hereinafter referred to as THF), tert-butyl methyl ether (hereinafter referred to as MTBE) (hereinafter referred to as ether).
- aromatic hydrocarbons such as toluene, benzene, and xylene (hereinafter referred to as aromatic hydrocarbons), esters, nitriles, and mixtures thereof.
- a condensing agent or an acid can be used.
- the condensing agent used in the reaction include organic bases such as triphenylphosphine, triethylamine and pyridine (hereinafter referred to as organic bases) and a mixture of carbon tetrachloride, azodiesters such as triphenylphosphine and diethyl azodicarboxylate. A mixture of the like.
- Examples of the acid used for the reaction include sulfonic acids such as paratoluenesulfonic acid.
- the condensing agent when a condensing agent is used, the condensing agent is usually in a proportion of 1 to 5 mol, and when an acid is used, the acid is usually in a proportion of 0.1 to 5 mol.
- the reaction temperature of the reaction is usually in the range of 0 to 200 ° C.
- the reaction time is usually in the range of 0.1 to 24 hours.
- a compound represented by formula (M23) (hereinafter referred to as compound (M23)) is a compound represented by formula (M2) (hereinafter referred to as compound (M2)) and a compound represented by formula (M3) ( Hereinafter, it can be produced by reacting with compound (M3).
- the reaction is usually performed in the presence of a solvent. Examples of the solvent used for the reaction include aromatic hydrocarbons.
- compound (M3) is usually used at a ratio of 1 to 1.2 mol with respect to 1 mol of compound (M2).
- the reaction temperature of the reaction is usually in the range of 50 to 150 ° C., and the reaction time is usually in the range of 0.1 to 24 hours.
- Compound (M3) can be produced according to the method described in International Publication No. 2012/0886848 or International Publication No. 2013/018928.
- the compound of the present invention can be produced by reacting the compound (M23) with an oxidizing agent.
- the reaction is usually performed in the presence of a solvent.
- the solvent used for the reaction include aromatic hydrocarbons.
- An example of the oxidizing agent used in the reaction is iodine.
- the reaction temperature of the reaction is usually in the range of 50 to 150 ° C., and the reaction time is usually in the range of 0.1 to 24 hours.
- the compound of the present invention can be produced in one pot from the compound (M2) without isolating the compound (23).
- the compound of the present invention is produced by reacting a compound represented by the formula (M4) (hereinafter referred to as compound (M4)) with trifluoromethanesulfonic anhydride or trifluoromethanesulfonyl chloride in the presence of a base.
- M4 a compound represented by the formula (M4)
- M4 trifluoromethanesulfonic anhydride or trifluoromethanesulfonyl chloride
- Examples of the solvent used in the reaction include aliphatic hydrocarbons such as ethers, hexane and heptane (hereinafter referred to as aliphatic hydrocarbons), aromatic hydrocarbons, halogenated hydrocarbons, esters, and nitriles. , Aprotic polar solvents and mixtures thereof.
- Examples of the base used for the reaction include organic bases.
- the reaction is carried out at a ratio of usually 0.8 to 1.5 mol of trifluoromethanesulfonic anhydride or trifluoromethanesulfonic acid chloride and usually 0.8 to 1.5 mol of base with respect to 1 mol of compound (M4). It is used in the ratio.
- the reaction temperature is usually in the range of ⁇ 78 to 50 ° C.
- the reaction time is usually in the range of 0.1 to 24 hours.
- Compound (M1) can be produced by reacting compound (M2) with a compound represented by formula (M5) (hereinafter referred to as compound (M5)).
- compound (M5) a compound represented by formula (M5)
- X represents a hydroxyl group or a chlorine atom, and other symbols have the same meaning as described above.
- This reaction can be carried out according to the method described in International Publication No. 2013/018928.
- Compound (M5) can be produced according to the method described in International Publication No. 2012/088684 or International Publication No. 2013/018928.
- Reference production method 2 Compound (M2) can be produced by the method shown below. [Wherein the symbols have the same meaning as described above. ]
- the step of producing a compound represented by formula (M7) (hereinafter referred to as compound (M7)) from a compound represented by formula (M6) can be carried out according to the method described in Production Method 5.
- the base is preferably added after completion of the reaction.
- the step of producing a compound represented by formula (M8) by nitrating compound (M7) (hereinafter referred to as compound (M8)) should be carried out according to the method described in International Publication No. 2013/018928. Can do.
- the step of producing compound (M2) by reducing compound (M8) is a method of using metallic iron described in New Experimental Chemistry Course 15 Oxidation and Reduction [II] (Maruzen) as a reducing reagent, or a method analogous thereto Can be implemented.
- Compound (M4) can be produced by reacting a compound represented by formula (M9) (hereinafter referred to as compound (M9)) with iodotrimethylsilane.
- compound (M9) a compound represented by formula (M9)
- one of R F and R G represents a methoxy group, the other represents a hydrogen atom, and the other symbols represent the same meaning as described above.
- the reaction is usually performed in the presence of a solvent. Nitriles are mentioned as a solvent used for reaction. Instead of iodotrimethylsilane used in the reaction, a mixture of chlorotrimethylsilane and sodium iodide can also be used.
- the reaction is carried out at a ratio of usually 1 to 10 moles of iodotrimethylsilane, usually 1 to 10 moles of chlorotrimethylsilane, and usually 1 to 10 moles of sodium iodide with respect to 1 mole of compound (M9). Used.
- the reaction temperature of the reaction is usually in the range of 20 to 100 ° C.
- the reaction time is usually in the range of 1 to 48 hours.
- Reference production method 4 Compound (M9) can be produced by the method shown below. [Wherein the symbols have the same meaning as described above. ]
- the step of producing a compound represented by the formula (M11) by reacting the compound represented by the formula (M10) with the compound (M5) (hereinafter referred to as the compound (M11)) is the method described in Reference Production Method 1. It can implement according to.
- the step of producing compound (M9) by reacting compound (M11) with a condensing agent or acid can be carried out according to the method described in Production Method 3.
- the compound represented by the formula (M10) is a known product or can be produced by a known method.
- the reaction mixture is poured into water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is poured into water.
- the resulting solid is collected by filtration; or by performing post-treatment operations such as collecting the solid produced in the reaction mixture by filtration, the compound of the present invention, compound (M1), compound (M7), compound (M8) , Compound (M2), Compound (M4), Compound (M11) or Compound (M9) can be isolated.
- the isolated compound of the present invention, compound (M1), compound (M7), compound (M8), compound (M2), compound (M4), compound (M11) or compound (M9) is recrystallized, chromatographed, etc. Can be further purified by
- Me means a methyl group
- Tr means a 1,2,4-triazol-1-yl group
- Pz means a pyrazol-1-yl group.
- [A; R 4 ; n] [CH; H; 0], [CH; H; 1], [CH; H; 2], [CH; F; 0], [CH; F; 1], [ CH; F; 2], [CH; Cl; 0], [CH; Cl; 1], [CH; Cl; 2], [CH; Br; 0], [CH; Br; 1], [CH; Br; 2], [CH; Me; 0], [CH; Me; 1], [CH; Me; 2], [CH; CF 3 ; 0], [CH; CF 3 ; 1], [CH; CF 3 ; 2], [CH; CF 2 CF 3 ; 0], [CH; CF 2 CF 3 ; 1], [CH; CF 2 CF 3 ; 2], [CH; CF 2 CF 3 ; 1], [CH; CF 2 CF 3 ; 2], [CH; OMe; 0], [CH; OMe; 1], [CH; OMe; 2], [CH; OCF 3 ;
- [A; R 4 ; n] [CH; F; 0], [CH; F; 1], [CH; F; 2], [CH; Cl; 0], [CH; Cl; 1], [ CH; Cl; 2], [CH; Br; 0], [CH; Br; 1], [CH; Br; 2], [CH; Me; 0], [CH; Me; 1], [CH; Me; 2], [CH; CF 3 ; 0], [CH; CF 3 ; 1], [CH; CF 3 ; 2], [CH; CF 2 CF 3 ; 0], [CH; CF 2 CF 3 ; 1], [CH; CF 2 CF 3 ; 2], [CH; OMe; 0], [CH; OMe; 1], [CH; OMe; 2], [CH; OCF 3 ; 0], [CH ; OCF 3 ; 1], [CH; OCF 3 ; 2], [CH; SCF 3 ; 0], [CH; SCF 3 ; 1], [CH; S
- pests for which the compounds of the present invention are effective include harmful animals such as harmful insects and harmful mites.
- harmful animals include, but are not limited to, the following.
- Hemiptera pests Japanese green planthopper (Laodelphax striatellus), Japanese green planthopper (Nilaparvata lugens), white planthopper (Sogatella furcifera), corn planter (Peregrinus maidis), etc .; (Nephotettix nigropictus), Incospider (Recilia dorsalis), Emporasca onukii, Empoasca fabae, Cornleaf Hopper (Dalbulus maidis), White-leafed beetle Mahanarva posticata, Mahanarva fimbriolata, etc .; Aphis goss ii, Aphis spiraecola, Myzus persicae, Japanese radish aphid (Br evicoryne brassicae), lipstick aphid (Lipaphis erysimi), tulip beetle aphid (Macrosiphum euphorbiae), potato beet
- Lepidopterous insects Chilo ⁇ suppressalis, Darkheaded stem borer (Chilo polychrysus), White stem borer (Scirpophaga innotata), Scirpophaga incertulas, Rupela albina, Cai halopatia cis (Marasmia exigua), cotton moth (Notarcha derogata), green eel (Ostrinia furnacalis), European corn borer (Ostrinia nubilalis), yellow moth (Hellula undalis), Shibatatsuga (Pediasia teterum (Pediasia teterum) Diatraea saccharalis), etc .; Sorgoptera ⁇ ⁇ litura, Spodoptera imexnagua, Spodoptera imexna rata), mushroom (Mamestra brassicae), rice mushroom (Sesamia inferens), white-footed mushroom (Spodoptera mauritia), frangipaya (Narang
- Cotton leafworm (Alabama argillacea), Hop vine borer (Hydraecia immanis) and other moths; White butterflies such as Pieris rapae; Nasihimeshinmoi (Grapholita molesta), Sumohimeshini (Grapholita dimorph) a), leguminous moth (Leguminivora ⁇ glycinivorella), Azuki beetle (Matsumuraeses azukivora), apple wolfberry (Adoxophyes orana fasciata), tea wolfberry (Adoxophyes honmai), chamonaki (Homona magnancos), (Cydia pomonella), Tetramoera schistaceana, Bean Shoot Borer (Epinotia aporema), Citrus fruit borer (Ecdytolopha aurantiana), etc .; Sinkigas (Carposina sasakii); Coffee Leaf miner (Leucoptera coffeela), A
- Citrus thrips (Frankliniella occidentalis), Thrips palmi, Scirtothrips dorsalis, Thrips tabaci, Thrips tabaci, Thrips tabaci, Thrips tabaci, Thrips tabaci, Thrips tabaci Thrips: The Thrips such as Haplothrips aculeatus.
- Diptera insect fly, Delia platura, Delia qua antiqua, etc .; sugar beet root maggot (Tetanops myopaeformis), etc .; (Liriomyza trifolii), leafhoppers (Chromatomyia horticola), etc .; leafhoppers (Chlorops oryzae); Fruit flies such as Ceratitis capitata; sand flies such as Hydrellia griseola, Hydrellia philippina, Hydrellia sasakii; Drosophila; flies such as Megaselia spiracularis; flies such as Clogmia albipunctata; black fly flies; Mayetiola destructor; Streptococcus such as Diopsis macrophthalma; Crane fly such as European ⁇ cranefly (Tipula palracosa), Common cranefly (Tipula oleracea), European cranefly (Tipula palud
- Coleoptera Western corn root worm (Diabrotica virgifera virgifera), Southern corn root worm (Diabrotica undecimpunctata howardi), Northern corn root worm (Diabrotica barberi), Mexican corn root worm (Diabrotica virgifera zeae), Banded cumber rot balte (ab) , Cucurbit Beetle (Diabrotica speciosa), Bean Leaf Beetle (Cerotoma trifurcata), Bark beetle Beetle (Oulema melanopus), Root beetle (Aulacophora femoralis), Kibushi horn beetle (Phyllotreta striolata), Colorado potato beetle (De , Grapes colaspis (Colaspis brunnea), corn flare beetle (Chaetocnema pulicaria), potato flare beetle (Epitrix cucumeris), rice beetle (Dicladispa armigera)
- Insect pests Locusta migratoria,ixie grasshopper (Dociostaurus maroccanus), Australian grasshopper (Chortoicetes terminifera), red locust (Nomadacris septemfasciata), Brown Locust (Locustana parust Calliptamus italicus), Differential grasshopper (Melanoplus differentialis), Two striped grasshopper (Melanoplus bivittatus), Migratory grasshopper (Melanoplus sanguinipes), Red-Legged grasshopper (Melanoplus femurrubrum), Grasshoppers such as Yellow-winged locust (Gastrimargus musicus), Spur-throated locust (Austracris ⁇ guttulosa), Cobaineago (Oxya yezoensis), Red-tailed hawk (Oxya japonica), Thai winged chinook (Patanga succincta); Kellys such as ryllotalpa
- Hymenopteran pests bees such as Athalia rosae and Athalia japonica; fire ants; ants such as Brown leaf-cutting ant (Atta capiguara)
- Cockroach insects German cockroaches such as the German cockroach (Blattella germanica); cockroaches such as the black cockroach (Periplaneta fuliginosa), the American cockroach (Periplaneta americana), the black cockroach (Periplaneta brunnea), and the American cockroach (Blatta orientalis).
- Termite pests Yamato termites (Reticulitermes speratus), termites (Coptotermes formosanus), American ants termites (Incisitermes minor), stag termites (Cryptotermes domesticus), ants, termites (Odontotermes eoformosaterm), ants Glyptotermes Reticulitermes kanmonensis), Takasago termites (Nasutitermes takasagoensis), Nitobe termites (Pericapritermes nitobei), Mushy termites (Sinocapritermes mushae), Cornitermes cumulans like.
- Mites Spider mites (Tetranychus urticae), spider mites (Tetranychus kanzawai), red spider mites (Panonychus ulmi), apple spider mites (Panonychus ulmi), spider mites (Aculops pelekassi), red mite Pistrum (copper) Tomato rustic mites (Aculops lycopersici), Chinese radish mites (Calacarus carinatus), Chinese radish mites (Acaphylla theavagrans), Green rustic mites (Eriophyes chibaensis), Apple ticks (Aculus Mattendali), etc .; Toad spider mites (Brevipalpus phoenicis) and other spider mites; Toxid spider mites (Haemaphysalis longicornis), tossed tick (Haemaphysalis flava), tortoise tick (Dermacentor taiwanens
- Tick such as: Tyrophagus putrescentiae, spiny mite (Tyrophagus similis), etc .; mite mite (Dermatophagoides pteronyssinus); , Mites (Cheyletus moorei), crayfish mites (Cheyletiella yasguri); mite mites (Otodectes cynotis), mite mites (Sarcoptes scabiei), etc .; Acne mites such as emodex canis; Carp mites; House crabs; Hornets such as Ornithonyssus sylviarum; Etc.
- Spiders Common spiders such as Cheracanthium japonicum; Brown spiders such as Latrodectus hasseltii.
- Lip and leg class Geges such as Gezi (Thereuonema hilgendorfi); Barley pods such as Scolopendra subspinipes.
- Double-legged class zelkova (Oxidus gracilis), zelkova (Nedyopus tambanus), etc.
- Isopods Rubber beetles such as Armadillidium vulgare.
- Gastropoda Coleoptera such as Limax marginatus and Limax flavus; Apple mussels such as Pomacea canaliculata; Monoaragai such as Austropeplea ollula.
- Nematodes Aphelenchoides besseyi, such as Aphelenchoides besseyi; Minaminegusaresenchu (Pratylenchus coffeae), Pratylenchus brachyurus, Pratylenchus neglectus ⁇ , Radsimus Cucumber species: Javaloid nematode Me (Meloidogyne javanica), Sweet potato nematode Me (Meloidogyne incognita), Kitaenbu nematode Me (Meloidogyne hapla), soybean cyst nematode (Heterodera glycines), potato cyst nematode (Globodera Heterodera; Hopro-Rimes such as Rotylenchulus reniformis; Anguinas such as Nothotylenchus acris and Ditylenchus dipsaci; Tirenkurusu such as Luz Semi penetrometer transformer (Tylenchulus semipen
- the target harmful insects and harmful ticks may be insects and ticks that have reduced drug sensitivity to insecticides / acaricides or have developed drug resistance.
- the drug sensitivity is greatly reduced or the drug resistance is greatly developed, it is desirable to use the composition of the present invention containing an insecticide / acaricide other than the target insecticide / acaricide.
- the compounds of the present invention can also be used to protect plants from plant diseases caused by insect-borne viruses.
- Examples of plant diseases caused by insect-borne viruses having the control effect of the compound of the present invention include the following.
- Rice dwarf disease (Rice waika virus), Tundra disease (Rice tungro spherical virus, Rice tungro bacilliform virus), Rice grassy stunt disease, Rice ragged stunt virus, Rice striped leaf blight Diseases (Rice stripe virus), rice black streaked dwarf virus, rice southern black-streaked dwarf virus, rice gall dwarf virus, rice leaf blight ( Rice hoja blanca virus), White leaf desease of rice, Yellow dwarf virus, Red disease (Rice penyakit merah virus), Rice yellow stunt virus, Transition yellowing Disease (Rice transitory yellowing virus), Rice yellow mottle virus, Rice necrosis mosaic virus, Rice dwarf stunt virus, North wheat mosaic disease Northern Cereal Mosaic Virus), barley yellowing atrophy disease (Barley Yellow Dwarf Virus), wheat yellow leaves disease (Wheat yellow dwarf virus), Oat sterile dwarf (Oat sterile dwarf virus), Wheat streak mosaic (Wheat streak mosaic virus) Maize dwarf mosaic virus, Maize stripe disease (maize stripe tenuivirus), Maize chlorotic
- the harmful arthropod control agent of the present invention contains the compound of the present invention and an inert carrier.
- the harmful arthropod control agent of the present invention is usually a mixture of the compound of the present invention and an inert carrier such as a solid carrier, a liquid carrier, a gaseous carrier, etc., and if necessary, a surfactant and other adjuvants for formulation.
- the harmful arthropod control agent of the present invention can be mixed with other insecticides, acaricides, nematicides, fungicides, plant growth regulators, herbicides and synergists.
- the harmful arthropod control agent of the present invention usually contains 0.01 to 95% by weight of the compound of the present invention.
- solid carriers used for formulation include clays (kaolin clay, diatomaceous earth, bentonite, fusami clay, acidic clay), synthetic hydrous silicon oxide, talc, ceramics, and other inorganic minerals (sericite, quartz, sulfur).
- Polyester resins such as polyethylene terephthalate, nylon resins such as nylon-6, nylon-11, and nylon-66, polyamide resins, polyvinyl chloride, polyvinylidene chloride, and vinyl chloride-propylene copolymers).
- liquid carrier examples include water, alcohols (methanol, ethanol, isopropyl alcohol, butanol, hexanol, benzyl alcohol, ethylene glycol, propylene glycol, phenoxyethanol, etc.), ketones (acetone, methyl ethyl ketone, cyclohexanone, etc.), aromatic hydrocarbons (Toluene, xylene, ethylbenzene, dodecylbenzene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, kerosene, light oil, etc.), esters (ethyl acetate, butyl acetate, isopropyl myristate, Ethyl oleate, diisopropyl adipate, diisobutyl adipate, propylene glycol monomethyl ether acetate, etc.), n
- DMF dimethylformamide
- halogenated hydrocarbons diichloromethane, trichloroethane, carbon tetrachloride, etc.
- sulfoxides dimethylsulfoxide, etc.
- propylene carbonate and vegetable oil Soybean oil, cottonseed oil, etc.
- gaseous carrier examples include fluorocarbon, butane gas, LPG (liquefied petroleum gas), dimethyl ether, and carbon dioxide gas.
- surfactant examples include nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene alkyl aryl ether, and polyethylene glycol fatty acid ester, and anions such as alkyl sulfonate, alkyl benzene sulfonate, and alkyl sulfate. Surfactant is mentioned.
- adjuvants for preparation include fixing agents, dispersants, colorants and stabilizers, such as casein, gelatin, saccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, bentonite, Synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), PAP (isopropyl acid phosphate), BHT (2,6-di-tert-butyl-4-methylphenol), BHA (2-tert- And a mixture of butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol).
- fixing agents such as casein, gelatin, saccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, bentonite, Synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), PAP (is
- the base material of the resin preparation examples include vinyl chloride polymers, polyurethanes, etc., and these base materials include phthalic acid esters (dimethyl phthalate, dioctyl phthalate, etc.) and adipic acid esters as necessary. Further, a plasticizer such as stearic acid may be added.
- the resin formulation is obtained by kneading the compound in the base material using a normal kneading apparatus, and then molding by injection molding, extrusion molding, press molding, etc., and if necessary, through steps such as molding, cutting, It can be processed into resin preparations such as plate, film, tape, net, and string.
- These resin preparations are processed, for example, as animal collars, animal ear tags, sheet preparations, attracting strings, or gardening supports.
- the bait base include cereal flour, vegetable oil, sugar, crystalline cellulose and the like, and if necessary, antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid, and preservatives such as dehydroacetic acid.
- antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid
- preservatives such as dehydroacetic acid.
- Additives for preventing accidental eating by children and pets such as pepper powder, pests such as cheese flavor, onion flavor and peanut oil are added.
- an effective amount of the compound of the present invention is applied directly to harmful arthropods and / or to the place where the harmful arthropods live (plants, soil, households, animal bodies, etc.). Is done.
- the harmful arthropod control method of the present invention is usually used in the form of the harmful arthropod control agent of the present invention.
- the application amount is usually 1 to 10,000 g as the amount of the compound of the present invention per 10,000 m 2 .
- the harmful arthropod control agent of the present invention is formulated into an emulsion, wettable powder, flowable agent, etc., it is usually diluted with water so that the concentration of the compound of the present invention becomes 0.01 to 10,000 ppm. Applied, granules, powders, etc. are usually applied as they are.
- These preparations and water dilutions of these preparations may be sprayed directly on harmful arthropods or plants such as crops to be protected from harmful arthropods, and harmful arthropods that inhabit the soil of cultivated land. You may treat to this soil in order to control.
- it can be treated by methods such as wrapping a resin preparation processed into a sheet or string around the crop, stretching it around the crop, or laying it on the stock soil.
- the amount applied is usually the amount of the compound of the present invention per 1 m 2 of treatment area when treated on the surface. 0.01 to 1000 mg, and when processing in a space, the amount of the compound of the present invention per 1 m 3 of the processing space is usually 0.01 to 500 mg.
- the harmful arthropod control agent of the present invention is formulated into an emulsion, wettable powder, flowable agent, etc., it is usually diluted with water so that the concentration of the compound of the present invention is 0.1 to 10,000 ppm. Apply oils, aerosols, smoke, poison baits, etc. as they are.
- the harmful arthropod control agent of the present invention When used to control ectoparasites of cattle, horses, pigs, sheep, goats, chickens, small animals such as dogs, cats, rats, mice, etc., it is well known in veterinary medicine. Can be used on animals.
- systemic suppression for example, administration by tablet, feed mixing, suppository, injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.) is intended for non-systemic suppression.
- an oil agent or an aqueous liquid is sprayed, a pour-on treatment or a spot-on treatment is performed, the animal is washed with a shampoo preparation, or a resin preparation is attached to the animal with a collar or ear tag.
- the amount of the compound of the present invention when administered to an animal body is usually in the range of 0.1 to 1000 mg per 1 kg body weight of the animal.
- room temperature usually indicates 10 to 30 ° C.
- 1 H NMR represents a proton nuclear magnetic resonance spectrum
- tetramethylsilane was used as an internal standard
- chemical shift ( ⁇ ) was expressed in ppm.
- Production Example 4 (1) A mixture of 500 mg of 3-ethylsulfanylpyridine-2-carboxylic acid, 0.5 mL of thionyl chloride, 1 drop of DMF and 5 mL of toluene was stirred at 100 ° C. for 2 hours and concentrated under reduced pressure. A mixture of the obtained residue and 6 mL of THF was added to a mixture of 380 mg of 2-amino-4-methoxyphenol and 6 mL of THF under ice-cooling, and the mixture was brought to room temperature and stirred at room temperature for 1 hour. Saturated aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate.
- a part represents a weight part.
- Formulation Example 1 10 parts of any one of compounds 1 to 12 are dissolved in a mixture of 35 parts of xylene and 35 parts of DMF, and 14 parts of polyoxyethylene styryl phenyl ether and 6 parts of calcium dodecylbenzenesulfonate are added and mixed. Each formulation is obtained.
- Formulation Example 2 4 parts of sodium lauryl sulfate, 2 parts of calcium lignin sulfonate, 20 parts of synthetic silicon hydroxide fine powder and 54 parts of diatomaceous earth are added, and 20 parts of any one of compounds 1 to 12 are added and mixed to each water. Get a glaze.
- Formulation Example 4 1 part of any one of compounds 1 to 12 is dissolved in an appropriate amount of acetone, and 5 parts of a synthetic silicon hydroxide fine powder, 0.3 part of isopropyl acid phosphate and 93.7 parts of fusami clay are added to the resulting mixture and stirred sufficiently. Mix and evaporate off the acetone to obtain each powder.
- Formulation Example 5 35 parts of a mixture of polyoxyethylene alkyl ether sulfate ammonium salt and white carbon (weight ratio 1: 1), 10 parts of any one of compounds 1 to 12, and 55 parts of water are mixed and finely divided by a wet grinding method. Each flowable agent is obtained by grinding.
- Formulation Example 6 0.1 part of any one of compounds 1 to 12 is dissolved in a mixture of 5 parts of xylene and 5 parts of trichloroethane, and this is mixed with 89.9 parts of kerosene to obtain each oil.
- Formulation Example 7 10 mg of any one of compounds 1 to 12 is dissolved in 0.5 mL of acetone, and this solution is added dropwise to 5 g of animal solid feed powder (bred breeding solid feed powder CE-2, Nippon Claire Co., Ltd.). Mix evenly. Then acetone is evaporated to dryness to obtain each poisonous bait.
- animal solid feed powder termed breeding solid feed powder CE-2, Nippon Claire Co., Ltd.
- Formulation Example 8 0.1 part of any one of compounds 1 to 12 and 49.9 parts of neothiozole (manufactured by Chuo Kasei Co., Ltd.) are placed in an aerosol can, and after mounting an aerosol valve, 25 parts of dimethyl ether and 25 parts of LPG are filled and shaken. Finally, an oil aerosol is obtained by mounting the actuator.
- Formulation Example 9 0.6 part of any one of compounds 1 to 12, 0.01 part of BHT (2,6-di-tert-butyl-4-methylphenol), 5 parts of xylene, 3.39 parts of kerosene and an emulsifier ⁇ Rheidol MO -60 (manufactured by Kao Corporation) ⁇ 1 part mixed and 50 parts distilled water are filled into an aerosol container, and after the valve is mounted, 40 parts of propellant (LPG) is pressure filled through the valve. To obtain an aqueous aerosol.
- BHT 2,6-di-tert-butyl-4-methylphenol
- xylene 3.39 parts of kerosene
- an emulsifier ⁇ Rheidol MO -60 (manufactured by Kao Corporation) ⁇ 1 part mixed and 50 parts distilled water are filled into an aerosol container, and after the valve is mounted, 40 parts of propellant (LPG) is pressure filled through the valve.
- LPG propellant
- Formulation Example 10 0.1 g of any one of compounds 1 to 12 is mixed with 2 mL of propylene glycol and impregnated into a porous ceramic plate of 4.0 ⁇ 4.0 cm and a thickness of 1.2 cm to obtain a heating smoke. .
- Formulation Example 11 5 parts of any one of compounds 1 to 12 and 95 parts of ethylene-methyl methacrylate copolymer (ratio of methyl methacrylate in the copolymer: 10% by weight, ACRIFT (registered trademark) WD301, manufactured by Sumitomo Chemical Co., Ltd.)
- the mixture is melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is extruded from an extruder through a molding die to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.
- Formulation Example 12 5 parts of any one of compounds 1 to 12 and 95 parts of a soft vinyl chloride resin are melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is extruded from an extrusion molding machine through a molding die. A rod-shaped molded body having a length of 15 cm and a diameter of 3 mm is obtained.
- Formulation Example 13 Any one of Compounds 1-12 100 mg, lactose 68.75 mg, corn starch 237.5 mg, microcrystalline cellulose 43.75 mg, polyvinylpyrrolidone 18.75 mg, sodium carboxymethyl starch 28.75 mg, and magnesium stearate 5 mg is mixed and the resulting mixture is compressed to an appropriate size to obtain tablets.
- Formulation Example 14 Any one of compounds 1 to 12 25 mg, lactose 60 mg, corn starch 25 mg, carmellose calcium 6 mg, and 5% hydroxypropylmethylcellulose are mixed in an appropriate amount, and the resulting mixture is filled into a hard shell gelatin capsule or hydroxypropylmethylcellulose capsule And a capsule is obtained.
- Formulation Example 15 Any one of Compounds 1-12 100 mg, fumaric acid 500 mg, sodium chloride 2000 mg, methylparaben 150 mg, propylparaben 50 mg, granule sugar 25000 mg, sorbitol (70% solution) 13000 mg, VeegumK (VanderbiltCo.) 100 mg, flavor 35 mg, and coloring Distilled water is added to 500 mg of the preparation so that the final volume becomes 100 mL, and mixed to obtain a suspension for oral administration.
- VanderbiltCo. VeegumK
- Formulation Example 16 5% by weight of any one of compounds 1 to 12 is dissolved in 5% by weight of polysorbate 85, 3% by weight of benzyl alcohol, and 30% by weight of propylene glycol, and the pH of this solution becomes 6.0 to 6.5. Thus, after adding a phosphate buffer solution, water is added as the remainder, and the liquid agent for oral administration is obtained.
- Formulation Example 17 5% by weight of aluminum distearate in 57% by weight of fractionated coconut oil and 3% by weight of polysorbate 85 is added and dispersed by heating. This is cooled to room temperature and 25% by weight of saccharin is dispersed in the oily vehicle. To this, 10% by weight of any one of compounds 1 to 12 is allocated to obtain a paste preparation for oral administration.
- Formulation Example 18 5% by weight of any one of compounds 1 to 12 is mixed with 95% by weight of limestone powder, and granules for oral administration are obtained using a wet granulation method.
- Formulation Example 19 5 parts of any one of compounds 1 to 12 are dissolved in 80 parts of diethylene glycol monoethyl ether, and 15 parts of propylene carbonate are mixed with this to obtain a spot-on solution.
- Formulation Example 20 10 parts of any one of compounds 1 to 12 are dissolved in 70 parts of diethylene glycol monoethyl ether, and 20 parts of 2-octyldodecanol is mixed with it to obtain a pour-on solution.
- Formulation Example 22 Any one of compounds 1 to 12 0.15% by weight, animal feed 95% by weight, and 4.85% by weight of a mixture composed of dicalcium phosphate, diatomaceous earth, Aerosil, and carbonate (or chalk) are sufficiently stirred and mixed. Obtain a premix for animal feed.
- Formulation Example 23 7.2 g of any one of compounds 1 to 12 and 92.8 g of Fosco (registered trademark) S-55 (manufactured by Maruishi Pharmaceutical Co., Ltd.) are dissolved and mixed at 100 ° C., poured into a suppository, and solidified by cooling. To obtain a suppository.
- Fosco registered trademark
- S-55 manufactured by Maruishi Pharmaceutical Co., Ltd.
- Test example 1 The preparation of Compound 1, 3, 4, 5, 7, 9, 10 or 12 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
- about 30 Aphis gossypi all stages were inoculated into cucumber seedlings (first true leaf development stage) planted in plastic cups, and left for 1 day. Scattered.
- Control value (%) ⁇ 1 ⁇ (Cb ⁇ Tai) / (Cai ⁇ Tb) ⁇ ⁇ 100
- the character in a formula represents the following meaning.
- Cb number of insects before treatment in the untreated group
- Cai number of live parasites when observed in the untreated group
- Tb number of insects before treatment in the treated group
- Tai number of live parasitic insects during observation of the treated group
- the group refers to a group in which a preparation diluted with the same amount of water as the treatment group was sprayed on the preparation not containing the compound of the present invention in Preparation Example 5. As a result, the control value of 90% or more was exhibited in all the treatment sections where the compounds of the present invention were tested.
- Test example 2 The preparation of Compound 4 or 5 obtained in Preparation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution. 10 mL of the diluted solution was sprayed on rice seedlings in the second leaf development stage planted in a polyethylene cup. After air drying, 20 3-4 instar larvae of the green planthopper (Nilaparvata lugens) were released and stored in a greenhouse at 25 ° C. Six days later, the number of brown planthopper infested with rice was investigated, and the control value was determined by the following formula.
- Control value (%) ⁇ 1 ⁇ (Cb ⁇ Tai) / (Cai ⁇ Tb) ⁇ ⁇ 100
- the character in a formula represents the following meaning.
- Cai number of insects at the time of observation in the untreated group
- Tb number of insects before the treatment in the treated group
- Tai number of insects at the time of observation in the treated group
- this refers to a group in which a preparation containing no compound of the present invention was sprayed with a solution diluted with the same amount of water as the treatment group.
- the control value of 90% or more was exhibited in all the treatment sections where the compounds of the present invention were tested.
- Test example 3 The formulation of Compound 4 obtained in Formulation Example 5 was diluted with water so that the concentration of Compound 4 was 200 ppm to obtain a diluted solution. On the other hand, 5 mL of the diluted solution was irrigated to rice seedlings planted in plastic cups (2 weeks after sowing, the second leaf development stage) and kept in a 25 ° C. greenhouse for 7 days. After releasing 20 3-4 instar larvae of the green planthopper (Nilaparvata lugens) and keeping it in the greenhouse for another 6 days, the number of surviving insects parasitic on the rice leaves was investigated, and the control value was calculated by the following formula: Asked.
- Control value (%) ⁇ 1 ⁇ (Cb ⁇ Tai) / (Cai ⁇ Tb) ⁇ ⁇ 100
- the character in a formula represents the following meaning.
- Cai number of live parasites when observed in the untreated group
- Tb number of insects before treatment in the treated group
- Tai number of live parasitic insects during observation of the treated group
- the group refers to a group in which a preparation diluted with the same amount of water as the treatment group was sprayed on the preparation not containing the compound of the present invention in Preparation Example 5. As a result, the treatment section in which Compound 4 was tested showed a control value of 100%.
- Test example 4 The preparation of Compound 1, 3, 4, 5, 7, 9, 10 or 12 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
- Test Example 5 The formulation of Compound 4 obtained in Formulation Example 5 was diluted with water so that the concentration of the compound was 500 ppm to obtain a diluted solution.
- a filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, and 0.7 mL of the diluted solution was dropped onto the filter paper, and 30 mg of sucrose was uniformly added as food.
- Test Example 6 The preparation of Compound 3 or 9 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
- a filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, and 0.7 mL of the diluted solution was dropped onto the filter paper, and 30 mg of sucrose was uniformly added as food.
- the compound of the present invention has a controlling effect on harmful arthropods and is useful as an active ingredient of a harmful arthropod controlling agent.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
A benzoxazole compound represented by formula (I) (in the formula: A represents nitrogen or CR5; one from among RA and RB represents -OSO2CF3, and the other represents hydrogen; R1 represents a C1-C4 alkyl group, a cyclopropyl group, or a cyclopropylmethyl group; R2 and R3 each independently represent hydrogen or a halogen; R4 and R5 each independently represent hydrogen, -S(O)mR6 {m represents 0, 1, or 2}, or a C3-C6 cycloalkyl group which may have at least one halogen; and n represents 0, 1, or 2) exhibits excellent control efficacy against noxious arthropods.
Description
本発明は、ベンゾオキサゾール化合物及びその有害節足動物防除用途に関する。
The present invention relates to a benzoxazole compound and its use for controlling harmful arthropods.
これまでに有害節足動物の防除を目的として、様々な化合物が検討されている(例えば特許文献1、2参照)。
So far, various compounds have been studied for the purpose of controlling harmful arthropods (see, for example, Patent Documents 1 and 2).
本発明は、有害節足動物に対して優れた防除効力を有する化合物を提供することを課題とする。
An object of the present invention is to provide a compound having an excellent control effect against harmful arthropods.
本発明者等は上記の課題を解決すべく検討した結果、下記式(I)で示されるベンゾオキサゾール化合物が有害節足動物に対して優れた防除効力を有することを見出し、本発明に至った。
As a result of studies to solve the above-mentioned problems, the present inventors have found that the benzoxazole compound represented by the following formula (I) has an excellent control effect against harmful arthropods, leading to the present invention. .
本発明は、以下の通りである。
[1] 式(I)
[式中、
Aは、窒素原子又はCR5を表し、
RA及びRBの一方は-OSO2CF3を表し、他方は水素原子を表し、
R1は、C1-C4アルキル基、シクロプロピル基又はシクロプロピルメチル基を表し、
R2及びR3は、それぞれ独立して、水素原子又はハロゲン原子を表し、
R4及びR5は、それぞれ独立して、水素原子、-S(O)mR6{mは、0、1、又は2を表す。}、1以上のハロゲン原子を有してもよいC3-C6シクロアルキル基、1以上のハロゲン原子を有してもよい(C1-C6アルコキシ)C1-C6アルキル基、1以上のハロゲン原子を有してもよい(C3-C6シクロアルキル)C1-C6アルキル基、-R7、-OR7、-NR8R9、-C(O)R10、-COOR10、-C(O)NR8R9、フェニル基、5~6員ヘテロアリール基{但し、該フェニル基、及び該5~6員へテロアリール基は、群Xから選ばれる1以上の原子又は置換基を有してもよく、2以上の原子もしくは置換基を有する場合、それらの原子及び置換基は同一でも異なっていてもよい。}、ニトロ基、シアノ基、ヒロドキシ基、スルファニル基、ハロゲン原子、-NR10C(O)R6、-NR10CO2R6、-NR10SO2R6、-NR10(OR6)、又は-N=S(O)pR6R11{pは、0又は1を表す。}を表し、
R6及びR11は、それぞれ独立して、1以上のハロゲン原子を有してもよいC1-C6アルキル基を表し、
R7は、1以上のハロゲン原子を有してもよいC1-C6鎖式炭化水素基を表し、
R8及びR9は、それぞれ独立して、水素原子又は1以上のハロゲン原子を有してもよいC1-C6鎖式炭化水素基を表すか、R8とR9とが結合して、1以上のハロゲン原子を有してもよいC2-C6アルカンジイル基を表し、
nは、0、1、又は2を表し、
群Xは-R6、-OR6、-S(O)mR6、-C(O)R6、-COOR6、-NR10R12、シアノ基、ニトロ基、及びハロゲン原子からなる群を表し、
R10及びR12は、それぞれ独立して、水素原子又は1以上のハロゲン原子を有してもよいC1-C6アルキル基を表す。]
で示されるベンゾオキサゾール化合物(以下、式(I)で示される化合物を本発明化合物と記す場合もある)。
[2] R1が、C1-C3アルキル基であり、
R4及びR5が、それぞれ独立して、水素原子、-R6、-S(O)mR6、-OR6、-NR8R9、-COOR6、群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基、ハロゲン原子、-NR10C(O)R6、-NR10CO2R6、-NR10(OR6)、又は-N=S(O)pR6R11である[1]に記載のベンゾオキサゾール化合物。
[3] RAが-OSO2CF3であり、RBが水素原子である[1]又は[2]に記載のベンゾオキサゾール化合物。
[4] R1が、エチル基であり、
R2及びR3が、共に水素原子であり、
R4が、水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C3アルキル基、又は1以上のハロゲン原子を有してもよいC1-C3アルコキシ基であり、
R5が、水素原子又はハロゲン原子である[3]に記載のベンゾオキサゾール化合物。
[5] Aが窒素原子である[1]~[4]のいずれかに記載のベンゾオキサゾール化合物。
[6] AがCR5である[1]~[4]のいずれかに記載のベンゾオキサゾール化合物。
[7] [1]~[6]のいずれかに記載のベンゾオキサゾール化合物と不活性担体とを含有する有害節足動物防除剤。
[8] [1]~[6]のいずれかに記載のベンゾオキサゾール化合物の有効量を有害節足動物又はその生息場所に施用する有害節足動物の防除方法。 The present invention is as follows.
[1] Formula (I)
[Where:
A represents a nitrogen atom or CR 5 ,
One of R A and R B represents —OSO 2 CF 3 , the other represents a hydrogen atom,
R 1 represents a C1-C4 alkyl group, a cyclopropyl group or a cyclopropylmethyl group,
R 2 and R 3 each independently represent a hydrogen atom or a halogen atom,
R 4 and R 5 each independently represents a hydrogen atom, —S (O) m R 6 {m represents 0, 1, or 2. } C3-C6 cycloalkyl group optionally having one or more halogen atoms, (C1-C6 alkoxy) optionally having one or more halogen atoms, C1-C6 alkyl group having one or more halogen atoms (C3-C6 cycloalkyl) C1-C6 alkyl group, —R 7 , —OR 7 , —NR 8 R 9 , —C (O) R 10 , —COOR 10 , —C (O) NR 8 R 9 , a phenyl group, a 5- to 6-membered heteroaryl group (provided that the phenyl group and the 5- to 6-membered heteroaryl group may have one or more atoms or substituents selected from group X; When it has two or more atoms or substituents, these atoms and substituents may be the same or different. }, Nitro group, cyano group, hydroxy group, sulfanyl group, halogen atom, —NR 10 C (O) R 6 , —NR 10 CO 2 R 6 , —NR 10 SO 2 R 6 , —NR 10 (OR 6 ) Or —N═S (O) p R 6 R 11 {p represents 0 or 1; },
R 6 and R 11 each independently represents a C1-C6 alkyl group which may have one or more halogen atoms,
R 7 represents a C1-C6 chain hydrocarbon group which may have one or more halogen atoms,
R 8 and R 9 each independently represents a hydrogen atom or a C1-C6 chain hydrocarbon group which may have one or more halogen atoms, or R 8 and R 9 are bonded to each other, Represents a C2-C6 alkanediyl group optionally having the above halogen atom,
n represents 0, 1, or 2;
Group X is a group consisting of —R 6 , —OR 6 , —S (O) m R 6 , —C (O) R 6 , —COOR 6 , —NR 10 R 12 , a cyano group, a nitro group, and a halogen atom. Represents
R 10 and R 12 each independently represents a hydrogen atom or a C1-C6 alkyl group which may have one or more halogen atoms. ]
(Hereinafter, the compound represented by the formula (I) may be referred to as the present compound).
[2] R 1 is a C1-C3 alkyl group,
R 4 and R 5 each independently represents one or more selected from a hydrogen atom, —R 6 , —S (O) m R 6 , —OR 6 , —NR 8 R 9 , —COOR 6 , group X An optionally substituted 5- to 6-membered heteroaryl group, a halogen atom, —NR 10 C (O) R 6 , —NR 10 CO 2 R 6 , —NR 10 (OR 6 ), or —N The benzoxazole compound according to [1], wherein = S (O) p R 6 R 11 .
[3] The benzoxazole compound according to [1] or [2], wherein R A is —OSO 2 CF 3 and R B is a hydrogen atom.
[4] R 1 is an ethyl group,
R 2 and R 3 are both hydrogen atoms,
R 4 is a hydrogen atom, a halogen atom, a C1-C3 alkyl group that may have one or more halogen atoms, or a C1-C3 alkoxy group that may have one or more halogen atoms,
The benzoxazole compound according to [3], wherein R 5 is a hydrogen atom or a halogen atom.
[5] The benzoxazole compound according to any one of [1] to [4], wherein A is a nitrogen atom.
[6] The benzoxazole compound according to any one of [1] to [4], wherein A is CR 5 .
[7] A harmful arthropod control agent comprising the benzoxazole compound according to any one of [1] to [6] and an inert carrier.
[8] A method for controlling harmful arthropods, which comprises applying an effective amount of the benzoxazole compound according to any one of [1] to [6] to harmful arthropods or their habitat.
[1] 式(I)
[式中、
Aは、窒素原子又はCR5を表し、
RA及びRBの一方は-OSO2CF3を表し、他方は水素原子を表し、
R1は、C1-C4アルキル基、シクロプロピル基又はシクロプロピルメチル基を表し、
R2及びR3は、それぞれ独立して、水素原子又はハロゲン原子を表し、
R4及びR5は、それぞれ独立して、水素原子、-S(O)mR6{mは、0、1、又は2を表す。}、1以上のハロゲン原子を有してもよいC3-C6シクロアルキル基、1以上のハロゲン原子を有してもよい(C1-C6アルコキシ)C1-C6アルキル基、1以上のハロゲン原子を有してもよい(C3-C6シクロアルキル)C1-C6アルキル基、-R7、-OR7、-NR8R9、-C(O)R10、-COOR10、-C(O)NR8R9、フェニル基、5~6員ヘテロアリール基{但し、該フェニル基、及び該5~6員へテロアリール基は、群Xから選ばれる1以上の原子又は置換基を有してもよく、2以上の原子もしくは置換基を有する場合、それらの原子及び置換基は同一でも異なっていてもよい。}、ニトロ基、シアノ基、ヒロドキシ基、スルファニル基、ハロゲン原子、-NR10C(O)R6、-NR10CO2R6、-NR10SO2R6、-NR10(OR6)、又は-N=S(O)pR6R11{pは、0又は1を表す。}を表し、
R6及びR11は、それぞれ独立して、1以上のハロゲン原子を有してもよいC1-C6アルキル基を表し、
R7は、1以上のハロゲン原子を有してもよいC1-C6鎖式炭化水素基を表し、
R8及びR9は、それぞれ独立して、水素原子又は1以上のハロゲン原子を有してもよいC1-C6鎖式炭化水素基を表すか、R8とR9とが結合して、1以上のハロゲン原子を有してもよいC2-C6アルカンジイル基を表し、
nは、0、1、又は2を表し、
群Xは-R6、-OR6、-S(O)mR6、-C(O)R6、-COOR6、-NR10R12、シアノ基、ニトロ基、及びハロゲン原子からなる群を表し、
R10及びR12は、それぞれ独立して、水素原子又は1以上のハロゲン原子を有してもよいC1-C6アルキル基を表す。]
で示されるベンゾオキサゾール化合物(以下、式(I)で示される化合物を本発明化合物と記す場合もある)。
[2] R1が、C1-C3アルキル基であり、
R4及びR5が、それぞれ独立して、水素原子、-R6、-S(O)mR6、-OR6、-NR8R9、-COOR6、群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基、ハロゲン原子、-NR10C(O)R6、-NR10CO2R6、-NR10(OR6)、又は-N=S(O)pR6R11である[1]に記載のベンゾオキサゾール化合物。
[3] RAが-OSO2CF3であり、RBが水素原子である[1]又は[2]に記載のベンゾオキサゾール化合物。
[4] R1が、エチル基であり、
R2及びR3が、共に水素原子であり、
R4が、水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C3アルキル基、又は1以上のハロゲン原子を有してもよいC1-C3アルコキシ基であり、
R5が、水素原子又はハロゲン原子である[3]に記載のベンゾオキサゾール化合物。
[5] Aが窒素原子である[1]~[4]のいずれかに記載のベンゾオキサゾール化合物。
[6] AがCR5である[1]~[4]のいずれかに記載のベンゾオキサゾール化合物。
[7] [1]~[6]のいずれかに記載のベンゾオキサゾール化合物と不活性担体とを含有する有害節足動物防除剤。
[8] [1]~[6]のいずれかに記載のベンゾオキサゾール化合物の有効量を有害節足動物又はその生息場所に施用する有害節足動物の防除方法。 The present invention is as follows.
[1] Formula (I)
[Where:
A represents a nitrogen atom or CR 5 ,
One of R A and R B represents —OSO 2 CF 3 , the other represents a hydrogen atom,
R 1 represents a C1-C4 alkyl group, a cyclopropyl group or a cyclopropylmethyl group,
R 2 and R 3 each independently represent a hydrogen atom or a halogen atom,
R 4 and R 5 each independently represents a hydrogen atom, —S (O) m R 6 {m represents 0, 1, or 2. } C3-C6 cycloalkyl group optionally having one or more halogen atoms, (C1-C6 alkoxy) optionally having one or more halogen atoms, C1-C6 alkyl group having one or more halogen atoms (C3-C6 cycloalkyl) C1-C6 alkyl group, —R 7 , —OR 7 , —NR 8 R 9 , —C (O) R 10 , —COOR 10 , —C (O) NR 8 R 9 , a phenyl group, a 5- to 6-membered heteroaryl group (provided that the phenyl group and the 5- to 6-membered heteroaryl group may have one or more atoms or substituents selected from group X; When it has two or more atoms or substituents, these atoms and substituents may be the same or different. }, Nitro group, cyano group, hydroxy group, sulfanyl group, halogen atom, —NR 10 C (O) R 6 , —NR 10 CO 2 R 6 , —NR 10 SO 2 R 6 , —NR 10 (OR 6 ) Or —N═S (O) p R 6 R 11 {p represents 0 or 1; },
R 6 and R 11 each independently represents a C1-C6 alkyl group which may have one or more halogen atoms,
R 7 represents a C1-C6 chain hydrocarbon group which may have one or more halogen atoms,
R 8 and R 9 each independently represents a hydrogen atom or a C1-C6 chain hydrocarbon group which may have one or more halogen atoms, or R 8 and R 9 are bonded to each other, Represents a C2-C6 alkanediyl group optionally having the above halogen atom,
n represents 0, 1, or 2;
Group X is a group consisting of —R 6 , —OR 6 , —S (O) m R 6 , —C (O) R 6 , —COOR 6 , —NR 10 R 12 , a cyano group, a nitro group, and a halogen atom. Represents
R 10 and R 12 each independently represents a hydrogen atom or a C1-C6 alkyl group which may have one or more halogen atoms. ]
(Hereinafter, the compound represented by the formula (I) may be referred to as the present compound).
[2] R 1 is a C1-C3 alkyl group,
R 4 and R 5 each independently represents one or more selected from a hydrogen atom, —R 6 , —S (O) m R 6 , —OR 6 , —NR 8 R 9 , —COOR 6 , group X An optionally substituted 5- to 6-membered heteroaryl group, a halogen atom, —NR 10 C (O) R 6 , —NR 10 CO 2 R 6 , —NR 10 (OR 6 ), or —N The benzoxazole compound according to [1], wherein = S (O) p R 6 R 11 .
[3] The benzoxazole compound according to [1] or [2], wherein R A is —OSO 2 CF 3 and R B is a hydrogen atom.
[4] R 1 is an ethyl group,
R 2 and R 3 are both hydrogen atoms,
R 4 is a hydrogen atom, a halogen atom, a C1-C3 alkyl group that may have one or more halogen atoms, or a C1-C3 alkoxy group that may have one or more halogen atoms,
The benzoxazole compound according to [3], wherein R 5 is a hydrogen atom or a halogen atom.
[5] The benzoxazole compound according to any one of [1] to [4], wherein A is a nitrogen atom.
[6] The benzoxazole compound according to any one of [1] to [4], wherein A is CR 5 .
[7] A harmful arthropod control agent comprising the benzoxazole compound according to any one of [1] to [6] and an inert carrier.
[8] A method for controlling harmful arthropods, which comprises applying an effective amount of the benzoxazole compound according to any one of [1] to [6] to harmful arthropods or their habitat.
本発明化合物は、有害節足動物に対して優れた防除活性を有する。
The compound of the present invention has excellent control activity against harmful arthropods.
本発明における置換基について説明する。
本明細書における「1以上のハロゲン原子を有してもよい」において、2以上のハロゲン原子を有する場合、それらのハロゲン原子は互いに同一でも異なってもよい。
本明細書における、例えば「C1-C4」との表記は、炭素原子数が1乃至4であることを意味する。
本明細書における「C1-C6鎖式炭化水素基」とは、C1-C6アルキル基、C2-C6アルケニル基及びC2-C6アルキニル基を意味する。 The substituent in the present invention will be described.
In the present specification, “may have one or more halogen atoms”, when having two or more halogen atoms, these halogen atoms may be the same or different from each other.
In this specification, for example, the expression “C1-C4” means that the number of carbon atoms is 1 to 4.
As used herein, “C1-C6 chain hydrocarbon group” means a C1-C6 alkyl group, a C2-C6 alkenyl group, and a C2-C6 alkynyl group.
本明細書における「1以上のハロゲン原子を有してもよい」において、2以上のハロゲン原子を有する場合、それらのハロゲン原子は互いに同一でも異なってもよい。
本明細書における、例えば「C1-C4」との表記は、炭素原子数が1乃至4であることを意味する。
本明細書における「C1-C6鎖式炭化水素基」とは、C1-C6アルキル基、C2-C6アルケニル基及びC2-C6アルキニル基を意味する。 The substituent in the present invention will be described.
In the present specification, “may have one or more halogen atoms”, when having two or more halogen atoms, these halogen atoms may be the same or different from each other.
In this specification, for example, the expression “C1-C4” means that the number of carbon atoms is 1 to 4.
As used herein, “C1-C6 chain hydrocarbon group” means a C1-C6 alkyl group, a C2-C6 alkenyl group, and a C2-C6 alkynyl group.
ハロゲン原子とは、フッ素原子、塩素原子、臭素原子及びヨウ素原子である。
1以上のハロゲン原子を有してもよいC1-C6アルキル基としては、例えば、メチル基、エチル基、プロピル基、イソプロピル基、ヘキシル基、フルオロメチル基、トリフルオロメチル基、クロロジフルオロメチル基、2-ブロモエチル基、1,1-ジフルオロエチル基、2,2,2-トリフルオロエチル基、及びペンタフルオロエチル基が挙げられる。
1以上のハロゲン原子を有してもよいC2-C6アルケニル基としては、例えば、ビニル基、アリル基、3-メチル-2-ブテニル基、2,2-ジクロロビニル基、1,1-ジフルオロアリル基及びペンタフルオロアリル基が挙げられる。
1以上のハロゲン原子を有してもよいC2-C6アルキニル基としては、例えば、エチニル基、1-プロピニル基、2-プロピニル基、クロロエチニル基、1-ブロモ-2-ヘキシニル基及び1-(トリフルオロ)-2-ブチニル基が挙げられる。
1以上のハロゲン原子を有してもよいC3-C6シクロアルキル基としては、例えば、シクロプロピル基、1-フルオロシクロプロピル基、2,2-ジクロロシクロプロピル基、3,3-ジブロモシクロブチル基及びシクロヘキシル基が挙げられる。
1以上のハロゲン原子を有してもよい(C1-C6アルコキシ)C1-C6アルキル基とは、1以上のハロゲン原子を有してもよいC1-C6アルコキシ基が1以上のハロゲン原子を有してもよいC1-C6アルキル基に結合した基を意味し、例えばメトキシメチル基、エトキシメチル基、1-(トリフルオロメトキシ)エチル基、及び3-フルオロ-6-(ヘキシルオキシ)ヘキシル基が挙げられる。
1以上のハロゲン原子を有してもよい(C3-C6シクロアルキル)C1-C6アルキル基とは、1以上のハロゲン原子を有してもよいC3-C6シクロアルキル基が1以上のハロゲン原子を有してもよいC1-C6アルキル基に結合した基を意味し、例えばシクロプロピルメチル基、1-シクロプロピルエチル基、4-(2,2-ジフルオロシクロプロピル)ブチル基及び6-シクロヘキシル-1-フルオロヘキシル基が挙げられる。
1以上のハロゲン原子を有してもよいC2-C6アルカンジイル基としては、例えば、エタン-1,2-ジイル基、2,2,3,3-テトラフルオロブタン-1,4-ジイル基、ペンタン-2,5-ジイル基、3-(トリフルオロメチル)ペンタン-1,5-ジイル基、及びヘキサン-1,6-ジイル基が挙げられる。
5~6員へテロアリール基とは、例えば、窒素原子、酸素原子及び硫黄原子からなる群より選ばれる原子を最大3つまで含有する5または6員の芳香族複素環基を意味し、例えば、フリル基、チエニル基、ピロリル基、ピラゾリル基、イミダゾリル基、1,2,3-トリアゾリル基、1,2,4-トリアゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、1,2,4-オキサジアゾリル基、1,3,4-オキサジアゾリル基、1,2,5-オキサジアゾリル基、1,2,3-チアジアゾリル基、1,2,4-チアジアゾリル基、1,3,4-チアジアゾリル基、1,2,5-チアジアゾリル基、ピリジル基、ピリダジニル基、ピリミジニル基、ピラジニル基、1,2,3-トリアジニル基及び1,2,4-トリアジニル基が挙げられる。 A halogen atom is a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
Examples of the C1-C6 alkyl group optionally having one or more halogen atoms include a methyl group, an ethyl group, a propyl group, an isopropyl group, a hexyl group, a fluoromethyl group, a trifluoromethyl group, a chlorodifluoromethyl group, Examples include 2-bromoethyl group, 1,1-difluoroethyl group, 2,2,2-trifluoroethyl group, and pentafluoroethyl group.
Examples of the C2-C6 alkenyl group which may have one or more halogen atoms include a vinyl group, an allyl group, a 3-methyl-2-butenyl group, a 2,2-dichlorovinyl group, and a 1,1-difluoroallyl group. Groups and pentafluoroallyl groups.
Examples of the C2-C6 alkynyl group which may have one or more halogen atoms include ethynyl group, 1-propynyl group, 2-propynyl group, chloroethynyl group, 1-bromo-2-hexynyl group and 1- ( A trifluoro) -2-butynyl group.
Examples of the C3-C6 cycloalkyl group optionally having one or more halogen atoms include a cyclopropyl group, a 1-fluorocyclopropyl group, a 2,2-dichlorocyclopropyl group, and a 3,3-dibromocyclobutyl group. And a cyclohexyl group.
The (C1-C6 alkoxy) C1-C6 alkyl group which may have one or more halogen atoms means that the C1-C6 alkoxy group which may have one or more halogen atoms has one or more halogen atoms Means a group bonded to an optionally substituted C1-C6 alkyl group, and examples thereof include a methoxymethyl group, an ethoxymethyl group, a 1- (trifluoromethoxy) ethyl group, and a 3-fluoro-6- (hexyloxy) hexyl group. It is done.
The (C3-C6 cycloalkyl) C1-C6 alkyl group which may have one or more halogen atoms is a C1-C6 cycloalkyl group which may have one or more halogen atoms. Means a group bonded to a C1-C6 alkyl group which may have, for example, cyclopropylmethyl group, 1-cyclopropylethyl group, 4- (2,2-difluorocyclopropyl) butyl group and 6-cyclohexyl-1 -Fluorohexyl group.
Examples of the C2-C6 alkanediyl group which may have one or more halogen atoms include ethane-1,2-diyl group, 2,2,3,3-tetrafluorobutane-1,4-diyl group, Examples include pentane-2,5-diyl group, 3- (trifluoromethyl) pentane-1,5-diyl group, and hexane-1,6-diyl group.
The 5- to 6-membered heteroaryl group means, for example, a 5- or 6-membered aromatic heterocyclic group containing up to 3 atoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom. Furyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1,2,4 -Oxadiazolyl group, 1,3,4-oxadiazolyl group, 1,2,5-oxadiazolyl group, 1,2,3-thiadiazolyl group, 1,2,4-thiadiazolyl group, 1,3,4-thiadiazolyl group, 1 , 2,5-thiadiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,2,3-triazinyl and 1,2,4- Riajiniru group, and the like.
1以上のハロゲン原子を有してもよいC1-C6アルキル基としては、例えば、メチル基、エチル基、プロピル基、イソプロピル基、ヘキシル基、フルオロメチル基、トリフルオロメチル基、クロロジフルオロメチル基、2-ブロモエチル基、1,1-ジフルオロエチル基、2,2,2-トリフルオロエチル基、及びペンタフルオロエチル基が挙げられる。
1以上のハロゲン原子を有してもよいC2-C6アルケニル基としては、例えば、ビニル基、アリル基、3-メチル-2-ブテニル基、2,2-ジクロロビニル基、1,1-ジフルオロアリル基及びペンタフルオロアリル基が挙げられる。
1以上のハロゲン原子を有してもよいC2-C6アルキニル基としては、例えば、エチニル基、1-プロピニル基、2-プロピニル基、クロロエチニル基、1-ブロモ-2-ヘキシニル基及び1-(トリフルオロ)-2-ブチニル基が挙げられる。
1以上のハロゲン原子を有してもよいC3-C6シクロアルキル基としては、例えば、シクロプロピル基、1-フルオロシクロプロピル基、2,2-ジクロロシクロプロピル基、3,3-ジブロモシクロブチル基及びシクロヘキシル基が挙げられる。
1以上のハロゲン原子を有してもよい(C1-C6アルコキシ)C1-C6アルキル基とは、1以上のハロゲン原子を有してもよいC1-C6アルコキシ基が1以上のハロゲン原子を有してもよいC1-C6アルキル基に結合した基を意味し、例えばメトキシメチル基、エトキシメチル基、1-(トリフルオロメトキシ)エチル基、及び3-フルオロ-6-(ヘキシルオキシ)ヘキシル基が挙げられる。
1以上のハロゲン原子を有してもよい(C3-C6シクロアルキル)C1-C6アルキル基とは、1以上のハロゲン原子を有してもよいC3-C6シクロアルキル基が1以上のハロゲン原子を有してもよいC1-C6アルキル基に結合した基を意味し、例えばシクロプロピルメチル基、1-シクロプロピルエチル基、4-(2,2-ジフルオロシクロプロピル)ブチル基及び6-シクロヘキシル-1-フルオロヘキシル基が挙げられる。
1以上のハロゲン原子を有してもよいC2-C6アルカンジイル基としては、例えば、エタン-1,2-ジイル基、2,2,3,3-テトラフルオロブタン-1,4-ジイル基、ペンタン-2,5-ジイル基、3-(トリフルオロメチル)ペンタン-1,5-ジイル基、及びヘキサン-1,6-ジイル基が挙げられる。
5~6員へテロアリール基とは、例えば、窒素原子、酸素原子及び硫黄原子からなる群より選ばれる原子を最大3つまで含有する5または6員の芳香族複素環基を意味し、例えば、フリル基、チエニル基、ピロリル基、ピラゾリル基、イミダゾリル基、1,2,3-トリアゾリル基、1,2,4-トリアゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、1,2,4-オキサジアゾリル基、1,3,4-オキサジアゾリル基、1,2,5-オキサジアゾリル基、1,2,3-チアジアゾリル基、1,2,4-チアジアゾリル基、1,3,4-チアジアゾリル基、1,2,5-チアジアゾリル基、ピリジル基、ピリダジニル基、ピリミジニル基、ピラジニル基、1,2,3-トリアジニル基及び1,2,4-トリアジニル基が挙げられる。 A halogen atom is a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
Examples of the C1-C6 alkyl group optionally having one or more halogen atoms include a methyl group, an ethyl group, a propyl group, an isopropyl group, a hexyl group, a fluoromethyl group, a trifluoromethyl group, a chlorodifluoromethyl group, Examples include 2-bromoethyl group, 1,1-difluoroethyl group, 2,2,2-trifluoroethyl group, and pentafluoroethyl group.
Examples of the C2-C6 alkenyl group which may have one or more halogen atoms include a vinyl group, an allyl group, a 3-methyl-2-butenyl group, a 2,2-dichlorovinyl group, and a 1,1-difluoroallyl group. Groups and pentafluoroallyl groups.
Examples of the C2-C6 alkynyl group which may have one or more halogen atoms include ethynyl group, 1-propynyl group, 2-propynyl group, chloroethynyl group, 1-bromo-2-hexynyl group and 1- ( A trifluoro) -2-butynyl group.
Examples of the C3-C6 cycloalkyl group optionally having one or more halogen atoms include a cyclopropyl group, a 1-fluorocyclopropyl group, a 2,2-dichlorocyclopropyl group, and a 3,3-dibromocyclobutyl group. And a cyclohexyl group.
The (C1-C6 alkoxy) C1-C6 alkyl group which may have one or more halogen atoms means that the C1-C6 alkoxy group which may have one or more halogen atoms has one or more halogen atoms Means a group bonded to an optionally substituted C1-C6 alkyl group, and examples thereof include a methoxymethyl group, an ethoxymethyl group, a 1- (trifluoromethoxy) ethyl group, and a 3-fluoro-6- (hexyloxy) hexyl group. It is done.
The (C3-C6 cycloalkyl) C1-C6 alkyl group which may have one or more halogen atoms is a C1-C6 cycloalkyl group which may have one or more halogen atoms. Means a group bonded to a C1-C6 alkyl group which may have, for example, cyclopropylmethyl group, 1-cyclopropylethyl group, 4- (2,2-difluorocyclopropyl) butyl group and 6-cyclohexyl-1 -Fluorohexyl group.
Examples of the C2-C6 alkanediyl group which may have one or more halogen atoms include ethane-1,2-diyl group, 2,2,3,3-tetrafluorobutane-1,4-diyl group, Examples include pentane-2,5-diyl group, 3- (trifluoromethyl) pentane-1,5-diyl group, and hexane-1,6-diyl group.
The 5- to 6-membered heteroaryl group means, for example, a 5- or 6-membered aromatic heterocyclic group containing up to 3 atoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom. Furyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1,2,4 -Oxadiazolyl group, 1,3,4-oxadiazolyl group, 1,2,5-oxadiazolyl group, 1,2,3-thiadiazolyl group, 1,2,4-thiadiazolyl group, 1,3,4-thiadiazolyl group, 1 , 2,5-thiadiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,2,3-triazinyl and 1,2,4- Riajiniru group, and the like.
本発明化合物としては、例えば、以下の化合物が挙げられる。
〔態様1〕式(I-a)
[式中、記号は前記と同じ意味を表す。]で示される化合物。
〔態様2〕態様1において、Aが窒素原子である化合物。
〔態様3〕態様2において、R1がC1-C4アルキル基であり、
R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基である化合物。
〔態様4〕態様3において、R4が水素原子、ハロゲン原子、又は1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。
〔態様5〕態様1において、AがCHである化合物。
〔態様6〕態様5において、R1がC1-C4アルキル基であり、
R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基である化合物。
〔態様7〕態様6において、R4が水素原子、ハロゲン原子、又は1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。
〔態様8〕式(I-b)
[式中、記号は前記と同じ意味を表す。]で示される化合物。
〔態様9〕態様8において、Aが窒素原子である化合物。
〔態様10〕態様9において、R1がC1-C4アルキル基であり、
R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基である化合物。
〔態様11〕態様10において、R4が水素原子、ハロゲン原子、又は1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。
〔態様12〕態様8において、AがCHである化合物。
〔態様13〕態様12において、R1がC1-C4アルキル基であり、
R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基である化合物。
〔態様14〕態様13において、R4が水素原子、ハロゲン原子、又は1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。 As this invention compound, the following compounds are mentioned, for example.
[Aspect 1] Formula (Ia)
[Wherein the symbols have the same meaning as described above. ] The compound shown.
[Aspect 2] A compound according to Aspect 1, wherein A is a nitrogen atom.
[Aspect 3] In aspect 2, R 1 is a C1-C4 alkyl group,
R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X A compound that is an aryl group.
[Aspect 4] A compound according to Aspect 3, wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
[Aspect 5] A compound according to Aspect 1, wherein A is CH.
[Aspect 6] In Aspect 5, R 1 is a C1-C4 alkyl group,
R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X A compound that is an aryl group.
[Aspect 7] A compound according to Aspect 6, wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
[Aspect 8] Formula (Ib)
[Wherein the symbols have the same meaning as described above. ] The compound shown.
[Aspect 9] A compound according to Aspect 8, wherein A is a nitrogen atom.
[Aspect 10] In Aspect 9, R 1 is a C1-C4 alkyl group,
R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X A compound that is an aryl group.
[Aspect 11] A compound according to Aspect 10, wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
[Aspect 12] A compound according to Aspect 8, wherein A is CH.
[Aspect 13] In aspect 12, R 1 is a C1-C4 alkyl group,
R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X A compound that is an aryl group.
[Aspect 14] A compound according to Aspect 13, wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
〔態様1〕式(I-a)
[式中、記号は前記と同じ意味を表す。]で示される化合物。
〔態様2〕態様1において、Aが窒素原子である化合物。
〔態様3〕態様2において、R1がC1-C4アルキル基であり、
R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基である化合物。
〔態様4〕態様3において、R4が水素原子、ハロゲン原子、又は1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。
〔態様5〕態様1において、AがCHである化合物。
〔態様6〕態様5において、R1がC1-C4アルキル基であり、
R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基である化合物。
〔態様7〕態様6において、R4が水素原子、ハロゲン原子、又は1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。
〔態様8〕式(I-b)
[式中、記号は前記と同じ意味を表す。]で示される化合物。
〔態様9〕態様8において、Aが窒素原子である化合物。
〔態様10〕態様9において、R1がC1-C4アルキル基であり、
R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基である化合物。
〔態様11〕態様10において、R4が水素原子、ハロゲン原子、又は1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。
〔態様12〕態様8において、AがCHである化合物。
〔態様13〕態様12において、R1がC1-C4アルキル基であり、
R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基である化合物。
〔態様14〕態様13において、R4が水素原子、ハロゲン原子、又は1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。 As this invention compound, the following compounds are mentioned, for example.
[Aspect 1] Formula (Ia)
[Wherein the symbols have the same meaning as described above. ] The compound shown.
[Aspect 2] A compound according to Aspect 1, wherein A is a nitrogen atom.
[Aspect 3] In aspect 2, R 1 is a C1-C4 alkyl group,
R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X A compound that is an aryl group.
[Aspect 4] A compound according to Aspect 3, wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
[Aspect 5] A compound according to Aspect 1, wherein A is CH.
[Aspect 6] In Aspect 5, R 1 is a C1-C4 alkyl group,
R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X A compound that is an aryl group.
[Aspect 7] A compound according to Aspect 6, wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
[Aspect 8] Formula (Ib)
[Wherein the symbols have the same meaning as described above. ] The compound shown.
[Aspect 9] A compound according to Aspect 8, wherein A is a nitrogen atom.
[Aspect 10] In Aspect 9, R 1 is a C1-C4 alkyl group,
R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X A compound that is an aryl group.
[Aspect 11] A compound according to Aspect 10, wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
[Aspect 12] A compound according to Aspect 8, wherein A is CH.
[Aspect 13] In aspect 12, R 1 is a C1-C4 alkyl group,
R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 5- to 6-membered hetero atom optionally having one or more atoms or substituents selected from group X A compound that is an aryl group.
[Aspect 14] A compound according to Aspect 13, wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
〔態様15-1〕本発明化合物において、RAが水素原子であり、RBが-OSO2CF3であり、Aが窒素原子であり、R1がC1-C4アルキル基であり、R2及びR3が水素原子であり、R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は1,2,4-トリアゾリル基である化合物。
〔態様15-2〕態様15-1において、R4が水素原子である化合物。 [Aspect 15-1] In the compound of the present invention, R A is a hydrogen atom, R B is —OSO 2 CF 3 , A is a nitrogen atom, R 1 is a C1-C4 alkyl group, R 2 And R 3 is a hydrogen atom, and R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group.
[Aspect 15-2] The compound according to Aspect 15-1, wherein R 4 is a hydrogen atom.
〔態様15-2〕態様15-1において、R4が水素原子である化合物。 [Aspect 15-1] In the compound of the present invention, R A is a hydrogen atom, R B is —OSO 2 CF 3 , A is a nitrogen atom, R 1 is a C1-C4 alkyl group, R 2 And R 3 is a hydrogen atom, and R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group.
[Aspect 15-2] The compound according to Aspect 15-1, wherein R 4 is a hydrogen atom.
〔態様16-1〕本発明化合物において、RAが-OSO2CF3であり、RBが水素原子であり、Aが窒素原子であり、R1がC1-C4アルキル基であり、R2及びR3が水素原子であり、R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は1,2,4-トリアゾリル基である化合物。
〔態様16-2〕態様16-1において、R4が水素原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は1,2,4-トリアゾリル基である化合物。 [Aspect 16-1] In the compound of the present invention, R A is —OSO 2 CF 3 , R B is a hydrogen atom, A is a nitrogen atom, R 1 is a C1-C4 alkyl group, and R 2 And R 3 is a hydrogen atom, and R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group.
[Aspect 16-2] A compound in which R 4 is a hydrogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group in Aspect 16-1.
〔態様16-2〕態様16-1において、R4が水素原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は1,2,4-トリアゾリル基である化合物。 [Aspect 16-1] In the compound of the present invention, R A is —OSO 2 CF 3 , R B is a hydrogen atom, A is a nitrogen atom, R 1 is a C1-C4 alkyl group, and R 2 And R 3 is a hydrogen atom, and R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group.
[Aspect 16-2] A compound in which R 4 is a hydrogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group in Aspect 16-1.
〔態様17-1〕本発明化合物において、RAが-OSO2CF3であり、RBが水素原子であり、AがCHであり、R1がC1-C4アルキル基であり、R2及びR3が水素原子であり、R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は1,2,4-トリアゾリル基である化合物。
〔態様17-2〕態様17-1において、R4が水素原子、ハロゲン原子、又は1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。 [Aspect 17-1] In the compound of the present invention, R A is —OSO 2 CF 3 , R B is a hydrogen atom, A is CH, R 1 is a C1-C4 alkyl group, R 2 and A compound in which R 3 is a hydrogen atom, and R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group.
[Aspect 17-2] A compound according to Aspect 17-1, wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
〔態様17-2〕態様17-1において、R4が水素原子、ハロゲン原子、又は1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。 [Aspect 17-1] In the compound of the present invention, R A is —OSO 2 CF 3 , R B is a hydrogen atom, A is CH, R 1 is a C1-C4 alkyl group, R 2 and A compound in which R 3 is a hydrogen atom, and R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or a 1,2,4-triazolyl group.
[Aspect 17-2] A compound according to Aspect 17-1, wherein R 4 is a hydrogen atom, a halogen atom, or a C1-C6 alkyl group optionally having one or more halogen atoms.
〔態様18〕態様2において、R4が水素原子である化合物。
〔態様19〕態様2において、R4がハロゲン原子である化合物。
〔態様20〕態様2において、R4が1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。
〔態様21〕態様9において、R4が水素原子である化合物。
〔態様22〕態様9において、R4が1,2,4-トリアゾリル基である化合物。
〔態様23〕本発明化合物において、R1がC1-C4アルキル基であり、R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は1,2,4-トリアゾリル基である化合物。
〔態様24〕本発明化合物において、R1がエチル基であり、R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は1,2,4-トリアゾリル基である化合物。 [Aspect 18] A compound according to Aspect 2, wherein R 4 is a hydrogen atom.
[Aspect 19] A compound according to Aspect 2, wherein R 4 is a halogen atom.
[Aspect 20] A compound according to Aspect 2, wherein R 4 is a C1-C6 alkyl group optionally having one or more halogen atoms.
[Aspect 21] The compound according to Aspect 9, wherein R 4 is a hydrogen atom.
[Aspect 22] The compound according to Aspect 9, wherein R 4 is a 1,2,4-triazolyl group.
[Aspect 23] In the compound of the present invention, R 1 is a C1-C4 alkyl group, R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or 1,2 , 4-triazolyl group.
[Aspect 24] In the compound of the present invention, R 1 is an ethyl group and R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or 1,2,4- A compound that is a triazolyl group.
〔態様19〕態様2において、R4がハロゲン原子である化合物。
〔態様20〕態様2において、R4が1以上のハロゲン原子を有してもよいC1-C6アルキル基である化合物。
〔態様21〕態様9において、R4が水素原子である化合物。
〔態様22〕態様9において、R4が1,2,4-トリアゾリル基である化合物。
〔態様23〕本発明化合物において、R1がC1-C4アルキル基であり、R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は1,2,4-トリアゾリル基である化合物。
〔態様24〕本発明化合物において、R1がエチル基であり、R4が水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C6アルキル基、又は1,2,4-トリアゾリル基である化合物。 [Aspect 18] A compound according to Aspect 2, wherein R 4 is a hydrogen atom.
[Aspect 19] A compound according to Aspect 2, wherein R 4 is a halogen atom.
[Aspect 20] A compound according to Aspect 2, wherein R 4 is a C1-C6 alkyl group optionally having one or more halogen atoms.
[Aspect 21] The compound according to Aspect 9, wherein R 4 is a hydrogen atom.
[Aspect 22] The compound according to Aspect 9, wherein R 4 is a 1,2,4-triazolyl group.
[Aspect 23] In the compound of the present invention, R 1 is a C1-C4 alkyl group, R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or 1,2 , 4-triazolyl group.
[Aspect 24] In the compound of the present invention, R 1 is an ethyl group and R 4 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group optionally having one or more halogen atoms, or 1,2,4- A compound that is a triazolyl group.
次に、本発明化合物の製造法について説明する。
Next, a method for producing the compound of the present invention will be described.
本発明化合物及び中間体化合物は、例えば以下の製造法1~5及び参考製造法1~4に記載の方法に準じて製造することができる。
The compound of the present invention and the intermediate compound can be produced, for example, according to the methods described in the following production methods 1 to 5 and reference production methods 1 to 4.
製造法1
本発明化合物のうち、式(I-n1)で示される化合物(以下、化合物(I-n1)と記す。)は、式(I-n0)で示される化合物(以下、化合物(I-n0)と記す。)を酸化することにより製造することができる。
[式中、記号は前記と同じ意味を表す。]
該反応は、通常溶媒中で行われる。溶媒としては、例えばジクロロメタン、クロロホルム、クロロベンゼン等のハロゲン化炭化水素類(以下、ハロゲン化炭化水素類と記す)、アセトニトリル等のニトリル類(以下、ニトリル類と記す)、メタノール、エタノール等のアルコール類(以下、アルコール類と記す)、酢酸エチル、酢酸ブチル等のエステル類(以下、エステル類と記す)、酢酸、水及びこれらの混合物が挙げられる。
酸化剤としては、例えば過酢酸、m-クロロ過安息香酸(以下、mCPBAと記す。)及び過酸化水素水が挙げられる。
酸化剤として過酸化水素を用いる場合は、必要に応じて塩基、又は触媒を加えてもよい。
反応に用いられる塩基としては、炭酸ナトリウム等が挙げられる。
反応に用いられる触媒としては、例えばタングステン酸、及びタングステン酸ナトリウムが挙げられる。
該反応は、化合物(I-n0)1モルに対して、酸化剤が通常1~1.2モルの割合で用いられる。
該反応は、化合物(I-n0)1モルに対して、塩基が通常0.01~1モル用いられる。
該反応は、化合物(I-n0)1モルに対して、触媒が通常0.01~0.5モル用いられる。
反応温度は、通常-50~50℃の範囲内である。反応時間は通常0.1~12時間の範囲内である。 Manufacturing method 1
Among the compounds of the present invention, a compound represented by the formula (Inn1) (hereinafter referred to as the compound (Inn1)) is a compound represented by the formula (Inn0) (hereinafter referred to as the compound (Inn0)). It can be produced by oxidizing.
[Wherein the symbols have the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent include halogenated hydrocarbons such as dichloromethane, chloroform and chlorobenzene (hereinafter referred to as halogenated hydrocarbons), nitriles such as acetonitrile (hereinafter referred to as nitriles), and alcohols such as methanol and ethanol. (Hereinafter referred to as alcohols), esters such as ethyl acetate and butyl acetate (hereinafter referred to as esters), acetic acid, water, and mixtures thereof.
Examples of the oxidizing agent include peracetic acid, m-chloroperbenzoic acid (hereinafter referred to as mCPBA), and aqueous hydrogen peroxide.
When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be added as necessary.
Examples of the base used for the reaction include sodium carbonate.
Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
In the reaction, with respect to 1 mol of compound (In0), the oxidizing agent is usually used at a ratio of 1 to 1.2 mol.
In the reaction, a base is usually used in an amount of 0.01 to 1 mol with respect to 1 mol of the compound (In0).
In the reaction, the catalyst is generally used in an amount of 0.01 to 0.5 mol per 1 mol of the compound (In0).
The reaction temperature is usually in the range of −50 to 50 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
本発明化合物のうち、式(I-n1)で示される化合物(以下、化合物(I-n1)と記す。)は、式(I-n0)で示される化合物(以下、化合物(I-n0)と記す。)を酸化することにより製造することができる。
[式中、記号は前記と同じ意味を表す。]
該反応は、通常溶媒中で行われる。溶媒としては、例えばジクロロメタン、クロロホルム、クロロベンゼン等のハロゲン化炭化水素類(以下、ハロゲン化炭化水素類と記す)、アセトニトリル等のニトリル類(以下、ニトリル類と記す)、メタノール、エタノール等のアルコール類(以下、アルコール類と記す)、酢酸エチル、酢酸ブチル等のエステル類(以下、エステル類と記す)、酢酸、水及びこれらの混合物が挙げられる。
酸化剤としては、例えば過酢酸、m-クロロ過安息香酸(以下、mCPBAと記す。)及び過酸化水素水が挙げられる。
酸化剤として過酸化水素を用いる場合は、必要に応じて塩基、又は触媒を加えてもよい。
反応に用いられる塩基としては、炭酸ナトリウム等が挙げられる。
反応に用いられる触媒としては、例えばタングステン酸、及びタングステン酸ナトリウムが挙げられる。
該反応は、化合物(I-n0)1モルに対して、酸化剤が通常1~1.2モルの割合で用いられる。
該反応は、化合物(I-n0)1モルに対して、塩基が通常0.01~1モル用いられる。
該反応は、化合物(I-n0)1モルに対して、触媒が通常0.01~0.5モル用いられる。
反応温度は、通常-50~50℃の範囲内である。反応時間は通常0.1~12時間の範囲内である。 Manufacturing method 1
Among the compounds of the present invention, a compound represented by the formula (Inn1) (hereinafter referred to as the compound (Inn1)) is a compound represented by the formula (Inn0) (hereinafter referred to as the compound (Inn0)). It can be produced by oxidizing.
[Wherein the symbols have the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent include halogenated hydrocarbons such as dichloromethane, chloroform and chlorobenzene (hereinafter referred to as halogenated hydrocarbons), nitriles such as acetonitrile (hereinafter referred to as nitriles), and alcohols such as methanol and ethanol. (Hereinafter referred to as alcohols), esters such as ethyl acetate and butyl acetate (hereinafter referred to as esters), acetic acid, water, and mixtures thereof.
Examples of the oxidizing agent include peracetic acid, m-chloroperbenzoic acid (hereinafter referred to as mCPBA), and aqueous hydrogen peroxide.
When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be added as necessary.
Examples of the base used for the reaction include sodium carbonate.
Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
In the reaction, with respect to 1 mol of compound (In0), the oxidizing agent is usually used at a ratio of 1 to 1.2 mol.
In the reaction, a base is usually used in an amount of 0.01 to 1 mol with respect to 1 mol of the compound (In0).
In the reaction, the catalyst is generally used in an amount of 0.01 to 0.5 mol per 1 mol of the compound (In0).
The reaction temperature is usually in the range of −50 to 50 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
製造法2
本発明化合物のうち、式(I-n2)で示される化合物(以下、化合物(I-n2)と記す。)は、式(I-n3)で示される化合物(以下、化合物(I-n3)と記す。)を酸化することにより製造することができる。
[式中、rは0又は1を表し、その他の記号は前記と同じ意味を表す。]
該反応は、化合物(I-n0)に代えて化合物(I-n3)を用い、酸化剤は化合物(I-n3)1モルに対してrが0の時は2~10モル、rが1の時は1~10モルを用い、製造法1に記載の方法に準じて化合物(I-n2)を得ることができる。 Manufacturing method 2
Among the compounds of the present invention, the compound represented by the formula (In2) (hereinafter referred to as the compound (In2)) is the compound represented by the formula (In3) (hereinafter referred to as the compound (In3)). It can be produced by oxidizing.
[Wherein, r represents 0 or 1 and other symbols have the same meaning as described above. ]
In this reaction, compound (In3) is used in place of compound (In0), and the oxidizing agent is 2 to 10 mol when r is 0 with respect to 1 mol of compound (In3), and r is 1 In this case, compound (In2) can be obtained according to the method described in Production Method 1 using 1 to 10 moles.
本発明化合物のうち、式(I-n2)で示される化合物(以下、化合物(I-n2)と記す。)は、式(I-n3)で示される化合物(以下、化合物(I-n3)と記す。)を酸化することにより製造することができる。
[式中、rは0又は1を表し、その他の記号は前記と同じ意味を表す。]
該反応は、化合物(I-n0)に代えて化合物(I-n3)を用い、酸化剤は化合物(I-n3)1モルに対してrが0の時は2~10モル、rが1の時は1~10モルを用い、製造法1に記載の方法に準じて化合物(I-n2)を得ることができる。 Manufacturing method 2
Among the compounds of the present invention, the compound represented by the formula (In2) (hereinafter referred to as the compound (In2)) is the compound represented by the formula (In3) (hereinafter referred to as the compound (In3)). It can be produced by oxidizing.
[Wherein, r represents 0 or 1 and other symbols have the same meaning as described above. ]
In this reaction, compound (In3) is used in place of compound (In0), and the oxidizing agent is 2 to 10 mol when r is 0 with respect to 1 mol of compound (In3), and r is 1 In this case, compound (In2) can be obtained according to the method described in Production Method 1 using 1 to 10 moles.
製造法3
本発明化合物は、式(M1)で示される化合物(以下、化合物(M1)と記す。)を脱水することにより製造することができる。
[式中、記号は前記と同じ意味を表す。]
該反応は、通常、溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば、1,4-ジオキサン、ジエチルエーテル、テトラヒドロフラン(以下、THFと記す。)、tert-ブチルメチルエーテル(以下、MTBEと記す。)等のエーテル類(以下、エーテル類と記す)、ハロゲン化炭化水素類、トルエン、ベンゼン、キシレン等の芳香族炭化水素類(以下、芳香族炭化水素類と記す)、エステル類、ニトリル類及びこれらの混合物が挙げられる。
該反応は、縮合剤又は酸を用いることができる。
反応に用いられる縮合剤としては、例えばトリフェニルホスフィン、トリエチルアミン、ピリジン等の有機塩基類(以下、有機塩基類と記す)及び四塩化炭素の混合物、トリフェニルホスフィンとアゾジカルボン酸ジエチル等のアゾジエステル類の混合物が挙げられる。
反応に用いられる酸としては、例えばパラトルエンスルホン酸等のスルホン酸類が挙げられる。
該反応は、化合物(M1)1モルに対して、縮合剤を用いる場合には縮合剤が通常1~5モルの割合、酸を用いる場合には酸が通常0.1モル~5モルの割合で用いられる。
該反応の反応温度は、通常、0~200℃の範囲である。該反応の反応時間は、通常、0.1~24時間の範囲である。 Production method 3
The compound of the present invention can be produced by dehydrating a compound represented by the formula (M1) (hereinafter referred to as compound (M1)).
[Wherein the symbols have the same meaning as described above. ]
The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran (hereinafter referred to as THF), tert-butyl methyl ether (hereinafter referred to as MTBE) (hereinafter referred to as ether). ), Halogenated hydrocarbons, aromatic hydrocarbons such as toluene, benzene, and xylene (hereinafter referred to as aromatic hydrocarbons), esters, nitriles, and mixtures thereof.
In the reaction, a condensing agent or an acid can be used.
Examples of the condensing agent used in the reaction include organic bases such as triphenylphosphine, triethylamine and pyridine (hereinafter referred to as organic bases) and a mixture of carbon tetrachloride, azodiesters such as triphenylphosphine and diethyl azodicarboxylate. A mixture of the like.
Examples of the acid used for the reaction include sulfonic acids such as paratoluenesulfonic acid.
In the reaction, with respect to 1 mol of the compound (M1), when a condensing agent is used, the condensing agent is usually in a proportion of 1 to 5 mol, and when an acid is used, the acid is usually in a proportion of 0.1 to 5 mol. Used in
The reaction temperature of the reaction is usually in the range of 0 to 200 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
本発明化合物は、式(M1)で示される化合物(以下、化合物(M1)と記す。)を脱水することにより製造することができる。
[式中、記号は前記と同じ意味を表す。]
該反応は、通常、溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば、1,4-ジオキサン、ジエチルエーテル、テトラヒドロフラン(以下、THFと記す。)、tert-ブチルメチルエーテル(以下、MTBEと記す。)等のエーテル類(以下、エーテル類と記す)、ハロゲン化炭化水素類、トルエン、ベンゼン、キシレン等の芳香族炭化水素類(以下、芳香族炭化水素類と記す)、エステル類、ニトリル類及びこれらの混合物が挙げられる。
該反応は、縮合剤又は酸を用いることができる。
反応に用いられる縮合剤としては、例えばトリフェニルホスフィン、トリエチルアミン、ピリジン等の有機塩基類(以下、有機塩基類と記す)及び四塩化炭素の混合物、トリフェニルホスフィンとアゾジカルボン酸ジエチル等のアゾジエステル類の混合物が挙げられる。
反応に用いられる酸としては、例えばパラトルエンスルホン酸等のスルホン酸類が挙げられる。
該反応は、化合物(M1)1モルに対して、縮合剤を用いる場合には縮合剤が通常1~5モルの割合、酸を用いる場合には酸が通常0.1モル~5モルの割合で用いられる。
該反応の反応温度は、通常、0~200℃の範囲である。該反応の反応時間は、通常、0.1~24時間の範囲である。 Production method 3
The compound of the present invention can be produced by dehydrating a compound represented by the formula (M1) (hereinafter referred to as compound (M1)).
[Wherein the symbols have the same meaning as described above. ]
The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran (hereinafter referred to as THF), tert-butyl methyl ether (hereinafter referred to as MTBE) (hereinafter referred to as ether). ), Halogenated hydrocarbons, aromatic hydrocarbons such as toluene, benzene, and xylene (hereinafter referred to as aromatic hydrocarbons), esters, nitriles, and mixtures thereof.
In the reaction, a condensing agent or an acid can be used.
Examples of the condensing agent used in the reaction include organic bases such as triphenylphosphine, triethylamine and pyridine (hereinafter referred to as organic bases) and a mixture of carbon tetrachloride, azodiesters such as triphenylphosphine and diethyl azodicarboxylate. A mixture of the like.
Examples of the acid used for the reaction include sulfonic acids such as paratoluenesulfonic acid.
In the reaction, with respect to 1 mol of the compound (M1), when a condensing agent is used, the condensing agent is usually in a proportion of 1 to 5 mol, and when an acid is used, the acid is usually in a proportion of 0.1 to 5 mol. Used in
The reaction temperature of the reaction is usually in the range of 0 to 200 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
製造法4
本発明化合物は、下記に示される方法により製造することができる。
[式中、記号は前記と同じ意味を表す。]
式(M23)で示される化合物(以下、化合物(M23)と記す。)は、式(M2)で示される化合物(以下、化合物(M2)と記す。)と式(M3)で示される化合物(以下、化合物(M3)と記す。)とを反応させることにより製造することができる。
該反応は、通常、溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば芳香族炭化水素類が挙げられる。
該反応は、化合物(M2)1モルに対して、化合物(M3)が通常1~1.2モルの割合で用いられる。
該反応の反応温度は、通常50~150℃の範囲であり、反応時間は通常0.1~24時間の範囲である。
化合物(M3)は、国際公開第2012/086848号又は国際公開第2013/018928号に記載の方法に準じて製造することができる。 Manufacturing method 4
The compound of the present invention can be produced by the method shown below.
[Wherein the symbols have the same meaning as described above. ]
A compound represented by formula (M23) (hereinafter referred to as compound (M23)) is a compound represented by formula (M2) (hereinafter referred to as compound (M2)) and a compound represented by formula (M3) ( Hereinafter, it can be produced by reacting with compound (M3).
The reaction is usually performed in the presence of a solvent. Examples of the solvent used for the reaction include aromatic hydrocarbons.
In the reaction, compound (M3) is usually used at a ratio of 1 to 1.2 mol with respect to 1 mol of compound (M2).
The reaction temperature of the reaction is usually in the range of 50 to 150 ° C., and the reaction time is usually in the range of 0.1 to 24 hours.
Compound (M3) can be produced according to the method described in International Publication No. 2012/0886848 or International Publication No. 2013/018928.
本発明化合物は、下記に示される方法により製造することができる。
[式中、記号は前記と同じ意味を表す。]
式(M23)で示される化合物(以下、化合物(M23)と記す。)は、式(M2)で示される化合物(以下、化合物(M2)と記す。)と式(M3)で示される化合物(以下、化合物(M3)と記す。)とを反応させることにより製造することができる。
該反応は、通常、溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば芳香族炭化水素類が挙げられる。
該反応は、化合物(M2)1モルに対して、化合物(M3)が通常1~1.2モルの割合で用いられる。
該反応の反応温度は、通常50~150℃の範囲であり、反応時間は通常0.1~24時間の範囲である。
化合物(M3)は、国際公開第2012/086848号又は国際公開第2013/018928号に記載の方法に準じて製造することができる。 Manufacturing method 4
The compound of the present invention can be produced by the method shown below.
[Wherein the symbols have the same meaning as described above. ]
A compound represented by formula (M23) (hereinafter referred to as compound (M23)) is a compound represented by formula (M2) (hereinafter referred to as compound (M2)) and a compound represented by formula (M3) ( Hereinafter, it can be produced by reacting with compound (M3).
The reaction is usually performed in the presence of a solvent. Examples of the solvent used for the reaction include aromatic hydrocarbons.
In the reaction, compound (M3) is usually used at a ratio of 1 to 1.2 mol with respect to 1 mol of compound (M2).
The reaction temperature of the reaction is usually in the range of 50 to 150 ° C., and the reaction time is usually in the range of 0.1 to 24 hours.
Compound (M3) can be produced according to the method described in International Publication No. 2012/0886848 or International Publication No. 2013/018928.
本発明化合物は、化合物(M23)と酸化剤とを反応させることにより製造することができる。
該反応は、通常、溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば芳香族炭化水素類が挙げられる。
反応に用いられる酸化剤としては、ヨウ素が挙げられる。
該反応は、化合物(M23)1モルに対して、酸化剤が通常2~5モルの割合で用いられる。
該反応の反応温度は、通常50~150℃の範囲であり、反応時間は通常0.1~24時間の範囲である。
本発明化合物は、化合物(23)を単離せずに化合物(M2)からワンポットで製造することができる。 The compound of the present invention can be produced by reacting the compound (M23) with an oxidizing agent.
The reaction is usually performed in the presence of a solvent. Examples of the solvent used for the reaction include aromatic hydrocarbons.
An example of the oxidizing agent used in the reaction is iodine.
In the reaction, with respect to 1 mol of the compound (M23), the oxidizing agent is usually used in a ratio of 2 to 5 mol.
The reaction temperature of the reaction is usually in the range of 50 to 150 ° C., and the reaction time is usually in the range of 0.1 to 24 hours.
The compound of the present invention can be produced in one pot from the compound (M2) without isolating the compound (23).
該反応は、通常、溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば芳香族炭化水素類が挙げられる。
反応に用いられる酸化剤としては、ヨウ素が挙げられる。
該反応は、化合物(M23)1モルに対して、酸化剤が通常2~5モルの割合で用いられる。
該反応の反応温度は、通常50~150℃の範囲であり、反応時間は通常0.1~24時間の範囲である。
本発明化合物は、化合物(23)を単離せずに化合物(M2)からワンポットで製造することができる。 The compound of the present invention can be produced by reacting the compound (M23) with an oxidizing agent.
The reaction is usually performed in the presence of a solvent. Examples of the solvent used for the reaction include aromatic hydrocarbons.
An example of the oxidizing agent used in the reaction is iodine.
In the reaction, with respect to 1 mol of the compound (M23), the oxidizing agent is usually used in a ratio of 2 to 5 mol.
The reaction temperature of the reaction is usually in the range of 50 to 150 ° C., and the reaction time is usually in the range of 0.1 to 24 hours.
The compound of the present invention can be produced in one pot from the compound (M2) without isolating the compound (23).
製造法5
本発明化合物は、式(M4)で示される化合物(以下、化合物(M4)と記す。)とトリフルオロメタンスルホン酸無水物又は塩化トリフルオロメタンスルホニルとを塩基の存在下で反応させることにより製造することができる。
[式中、RD及びREの一方は水酸基を表し、他方は水素原子を表し、その他の記号は前記と同じ意味を表す。]
該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えばエーテル類、ヘキサン、ヘプタン等の脂肪族炭化水素類(以下、脂肪族炭化水素類と記す)、芳香族炭化水素類、ハロゲン化炭化水素類、エステル類、ニトリル類、非プロトン性極性溶媒及びこれらの混合物が挙げられる。
反応に用いられる塩基としては、有機塩基類が挙げられる。
該反応は、化合物(M4)1モルに対して、トリフルオロメタンスルホン酸無水物又は塩化トリフルオロメタンスルホン酸が通常0.8~1.5モルの割合、塩基が通常0.8~1.5モルの割合で用いられる。
該反応の反応温度は、通常-78~50℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。 Manufacturing method 5
The compound of the present invention is produced by reacting a compound represented by the formula (M4) (hereinafter referred to as compound (M4)) with trifluoromethanesulfonic anhydride or trifluoromethanesulfonyl chloride in the presence of a base. Can do.
[Wherein, one of R D and R E represents a hydroxyl group, the other represents a hydrogen atom, and the other symbols represent the same meaning as described above. ]
The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic hydrocarbons such as ethers, hexane and heptane (hereinafter referred to as aliphatic hydrocarbons), aromatic hydrocarbons, halogenated hydrocarbons, esters, and nitriles. , Aprotic polar solvents and mixtures thereof.
Examples of the base used for the reaction include organic bases.
The reaction is carried out at a ratio of usually 0.8 to 1.5 mol of trifluoromethanesulfonic anhydride or trifluoromethanesulfonic acid chloride and usually 0.8 to 1.5 mol of base with respect to 1 mol of compound (M4). It is used in the ratio.
The reaction temperature is usually in the range of −78 to 50 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
本発明化合物は、式(M4)で示される化合物(以下、化合物(M4)と記す。)とトリフルオロメタンスルホン酸無水物又は塩化トリフルオロメタンスルホニルとを塩基の存在下で反応させることにより製造することができる。
[式中、RD及びREの一方は水酸基を表し、他方は水素原子を表し、その他の記号は前記と同じ意味を表す。]
該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えばエーテル類、ヘキサン、ヘプタン等の脂肪族炭化水素類(以下、脂肪族炭化水素類と記す)、芳香族炭化水素類、ハロゲン化炭化水素類、エステル類、ニトリル類、非プロトン性極性溶媒及びこれらの混合物が挙げられる。
反応に用いられる塩基としては、有機塩基類が挙げられる。
該反応は、化合物(M4)1モルに対して、トリフルオロメタンスルホン酸無水物又は塩化トリフルオロメタンスルホン酸が通常0.8~1.5モルの割合、塩基が通常0.8~1.5モルの割合で用いられる。
該反応の反応温度は、通常-78~50℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。 Manufacturing method 5
The compound of the present invention is produced by reacting a compound represented by the formula (M4) (hereinafter referred to as compound (M4)) with trifluoromethanesulfonic anhydride or trifluoromethanesulfonyl chloride in the presence of a base. Can do.
[Wherein, one of R D and R E represents a hydroxyl group, the other represents a hydrogen atom, and the other symbols represent the same meaning as described above. ]
The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic hydrocarbons such as ethers, hexane and heptane (hereinafter referred to as aliphatic hydrocarbons), aromatic hydrocarbons, halogenated hydrocarbons, esters, and nitriles. , Aprotic polar solvents and mixtures thereof.
Examples of the base used for the reaction include organic bases.
The reaction is carried out at a ratio of usually 0.8 to 1.5 mol of trifluoromethanesulfonic anhydride or trifluoromethanesulfonic acid chloride and usually 0.8 to 1.5 mol of base with respect to 1 mol of compound (M4). It is used in the ratio.
The reaction temperature is usually in the range of −78 to 50 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
参考製造法1
化合物(M1)は、化合物(M2)と式(M5)で示される化合物(以下、化合物(M5)と記す。)とを反応させることにより製造することができる。
[式中、Xは水酸基又は塩素原子を表し、その他の記号は前記と同じ意味を表す。]
該反応は、国際公開第2013/018928号に記載の方法に準じて実施することができる。
化合物(M5)は、国際公開第2012/086848号又は国際公開第2013/018928号に記載の方法に準じて製造することができる。 Reference manufacturing method 1
Compound (M1) can be produced by reacting compound (M2) with a compound represented by formula (M5) (hereinafter referred to as compound (M5)).
[Wherein, X represents a hydroxyl group or a chlorine atom, and other symbols have the same meaning as described above. ]
This reaction can be carried out according to the method described in International Publication No. 2013/018928.
Compound (M5) can be produced according to the method described in International Publication No. 2012/088684 or International Publication No. 2013/018928.
化合物(M1)は、化合物(M2)と式(M5)で示される化合物(以下、化合物(M5)と記す。)とを反応させることにより製造することができる。
[式中、Xは水酸基又は塩素原子を表し、その他の記号は前記と同じ意味を表す。]
該反応は、国際公開第2013/018928号に記載の方法に準じて実施することができる。
化合物(M5)は、国際公開第2012/086848号又は国際公開第2013/018928号に記載の方法に準じて製造することができる。 Reference manufacturing method 1
Compound (M1) can be produced by reacting compound (M2) with a compound represented by formula (M5) (hereinafter referred to as compound (M5)).
[Wherein, X represents a hydroxyl group or a chlorine atom, and other symbols have the same meaning as described above. ]
This reaction can be carried out according to the method described in International Publication No. 2013/018928.
Compound (M5) can be produced according to the method described in International Publication No. 2012/088684 or International Publication No. 2013/018928.
参考製造法2
化合物(M2)は、下記に示される方法により製造することができる。
[式中、記号は前記と同じ意味を表す。]
式(M6)で示される化合物から式(M7)で示される化合物(以下、化合物(M7)と記す。)を製造する工程は、製造法5に記載の方法に準じて実施することができる。塩基は反応終了後に加えることが好ましい。
化合物(M7)をニトロ化して式(M8)で示される化合物(以下、化合物(M8)と記す。)を製造する工程は、国際公開第2013/018928号に記載の方法に準じて実施することができる。
化合物(M8)を還元して化合物(M2)を製造する工程は、新実験化学講座15酸化と還元[II](丸善)に記載されている金属鉄を還元試薬として用いる方法、またはそれに準じる方法により実施することができる。 Reference production method 2
Compound (M2) can be produced by the method shown below.
[Wherein the symbols have the same meaning as described above. ]
The step of producing a compound represented by formula (M7) (hereinafter referred to as compound (M7)) from a compound represented by formula (M6) can be carried out according to the method described in Production Method 5. The base is preferably added after completion of the reaction.
The step of producing a compound represented by formula (M8) by nitrating compound (M7) (hereinafter referred to as compound (M8)) should be carried out according to the method described in International Publication No. 2013/018928. Can do.
The step of producing compound (M2) by reducing compound (M8) is a method of using metallic iron described in New Experimental Chemistry Course 15 Oxidation and Reduction [II] (Maruzen) as a reducing reagent, or a method analogous thereto Can be implemented.
化合物(M2)は、下記に示される方法により製造することができる。
[式中、記号は前記と同じ意味を表す。]
式(M6)で示される化合物から式(M7)で示される化合物(以下、化合物(M7)と記す。)を製造する工程は、製造法5に記載の方法に準じて実施することができる。塩基は反応終了後に加えることが好ましい。
化合物(M7)をニトロ化して式(M8)で示される化合物(以下、化合物(M8)と記す。)を製造する工程は、国際公開第2013/018928号に記載の方法に準じて実施することができる。
化合物(M8)を還元して化合物(M2)を製造する工程は、新実験化学講座15酸化と還元[II](丸善)に記載されている金属鉄を還元試薬として用いる方法、またはそれに準じる方法により実施することができる。 Reference production method 2
Compound (M2) can be produced by the method shown below.
[Wherein the symbols have the same meaning as described above. ]
The step of producing a compound represented by formula (M7) (hereinafter referred to as compound (M7)) from a compound represented by formula (M6) can be carried out according to the method described in Production Method 5. The base is preferably added after completion of the reaction.
The step of producing a compound represented by formula (M8) by nitrating compound (M7) (hereinafter referred to as compound (M8)) should be carried out according to the method described in International Publication No. 2013/018928. Can do.
The step of producing compound (M2) by reducing compound (M8) is a method of using metallic iron described in New Experimental Chemistry Course 15 Oxidation and Reduction [II] (Maruzen) as a reducing reagent, or a method analogous thereto Can be implemented.
参考製造法3
化合物(M4)は、式(M9)で示される化合物(以下、化合物(M9)と記す。)とヨードトリメチルシランとを反応させることにより製造することができる。
[式中、RF及びRGの一方はメトキシ基を表し、他方は水素原子を表し、その他の記号は前記と同じ意味を表す。]
該反応は、通常、溶媒の存在下で行われる。反応に用いられる溶媒としては、ニトリル類が挙げられる。
該反応に用いられるヨードトリメチルシランの代わりに、クロロトリメチルシラン及びヨウ化ナトリウムの混合物を用いることもできる。
該反応は、化合物(M9)1モルに対して、ヨードトリメチルシランが通常1~10モルの割合、クロロトリメチルシランが通常1~10モルの割合、ヨウ化ナトリウムが通常1~10モルの割合で用いられる。
該反応の反応温度は、通常、20~100℃の範囲である。該反応の反応時間は、通常、1~48時間の範囲である。 Reference manufacturing method 3
Compound (M4) can be produced by reacting a compound represented by formula (M9) (hereinafter referred to as compound (M9)) with iodotrimethylsilane.
[Wherein, one of R F and R G represents a methoxy group, the other represents a hydrogen atom, and the other symbols represent the same meaning as described above. ]
The reaction is usually performed in the presence of a solvent. Nitriles are mentioned as a solvent used for reaction.
Instead of iodotrimethylsilane used in the reaction, a mixture of chlorotrimethylsilane and sodium iodide can also be used.
The reaction is carried out at a ratio of usually 1 to 10 moles of iodotrimethylsilane, usually 1 to 10 moles of chlorotrimethylsilane, and usually 1 to 10 moles of sodium iodide with respect to 1 mole of compound (M9). Used.
The reaction temperature of the reaction is usually in the range of 20 to 100 ° C. The reaction time is usually in the range of 1 to 48 hours.
化合物(M4)は、式(M9)で示される化合物(以下、化合物(M9)と記す。)とヨードトリメチルシランとを反応させることにより製造することができる。
[式中、RF及びRGの一方はメトキシ基を表し、他方は水素原子を表し、その他の記号は前記と同じ意味を表す。]
該反応は、通常、溶媒の存在下で行われる。反応に用いられる溶媒としては、ニトリル類が挙げられる。
該反応に用いられるヨードトリメチルシランの代わりに、クロロトリメチルシラン及びヨウ化ナトリウムの混合物を用いることもできる。
該反応は、化合物(M9)1モルに対して、ヨードトリメチルシランが通常1~10モルの割合、クロロトリメチルシランが通常1~10モルの割合、ヨウ化ナトリウムが通常1~10モルの割合で用いられる。
該反応の反応温度は、通常、20~100℃の範囲である。該反応の反応時間は、通常、1~48時間の範囲である。 Reference manufacturing method 3
Compound (M4) can be produced by reacting a compound represented by formula (M9) (hereinafter referred to as compound (M9)) with iodotrimethylsilane.
[Wherein, one of R F and R G represents a methoxy group, the other represents a hydrogen atom, and the other symbols represent the same meaning as described above. ]
The reaction is usually performed in the presence of a solvent. Nitriles are mentioned as a solvent used for reaction.
Instead of iodotrimethylsilane used in the reaction, a mixture of chlorotrimethylsilane and sodium iodide can also be used.
The reaction is carried out at a ratio of usually 1 to 10 moles of iodotrimethylsilane, usually 1 to 10 moles of chlorotrimethylsilane, and usually 1 to 10 moles of sodium iodide with respect to 1 mole of compound (M9). Used.
The reaction temperature of the reaction is usually in the range of 20 to 100 ° C. The reaction time is usually in the range of 1 to 48 hours.
参考製造法4
化合物(M9)は、下記に示される方法により製造することができる。
[式中、記号は前記と同じ意味を表す。]
式(M10)で示される化合物と化合物(M5)とを反応させて式(M11)で示される化合物(以下、化合物(M11)と記す)を製造する工程は、参考製造法1に記載の方法に準じて実施することができる。化合物(M11)を縮合剤又は酸と反応させて化合物(M9)を製造する工程は、製造法3に記載の方法に準じて実施することができる。
式(M10)で示される化合物は公知物であるか、公知の方法により製造することができる。 Reference production method 4
Compound (M9) can be produced by the method shown below.
[Wherein the symbols have the same meaning as described above. ]
The step of producing a compound represented by the formula (M11) by reacting the compound represented by the formula (M10) with the compound (M5) (hereinafter referred to as the compound (M11)) is the method described in Reference Production Method 1. It can implement according to. The step of producing compound (M9) by reacting compound (M11) with a condensing agent or acid can be carried out according to the method described in Production Method 3.
The compound represented by the formula (M10) is a known product or can be produced by a known method.
化合物(M9)は、下記に示される方法により製造することができる。
[式中、記号は前記と同じ意味を表す。]
式(M10)で示される化合物と化合物(M5)とを反応させて式(M11)で示される化合物(以下、化合物(M11)と記す)を製造する工程は、参考製造法1に記載の方法に準じて実施することができる。化合物(M11)を縮合剤又は酸と反応させて化合物(M9)を製造する工程は、製造法3に記載の方法に準じて実施することができる。
式(M10)で示される化合物は公知物であるか、公知の方法により製造することができる。 Reference production method 4
Compound (M9) can be produced by the method shown below.
[Wherein the symbols have the same meaning as described above. ]
The step of producing a compound represented by the formula (M11) by reacting the compound represented by the formula (M10) with the compound (M5) (hereinafter referred to as the compound (M11)) is the method described in Reference Production Method 1. It can implement according to. The step of producing compound (M9) by reacting compound (M11) with a condensing agent or acid can be carried out according to the method described in Production Method 3.
The compound represented by the formula (M10) is a known product or can be produced by a known method.
上記の製造法1~5及び参考製造法1~4の反応終了後は、反応混合物を水に注加してから有機溶媒で抽出し、有機層を濃縮する;反応混合物を水に注加して生じた固体を濾過により集める;又は、反応混合物中に生成した固体を濾過により集める等の後処理操作を行うことにより、本発明化合物、化合物(M1)、化合物(M7)、化合物(M8)、化合物(M2)、化合物(M4)、化合物(M11)又は化合物(M9)を単離することができる。単離された本発明化合物、化合物(M1)、化合物(M7)、化合物(M8)、化合物(M2)、化合物(M4)、化合物(M11)又は化合物(M9)は、再結晶、クロマトグラフィ-等により更に精製することもできる。
After completion of the reactions of the above production methods 1 to 5 and reference production methods 1 to 4, the reaction mixture is poured into water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is poured into water. The resulting solid is collected by filtration; or by performing post-treatment operations such as collecting the solid produced in the reaction mixture by filtration, the compound of the present invention, compound (M1), compound (M7), compound (M8) , Compound (M2), Compound (M4), Compound (M11) or Compound (M9) can be isolated. The isolated compound of the present invention, compound (M1), compound (M7), compound (M8), compound (M2), compound (M4), compound (M11) or compound (M9) is recrystallized, chromatographed, etc. Can be further purified by
上記の製造法1~5に記載の方法に準じて製造できる本発明化合物の具体例を以下に示す。
尚、本明細書において、Meはメチル基を、Trは1,2,4-トリアゾール-1-イル基を、Pzはピラゾール-1-イル基を、夫々意味する。
1)下記式(A)
で示される化合物において、A、R4及びnが、リスト1に記載のいずれかである化合物。 Specific examples of the compound of the present invention that can be produced according to the methods described in the above production methods 1 to 5 are shown below.
In this specification, Me means a methyl group, Tr means a 1,2,4-triazol-1-yl group, and Pz means a pyrazol-1-yl group.
1) The following formula (A)
A compound in which A, R 4 and n are any one of those listed in List 1.
尚、本明細書において、Meはメチル基を、Trは1,2,4-トリアゾール-1-イル基を、Pzはピラゾール-1-イル基を、夫々意味する。
1)下記式(A)
で示される化合物において、A、R4及びnが、リスト1に記載のいずれかである化合物。 Specific examples of the compound of the present invention that can be produced according to the methods described in the above production methods 1 to 5 are shown below.
In this specification, Me means a methyl group, Tr means a 1,2,4-triazol-1-yl group, and Pz means a pyrazol-1-yl group.
1) The following formula (A)
A compound in which A, R 4 and n are any one of those listed in List 1.
リスト1:
〔A; R4; n〕=〔CH; H; 0〕,〔CH; H; 1〕,〔CH; H; 2〕,〔CH; F; 0〕,〔CH; F; 1〕,〔CH; F; 2〕,〔CH; Cl; 0〕,〔CH; Cl; 1〕,〔CH; Cl; 2〕,〔CH; Br; 0〕,〔CH; Br; 1〕,〔CH; Br; 2〕,〔CH; Me; 0〕,〔CH; Me; 1〕,〔CH; Me; 2〕,〔CH; CF3; 0〕,〔CH; CF3; 1〕,〔CH; CF3; 2〕,〔CH; CF2CF3; 0〕,〔CH; CF2CF3; 1〕,〔CH; CF2CF3; 2〕,〔CH; OMe; 0〕,〔CH; OMe; 1〕,〔CH; OMe; 2〕,〔CH; OCF3; 0〕,〔CH; OCF3; 1〕,〔CH; OCF3; 2〕,〔CH; SCF3; 0〕,〔CH; SCF3; 1〕,〔CH; SCF3; 2〕,〔CH; S(O)CF3; 0〕,〔CH; S(O)CF3; 1〕,〔CH; S(O)CF3; 2〕,〔CH; S(O)2CF3; 0〕,〔CH; S(O)2CF3; 1〕,〔CH; S(O)2CF3; 2〕,〔N; H; 0〕,〔N; H; 1〕,〔N; H; 2〕,〔N; F; 0〕,〔N; F; 1〕,〔N; F; 2〕,〔N; Cl; 0〕,〔N; Cl; 1〕,〔N; Cl; 2〕,〔N; Br; 0〕,〔N; Br; 1〕,〔N; Br; 2〕,〔N; Me; 0〕,〔N; Me; 1〕,〔N; Me; 2〕,〔N; CF3; 0〕,〔N; CF3; 1〕,〔N; CF3; 2〕,〔N; CF2CF3; 0〕,〔N; CF2CF3; 1〕,〔N; CF2CF3; 2〕,〔N; OMe; 0〕,〔N; OMe; 1〕,〔N; OMe; 2〕 Listing 1:
[A; R 4 ; n] = [CH; H; 0], [CH; H; 1], [CH; H; 2], [CH; F; 0], [CH; F; 1], [ CH; F; 2], [CH; Cl; 0], [CH; Cl; 1], [CH; Cl; 2], [CH; Br; 0], [CH; Br; 1], [CH; Br; 2], [CH; Me; 0], [CH; Me; 1], [CH; Me; 2], [CH; CF 3 ; 0], [CH; CF 3 ; 1], [CH; CF 3 ; 2], [CH; CF 2 CF 3 ; 0], [CH; CF 2 CF 3 ; 1], [CH; CF 2 CF 3 ; 2], [CH; OMe; 0], [CH; OMe; 1], [CH; OMe; 2], [CH; OCF 3 ; 0], [CH; OCF 3 ; 1], [CH; OCF 3 ; 2], [CH; SCF 3 ; 0], [ CH; SCF 3 ; 1], [CH; SCF 3 ; 2], [CH; S (O) CF 3 ; 0], [CH; S (O) CF 3 ; 1], [CH; S (O) CF 3 ; 2], [CH; S (O) 2 CF 3 ; 0], [CH; S (O) 2 CF 3 ; 1], [CH; S (O) 2 CF 3 ; 2], [N ; H; 0], [N; H; 1], [N; H; 2], [N; F; 0], [N; F; 1], [N; F; 2], [N; Cl 0], [N; Cl; 1], [N; Cl; 2], [N; Br; 0], [N; Br; 1], [N; Br; 2], [N; Me; 0 ], [N; Me; 1] [N; Me; 2], [N; CF 3; 0], [N; CF 3; 1), (N; CF 3; 2), (N; CF 2 CF 3; 0], [N; CF 2 CF 3 ; 1], [N; CF 2 CF 3 ; 2], [N; OMe; 0], [N; OMe; 1], [N; OMe; 2]
〔A; R4; n〕=〔CH; H; 0〕,〔CH; H; 1〕,〔CH; H; 2〕,〔CH; F; 0〕,〔CH; F; 1〕,〔CH; F; 2〕,〔CH; Cl; 0〕,〔CH; Cl; 1〕,〔CH; Cl; 2〕,〔CH; Br; 0〕,〔CH; Br; 1〕,〔CH; Br; 2〕,〔CH; Me; 0〕,〔CH; Me; 1〕,〔CH; Me; 2〕,〔CH; CF3; 0〕,〔CH; CF3; 1〕,〔CH; CF3; 2〕,〔CH; CF2CF3; 0〕,〔CH; CF2CF3; 1〕,〔CH; CF2CF3; 2〕,〔CH; OMe; 0〕,〔CH; OMe; 1〕,〔CH; OMe; 2〕,〔CH; OCF3; 0〕,〔CH; OCF3; 1〕,〔CH; OCF3; 2〕,〔CH; SCF3; 0〕,〔CH; SCF3; 1〕,〔CH; SCF3; 2〕,〔CH; S(O)CF3; 0〕,〔CH; S(O)CF3; 1〕,〔CH; S(O)CF3; 2〕,〔CH; S(O)2CF3; 0〕,〔CH; S(O)2CF3; 1〕,〔CH; S(O)2CF3; 2〕,〔N; H; 0〕,〔N; H; 1〕,〔N; H; 2〕,〔N; F; 0〕,〔N; F; 1〕,〔N; F; 2〕,〔N; Cl; 0〕,〔N; Cl; 1〕,〔N; Cl; 2〕,〔N; Br; 0〕,〔N; Br; 1〕,〔N; Br; 2〕,〔N; Me; 0〕,〔N; Me; 1〕,〔N; Me; 2〕,〔N; CF3; 0〕,〔N; CF3; 1〕,〔N; CF3; 2〕,〔N; CF2CF3; 0〕,〔N; CF2CF3; 1〕,〔N; CF2CF3; 2〕,〔N; OMe; 0〕,〔N; OMe; 1〕,〔N; OMe; 2〕 Listing 1:
[A; R 4 ; n] = [CH; H; 0], [CH; H; 1], [CH; H; 2], [CH; F; 0], [CH; F; 1], [ CH; F; 2], [CH; Cl; 0], [CH; Cl; 1], [CH; Cl; 2], [CH; Br; 0], [CH; Br; 1], [CH; Br; 2], [CH; Me; 0], [CH; Me; 1], [CH; Me; 2], [CH; CF 3 ; 0], [CH; CF 3 ; 1], [CH; CF 3 ; 2], [CH; CF 2 CF 3 ; 0], [CH; CF 2 CF 3 ; 1], [CH; CF 2 CF 3 ; 2], [CH; OMe; 0], [CH; OMe; 1], [CH; OMe; 2], [CH; OCF 3 ; 0], [CH; OCF 3 ; 1], [CH; OCF 3 ; 2], [CH; SCF 3 ; 0], [ CH; SCF 3 ; 1], [CH; SCF 3 ; 2], [CH; S (O) CF 3 ; 0], [CH; S (O) CF 3 ; 1], [CH; S (O) CF 3 ; 2], [CH; S (O) 2 CF 3 ; 0], [CH; S (O) 2 CF 3 ; 1], [CH; S (O) 2 CF 3 ; 2], [N ; H; 0], [N; H; 1], [N; H; 2], [N; F; 0], [N; F; 1], [N; F; 2], [N; Cl 0], [N; Cl; 1], [N; Cl; 2], [N; Br; 0], [N; Br; 1], [N; Br; 2], [N; Me; 0 ], [N; Me; 1] [N; Me; 2], [N; CF 3; 0], [N; CF 3; 1), (N; CF 3; 2), (N; CF 2 CF 3; 0], [N; CF 2 CF 3 ; 1], [N; CF 2 CF 3 ; 2], [N; OMe; 0], [N; OMe; 1], [N; OMe; 2]
2)下記式(B)
で示される化合物において、A、R4及びnが、リスト1に記載のいずれかである化合物。 2) The following formula (B)
A compound in which A, R 4 and n are any one of those listed in List 1.
で示される化合物において、A、R4及びnが、リスト1に記載のいずれかである化合物。 2) The following formula (B)
A compound in which A, R 4 and n are any one of those listed in List 1.
3)下記式(C)
で示される化合物において、A、R4及びnが、リスト2に記載のいずれかである化合物。 3) The following formula (C)
A compound in which A, R 4 and n are any one of those listed in List 2.
で示される化合物において、A、R4及びnが、リスト2に記載のいずれかである化合物。 3) The following formula (C)
A compound in which A, R 4 and n are any one of those listed in List 2.
リスト2:
〔A; R4; n〕=〔CH; F; 0〕,〔CH; F; 1〕,〔CH; F; 2〕,〔CH; Cl; 0〕,〔CH; Cl; 1〕,〔CH; Cl; 2〕,〔CH; Br; 0〕,〔CH; Br; 1〕,〔CH; Br; 2〕,〔CH; Me; 0〕,〔CH; Me; 1〕,〔CH; Me; 2〕,〔CH; CF3; 0〕,〔CH; CF3; 1〕,〔CH; CF3; 2〕,〔CH; CF2CF3; 0〕,〔CH; CF2CF3; 1〕,〔CH; CF2CF3; 2〕,〔CH; OMe; 0〕,〔CH; OMe; 1〕,〔CH; OMe; 2〕,〔CH; OCF3; 0〕,〔CH; OCF3; 1〕,〔CH; OCF3; 2〕,〔CH; SCF3; 0〕,〔CH; SCF3; 1〕,〔CH; SCF3; 2〕,〔CH; S(O)CF3; 0〕,〔CH; S(O)CF3; 1〕,〔CH; S(O)CF3; 2〕,〔CH; S(O)2CF3; 0〕,〔CH; S(O)2CF3; 1〕,〔CH; S(O)2CF3; 2〕,〔N; Cl; 0〕,〔N; Cl; 1〕,〔N; Cl; 2〕,〔N; Br; 0〕,〔N; Br; 1〕,〔N; Br; 2〕,〔N; Me; 0〕,〔N; Me; 1〕,〔N; Me; 2〕,〔N; CF3; 0〕,〔N; CF3; 1〕,〔N; CF3; 2〕,〔N; OMe; 0〕,〔N; OMe; 1〕,〔N; OMe; 2〕,〔N; NH2; 0〕,〔N; NH2; 1〕,〔N; NH2; 2〕,〔N; NHMe; 0〕,〔N; NHMe; 1〕,〔N; NHMe; 2〕,〔N; NH(CH2CF3); 0〕,〔N; NH(CH2CF3); 1〕,〔N; NH(CH2CF3); 2〕,〔N; NMe2; 0〕,〔N; NMe2; 1〕,〔N; NMe2; 2〕,〔N; Tr; 0〕,〔N; Tr; 1〕,〔N; Tr; 2〕,〔N; Pz; 0〕,〔N; Pz; 1〕,〔N; Pz; 2〕 Listing 2:
[A; R 4 ; n] = [CH; F; 0], [CH; F; 1], [CH; F; 2], [CH; Cl; 0], [CH; Cl; 1], [ CH; Cl; 2], [CH; Br; 0], [CH; Br; 1], [CH; Br; 2], [CH; Me; 0], [CH; Me; 1], [CH; Me; 2], [CH; CF 3 ; 0], [CH; CF 3 ; 1], [CH; CF 3 ; 2], [CH; CF 2 CF 3 ; 0], [CH; CF 2 CF 3 ; 1], [CH; CF 2 CF 3 ; 2], [CH; OMe; 0], [CH; OMe; 1], [CH; OMe; 2], [CH; OCF 3 ; 0], [CH ; OCF 3 ; 1], [CH; OCF 3 ; 2], [CH; SCF 3 ; 0], [CH; SCF 3 ; 1], [CH; SCF 3 ; 2], [CH; S (O) CF 3 ; 0], [CH; S (O) CF 3 ; 1], [CH; S (O) CF 3 ; 2], [CH; S (O) 2 CF 3 ; 0], [CH; S (O) 2 CF 3 ; 1], [CH; S (O) 2 CF 3 ; 2], [N; Cl; 0], [N; Cl; 1], [N; Cl; 2], [N ; Br; 0], [N; Br; 1], [N; Br; 2], [N; Me; 0], [N; Me; 1], [N; Me; 2], [N; CF 3 ; 0], [N; CF 3 ; 1], [N; CF 3 ; 2], [N; OMe; 0], [N; OMe; 1], [N; OMe; 2], [N; NH 2 ; 0 ], [N; NH 2 ; 1], [N; NH 2 ; 2], [N; NHMe; 0], [N; NHMe; 1], [N; NHMe; 2], [N; NH (CH 2 CF 3 ); 0], [N; NH (CH 2 CF 3 ); 1], [N; NH (CH 2 CF 3 ); 2], [N; NMe 2 ; 0], [N; NMe 2 ; 1], [N; NMe 2 ; 2], [N; Tr; 0], [N; Tr; 1], [N; Tr; 2], [N; Pz; 0], [N; Pz; 1], [N; Pz; 2]
〔A; R4; n〕=〔CH; F; 0〕,〔CH; F; 1〕,〔CH; F; 2〕,〔CH; Cl; 0〕,〔CH; Cl; 1〕,〔CH; Cl; 2〕,〔CH; Br; 0〕,〔CH; Br; 1〕,〔CH; Br; 2〕,〔CH; Me; 0〕,〔CH; Me; 1〕,〔CH; Me; 2〕,〔CH; CF3; 0〕,〔CH; CF3; 1〕,〔CH; CF3; 2〕,〔CH; CF2CF3; 0〕,〔CH; CF2CF3; 1〕,〔CH; CF2CF3; 2〕,〔CH; OMe; 0〕,〔CH; OMe; 1〕,〔CH; OMe; 2〕,〔CH; OCF3; 0〕,〔CH; OCF3; 1〕,〔CH; OCF3; 2〕,〔CH; SCF3; 0〕,〔CH; SCF3; 1〕,〔CH; SCF3; 2〕,〔CH; S(O)CF3; 0〕,〔CH; S(O)CF3; 1〕,〔CH; S(O)CF3; 2〕,〔CH; S(O)2CF3; 0〕,〔CH; S(O)2CF3; 1〕,〔CH; S(O)2CF3; 2〕,〔N; Cl; 0〕,〔N; Cl; 1〕,〔N; Cl; 2〕,〔N; Br; 0〕,〔N; Br; 1〕,〔N; Br; 2〕,〔N; Me; 0〕,〔N; Me; 1〕,〔N; Me; 2〕,〔N; CF3; 0〕,〔N; CF3; 1〕,〔N; CF3; 2〕,〔N; OMe; 0〕,〔N; OMe; 1〕,〔N; OMe; 2〕,〔N; NH2; 0〕,〔N; NH2; 1〕,〔N; NH2; 2〕,〔N; NHMe; 0〕,〔N; NHMe; 1〕,〔N; NHMe; 2〕,〔N; NH(CH2CF3); 0〕,〔N; NH(CH2CF3); 1〕,〔N; NH(CH2CF3); 2〕,〔N; NMe2; 0〕,〔N; NMe2; 1〕,〔N; NMe2; 2〕,〔N; Tr; 0〕,〔N; Tr; 1〕,〔N; Tr; 2〕,〔N; Pz; 0〕,〔N; Pz; 1〕,〔N; Pz; 2〕 Listing 2:
[A; R 4 ; n] = [CH; F; 0], [CH; F; 1], [CH; F; 2], [CH; Cl; 0], [CH; Cl; 1], [ CH; Cl; 2], [CH; Br; 0], [CH; Br; 1], [CH; Br; 2], [CH; Me; 0], [CH; Me; 1], [CH; Me; 2], [CH; CF 3 ; 0], [CH; CF 3 ; 1], [CH; CF 3 ; 2], [CH; CF 2 CF 3 ; 0], [CH; CF 2 CF 3 ; 1], [CH; CF 2 CF 3 ; 2], [CH; OMe; 0], [CH; OMe; 1], [CH; OMe; 2], [CH; OCF 3 ; 0], [CH ; OCF 3 ; 1], [CH; OCF 3 ; 2], [CH; SCF 3 ; 0], [CH; SCF 3 ; 1], [CH; SCF 3 ; 2], [CH; S (O) CF 3 ; 0], [CH; S (O) CF 3 ; 1], [CH; S (O) CF 3 ; 2], [CH; S (O) 2 CF 3 ; 0], [CH; S (O) 2 CF 3 ; 1], [CH; S (O) 2 CF 3 ; 2], [N; Cl; 0], [N; Cl; 1], [N; Cl; 2], [N ; Br; 0], [N; Br; 1], [N; Br; 2], [N; Me; 0], [N; Me; 1], [N; Me; 2], [N; CF 3 ; 0], [N; CF 3 ; 1], [N; CF 3 ; 2], [N; OMe; 0], [N; OMe; 1], [N; OMe; 2], [N; NH 2 ; 0 ], [N; NH 2 ; 1], [N; NH 2 ; 2], [N; NHMe; 0], [N; NHMe; 1], [N; NHMe; 2], [N; NH (CH 2 CF 3 ); 0], [N; NH (CH 2 CF 3 ); 1], [N; NH (CH 2 CF 3 ); 2], [N; NMe 2 ; 0], [N; NMe 2 ; 1], [N; NMe 2 ; 2], [N; Tr; 0], [N; Tr; 1], [N; Tr; 2], [N; Pz; 0], [N; Pz; 1], [N; Pz; 2]
3)下記式(D)
で示される化合物において、A、R4及びnが、リスト2に記載のいずれかである化合物。 3) The following formula (D)
A compound in which A, R 4 and n are any one of those listed in List 2.
で示される化合物において、A、R4及びnが、リスト2に記載のいずれかである化合物。 3) The following formula (D)
A compound in which A, R 4 and n are any one of those listed in List 2.
本発明化合物が効力を有する有害生物としては、例えば、有害昆虫や有害ダニ類等の有害動物が挙げられる。かかる有害動物としては、具体的には例えば、以下のものが挙げられるが、これらに限定されるものではない。
Examples of pests for which the compounds of the present invention are effective include harmful animals such as harmful insects and harmful mites. Specific examples of such harmful animals include, but are not limited to, the following.
半翅目害虫:ヒメトビウンカ(Laodelphax striatellus)、トビイロウンカ(Nilaparvata lugens)、セジロウンカ(Sogatella furcifera)、トウモロコシウンカ(Peregrinus maidis)等のウンカ類;ツマグロヨコバイ(Nephotettix cincticeps)、タイワンツマグロヨコバイ(Nephotettix virescens)、クロスジツマグロヨコバイ(Nephotettix nigropictus)、イナズマヨコバイ(Recilia dorsalis)、チャノミドリヒメヨコバイ(Empoasca onukii)、ジャガイモヒメヨコバイ(Empoasca fabae)、コーンリーフホッパー(Dalbulus maidis)、シロオオヨコバイ(Cofana spectra)、等のヨコバイ類;Mahanarva posticata、Mahanarva fimbriolata等のコガシラアワフキムシ類;ワタアブラムシ(Aphis gossypii)、ユキヤナギアブラムシ(Aphis spiraecola)、モモアカアブラムシ(Myzus persicae)、ダイコンアブラムシ(Brevicoryne brassicae)、ニセダイコンアブラムシ(Lipaphis erysimi)、チューリップヒゲナガアブラムシ(Macrosiphum euphorbiae)、ジャガイモヒゲナガアブラムシ(Aulacorthum solani)、レタスヒゲナガアブラムシ(Nasonovia ribisnigri)、ムギクビレアブラムシ(Rhopalosiphum padi)、ミカンクロアブラムシ(Toxoptera citricidus)、モモコフキアブラムシ(Hyalopterus pruni)、ダイズアブラムシ(Aphis glycines)、トウモロコシアブラムシ(Rhopalosiphum maidis)、オカボノクロアブラムシ(Tetraneura nigriabdominalis)、カンシャワタアブラムシ(Ceratovacuna lanigera)、リンゴワタムシ(Eriosoma lanigerum)等のアブラムシ類;ブドウネアブラムシ(Daktulosphaira vitifoliae)、Pecan phylloxera (Phylloxera devastatrix)、Pecan leaf phylloxera(Phylloxera notabilis)、Southern pecan leaf phylloxera (Phylloxera russellae)等のネアブラムシ類;ツガカサアブラムシ(Adelges tsugae)、Adelges piceae、ヒメカサアブラムシ(Aphrastasia pectinatae)等のカサアブラムシ類;イネクロカメムシ(Scotinophara lurida)、Malayan rice black bug (Scotinophara coarctata)、アオクサカメムシ(Nezara antennata)、トゲシラホシカメムシ(Eysarcoris aeneus)、オオトゲシラホシカメムシ(Eysarcoris lewisi)、シラホシカメムシ(Eysarcoris ventralis)、ムラサキシラホシカメムシ(Eysarcoris annamita)、クサギカメムシ(Halyomorpha halys)、ミナミアオカメムシ(Nezara viridula)、Brown stink bug (Euschistus heros)、Red banded stink bug (Piezodorus guildinii)、Oebalus pugnax、Dichelops melacanthus等のカメムシ類;Burrower brown bug (Scaptocoris castanea)等のツチカメムシ類;ホソヘリカメムシ(Riptortus pedestris)、クモヘリカメムシ(Leptocorisa chinensis)、ホソクモヘリカメムシ(Leptocorisa acuta)等のホソヘリカメムシ類;ホソハリカメムシ(Cletus punctiger)等のヘリカメムシ類;カンシャコバネナガカメムシ(Caverelius saccharivorus)、コバネヒョウタンナガカメムシ(Togo hemipterus)、アメリカコバネナガカメムシ(Blissus leucopterus)等のナガカメムシ類;アカヒゲホソミドリカスミカメ(Trigonotylus caelestialium)、アカスジカスミカメ(Stenotus rubrovittatus)、フタトゲムギカスミカメ(Stenodema calcarata)、サビイロカスミカメ(Lygus lineolaris)等のカスミカメムシ類;オンシツコナジラミ(Trialeurodes vaporariorum)、タバココナジラミ(Bemisia tabaci)、ミカンコナジラミ(Dialeurodes citri)、ミカントゲコナジラミ(Aleurocanthus spiniferus)、チャトゲコナジラミ(Aleurocanthus camelliae)等のコナジラミ類;シュロマルカイガラムシ(Abgrallaspis cyanophylli)、アカマルカイガラムシ(Aonidiella aurantii)、ナシマルカイガラムシ(Diaspidiotus perniciosus)、クワシロカイガラムシ(Pseudaulacaspis pentagona)、ヤノネカイガラムシ(Unaspis yanonensis)、ニセヤノネカイガラムシ(Unaspis citri)、等のマルカイガラムシ類;ルビーロウムシ(Ceroplastes rubens)等のカタカイガラムシ類;イセリアカイガラムシ(Icerya purchasi)等のワタフキカイガラムシ類;フジコナカイガラムシ(Planococcus kraunhiae)、クワコナカイガラムシ(Planococcus comstocki)、ナガオコナカイガラムシ(Pseudococcus longispinus)、タトルミーリーバグ(Brevennia rehi)等のコナカイガラムシ類;ミカンキジラミ(Diaphorina citri)、ナシキジラミ(Cacopsylla pyrisuga)、チュウゴクナシキジラミ(Cacopsylla chinensis)、ジャガイモトガリキジラミ(Bactericera cockerelli)等のキジラミ類;アワダチソウグンバイ(Corythucha marmorata)、ナシグンバイ(Stephanitis nashi)、ツツジグンバイ(Stephanitis pyrioides)等のグンバイムシ類;トコジラミ(Cimex lectularius)等のトコジラミ類及びGiant Cicada(Quesada gigas)等のセミ類。
Hemiptera pests: Japanese green planthopper (Laodelphax striatellus), Japanese green planthopper (Nilaparvata lugens), white planthopper (Sogatella furcifera), corn planter (Peregrinus maidis), etc .; (Nephotettix nigropictus), Incospider (Recilia dorsalis), Emporasca onukii, Empoasca fabae, Cornleaf Hopper (Dalbulus maidis), White-leafed beetle Mahanarva posticata, Mahanarva fimbriolata, etc .; Aphis goss ii, Aphis spiraecola, Myzus persicae, Japanese radish aphid (Br evicoryne brassicae), lipstick aphid (Lipaphis erysimi), tulip beetle aphid (Macrosiphum euphorbiae), potato beetle aphid (Aulacorthum solani), lettuce beetle aphid (Nasonovia ribisnigri), hum ), Peach beetle (Hyalopterus pruni), soybean aphid (Aphis glycines), corn aphid (Rhopalosiphum maidis), sugar beetle aphid (Tetraneuraabnigriabdominalis), scorpion aphid (Ceratovacuna lanigera), rio rotoma Vine grape aphids (Daktulosphaira vitifoliae), Pecan phylloxera (Phylloxera devastatrix), Pecan leaf phylloxera (Phylloxera notabilis), Southern pecan leaf phylloxera (Phyll) oxera russellae) and other aphids; Adelges tsugae, Adelges piceae, Aphrastasia pectinatae and other aphids; Scotinophara lurida, Malayan Blue-headed beetle (Nezara antennata), White-headed beetle (Eysarcoriseneaeneus), White-headed beetle (Eysarcoris lewisi), White-headed beetle (Eysarcorisralventralis), Purple-headed beetle (Eysarcoris memashimina) (Nezara viridula), Brown stink bug (Euschistus heros), Red banded stink bug (Piezodorus guildinii), stink bugs such as Oebalus pugnax, Dichelops melacanthus; Burrower brown bug (Scaptocoris caste , Spider helicopters (Leptocorisa chinensis), spider helicopters (Leptocorisa acuta), etc .; (Togo hemipterus), American bug beetle (Blissus leucopterus), etc .; Mosquito bugs such as Trileurodes vaporariorum, Tobacco whitefly (Bemisia tabaci), Citrus whitefly (Dialeurodes citri), Citrus whitefly (Aleurocanthus spiniferus), Chattoge whitefly (Al whitefly, such as eurocanthus camelliae; aphid beetle (Abidi moth), Aonidiella aurantii, diaspidiotus perniciosus, Pseudaulacaspis Scale insects such as scale insects (Unaspis citri), etc .; Scale insects such as ruby beetles (Ceroplastes rubens); ), Pseudodococcus longispinus, Brattlenia rehi, and other species; Diaphorina citri, Cacopsylla pyrisuga, Chi Whales such as Cacopsylla chinensis and Bactericera cockerelli; Corythucha marmorata, Stepiusitis nashi, exander Bed bugs such as Giant Cicada (Quesada gigas).
鱗翅目害虫:ニカメイガ(Chilo suppressalis)、Darkheaded stem borer (Chilo polychrysus)、White stem borer(Scirpophaga innotata)、イッテンオオメイガ(Scirpophaga incertulas)、Rupela albina、コブノメイガ(Cnaphalocrocis medinalis)、Marasmia patnalis、イネハカジノメイガ(Marasmia exigua)、ワタノメイガ(Notarcha derogata)、アワノメイガ(Ostrinia furnacalis)、European corn borer (Ostrinia nubilalis)、ハイマダラノメイガ(Hellula undalis)、シバツトガ(Pediasia teterrellus)、ライスケースワーム(Nymphula depunctalis)、Sugarcane borer(Diatraea saccharalis)等のツトガ類;モロコシマダラメイガ(Elasmopalpus lignosellus)、ノシメマダラメイガ(Plodia interpunctella)等のメイガ類;ハスモンヨトウ(Spodoptera litura)、シロイチモジヨトウ(Spodoptera exigua)、アワヨトウ(Mythimna separata)、ヨトウガ(Mamestra brassicae)、イネヨトウ(Sesamia inferens)、シロナヨトウ(Spodoptera mauritia)、フタオビコヤガ(Naranga aenescens)、ツマジロクサヨトウ(Spodoptera frugiperda)、アフリカシロナヨトウ(Spodoptera exempta)、タマナヤガ(Agrotis ipsilon)、タマナギンウワバ(Autographa nigrisigna)、イネキンウワバ(Plusia festucae)、Soybean looper (Chrysodeixis includens)、トリコプルシア属、ニセアメリカタバコガ(Heliothis virescens)等ヘリオティス属、オオタバコガ(Helicoverpa armigera)等ヘリコベルパ属、Velvetbean caterpillar(Anticarsia gemmatalis)、Cotton leafworm (Alabama argillacea)、Hop vine borer(Hydraecia immanis)等のヤガ類;モンシロチョウ(Pieris rapae)等のシロチョウ類;ナシヒメシンクイ(Grapholita molesta)、スモモヒメシンクイ(Grapholita dimorpha)、マメシンクイガ(Leguminivora glycinivorella)、アズキサヤムシガ(Matsumuraeses azukivora)、リンゴコカクモンハマキ(Adoxophyes orana fasciata)、チャノコカクモンハマキ(Adoxophyes honmai)、チャハマキ(Homona magnanima)、ミダレカクモンハマキ(Archips fuscocupreanus)、コドリンガ(Cydia pomonella)、カンシャシンクイハマキ(Tetramoera schistaceana)、Bean Shoot Borer (Epinotia aporema)、Citrus fruit borer(Ecdytolopha aurantiana)等のハマキガ類;チャノホソガ(Caloptilia theivora)、キンモンホソガ(Phyllonorycter ringoniella)のホソガ類;モモシンクイガ(Carposina sasakii)等のシンクイガ類;Coffee Leaf miner(Leucoptera coffeela)、リオネティア属等のハモグリガ類;マイマイガ(Lymantria dispar)等リマントリア属、チャドクガ(Euproctis pseudoconspersa)等ユープロクティス属等のドクガ類;コナガ(Plutella xylostella)等のコナガ類;ワタアカミムシガ(Pectinophora gossypiella)、ジャガイモガ(Phthorimaea operculella)等のキバガ類;アメリカシロヒトリ(Hyphantria cunea)等のヒトリガ類;Giant Sugarcane borer(Telchin licus)等のカストニアガ類;イネツトムシ (Parnara guttata)等のセセリチョウ類。
Lepidopterous insects: Chilo ニ suppressalis, Darkheaded stem borer (Chilo polychrysus), White stem borer (Scirpophaga innotata), Scirpophaga incertulas, Rupela albina, Cai halopatia cis (Marasmia exigua), cotton moth (Notarcha derogata), green eel (Ostrinia furnacalis), European corn borer (Ostrinia nubilalis), yellow moth (Hellula undalis), Shibatatsuga (Pediasia teterum (Pediasia teterum) Diatraea saccharalis), etc .; Sorgoptera メ イ litura, Spodoptera imexnagua, Spodoptera imexna rata), mushroom (Mamestra brassicae), rice mushroom (Sesamia inferens), white-footed mushroom (Spodoptera mauritia), frangipaya (Naranga aenescens), tsumoji-royo (Spodoptera frugiperda), exotica pod Tamanaginwowa (Autographa nigrisigna), rice kinawaba (Plusia festucae), Soybean looper (Chrysodeixis includens), Trichopulsia genus, Heliothis virescens, etc. Cotton leafworm (Alabama argillacea), Hop vine borer (Hydraecia immanis) and other moths; White butterflies such as Pieris rapae; Nasihimeshinmoi (Grapholita molesta), Sumohimeshini (Grapholita dimorph) a), leguminous moth (Leguminivora 、 glycinivorella), Azuki beetle (Matsumuraeses azukivora), apple wolfberry (Adoxophyes orana fasciata), tea wolfberry (Adoxophyes honmai), chamonaki (Homona magnancos), (Cydia pomonella), Tetramoera schistaceana, Bean Shoot Borer (Epinotia aporema), Citrus fruit borer (Ecdytolopha aurantiana), etc .; Sinkigas (Carposina sasakii); Coffee Leaf miner (Leucoptera coffeela), Anemone genus such as Rionetia; Limantria genus such as Lymantria dispar, Euproctis pseudoconspersa, etc. Species of the genus, such as Spodoptera (Plutella xylostella), etc licus); celery butterflies, such as Parnara guttata.
総翅目害虫:ミカンキイロアザミウマ(Frankliniella occidentalis)、ミナミキイロアザミウマ(Thrips palmi)、チャノキイロアザミウマ(Scirtothrips dorsalis)、ネギアザミウマ(Thrips tabaci)、ヒラズハナアザミウマ(Frankliniella intonsa)、イネアザミウマ(Stenchaetothrips biformis)等のアザミウマ類;イネクダアザミウマ(Haplothrips aculeatus)等のクダアザミウマ類。
Common pests: Citrus thrips (Frankliniella occidentalis), Thrips palmi, Scirtothrips dorsalis, Thrips tabaci, Thrips tabaci, Thrips tabaci, Thrips tabaci, Thrips tabaci Thrips: The Thrips such as Haplothrips aculeatus.
双翅目害虫:タネバエ(Delia platura)、タマネギバエ(Delia antiqua)等のハナバエ類;シュガービートルートマゴット(Tetanops myopaeformis)等のハナフリバエ類;イネハモグリバエ(Agromyza oryzae)、トマトハモグリバエ(Liriomyza sativae)、マメハモグリバエ(Liriomyza trifolii)、ナモグリバエ(Chromatomyia horticola)等のハモグリバエ類;イネキモグリバエ(Chlorops oryzae)等のキモグリバエ類;ウリミバエ(Bactrocera cucurbitae)、ミカンコミバエ(Bactrocera dorsalis)、オリーブミバエ(Bactrocera oleae)、ナスミバエ(Bactrocera latifrons)、チチュウカイミバエ(Ceratitis capitata)等のミバエ類;イネヒメハモグリバエ(Hydrellia griseola)、トウヨウイネクキミギワバエ(Hydrellia philippina)、イネクキミギワバエ(Hydrellia sasakii)等のミギワバエ類;ショウジョウバエ類;オオキモンノミバエ(Megaselia spiracularis)等のノミバエ類;オオチョウバエ(Clogmia albipunctata)等のチョウバエ類;クロバネキノコバエ類;ヘシアンバエ(Mayetiola destructor)、イネノシントメタマバエ(Orseolia oryzae)等のタマバエ類;Diopsis macrophthalma等のシュモクバエ類;キリウジガガンボ(Tipula aino)、Common cranefly(Tipula oleracea)、European cranefly(Tipula paludosa)等のガガンボ類。
Diptera: insect fly, Delia platura, Delia qua antiqua, etc .; sugar beet root maggot (Tetanops myopaeformis), etc .; (Liriomyza trifolii), leafhoppers (Chromatomyia horticola), etc .; leafhoppers (Chlorops oryzae); Fruit flies such as Ceratitis capitata; sand flies such as Hydrellia griseola, Hydrellia philippina, Hydrellia sasakii; Drosophila; flies such as Megaselia spiracularis; flies such as Clogmia albipunctata; black fly flies; Mayetiola destructor; Streptococcus such as Diopsis macrophthalma; Crane fly such as European ジ cranefly (Tipula palracosa), Common cranefly (Tipula oleracea), European cranefly (Tipula paludosa)
鞘翅目害虫:ウエスタンコーンルートワーム(Diabrotica virgifera virgifera)、サザンコーンルートワーム(Diabrotica undecimpunctata howardi)、ノザンコーンルートワーム(Diabrotica barberi)、メキシカンコーンルートワーム(Diabrotica virgifera zeae)、バンデッドキューカンバービートル(Diabrotica balteata)、Cucurbit Beetle(Diabrotica speciosa)、ビーンリーフビートル(Cerotoma trifurcata)、クビアカクビホソハムシ(Oulema melanopus)、ウリハムシ(Aulacophora femoralis)、キスジノミハムシ(Phyllotreta striolata)、コロラドハムシ(Leptinotarsa decemlineata)、イネドロオイムシ(Oulema oryzae)、グレープ・コラスピス(Colaspis brunnea)、コーン・フレアビートル(Chaetocnema pulicaria)、ポテト・フレアビートル(Epitrix cucumeris)、イネトゲハムシ(Dicladispa armigera)、Grape Colaspis(Colaspis brunnea)、southern corn leaf beetle (Myochrous denticollis)等のハムシ類;Seedcorn beetle(Stenolophus lecontei)、Slender seedcorn beetle (Clivina impressifrons)等のオサムシ類;ドウガネブイブイ(Anomala cuprea)、ヒメコガネ(Anomala rufocuprea)、アオドウガネ(Anomala albopilosa)、マメコガネ(Popillia japonica)、ナガチャコガネ(Heptophylla picea)、European Chafer(Rhizotrogus majalis)、クロマルコガネ(Tomarus gibbosus)、Holotrichia属、ジューン・ビートル(Phyllophaga crinita)などPhyllophaga属等のコガネムシ類;コクゾウムシ(Sitophilus zeamais)、イネゾウムシ(Echinocnemus squameus)、イネミズゾウムシ(Lissorhoptrus oryzophilus)、シロスジオサゾウムシ(Rhabdoscelus lineatocollis)、ワタミハナゾウムシ(Anthonomus grandis)、シバオサゾウムシ(Sphenophorus venatus)、Southern Corn Billbug(Sphenophorus callosus)、Soybean stalk weevil (Sternechus subsignatus)、Sgarcane wiivil(Sphenophorus levis)、サビヒョウタンゾウムシ(Scepticus griseus)、トビイロヒョウタンゾウムシ(Scepticus uniformis)、マツノキクイムシ(Tomicus piniperda)、Coffee Berry Borer(Hypothenemus hampei)等のゾウムシ類;コクヌストモドキ(Tribolium castaneum)、ヒラタコクヌストモドキ(Tribolium confusum)等のゴミムシダマシ類、ニジュウヤホシテントウ(Epilachna vigintioctopunctata)等のテントウムシ類;ヒラタキクイムシ(Lyctus brunneus)等のナガシンクイムシ類;ヒョウホンムシ類;ゴマダラカミキリ(Anoplophora malasiaca)、Migdolus fryanus等のカミキリムシ類;オキナワカンシャクシコメツキ(Melanotus okinawensis)、トビイロムナボソコメツキ(Agriotes fuscicollis)、クシコメツキ(Melanotus legatus)等のコメツキムシ類(Agriotes sp.、Aelous sp.、Anchastus sp.、Melanotus sp.、Limonius sp.、Conoderus sp.、Ctenicera sp.);アオバアリガタハネカクシ(Paederus fuscipes)等のハネカクシ類。
Coleoptera: Western corn root worm (Diabrotica virgifera virgifera), Southern corn root worm (Diabrotica undecimpunctata howardi), Northern corn root worm (Diabrotica barberi), Mexican corn root worm (Diabrotica virgifera zeae), Banded cumber rot balte (ab) , Cucurbit Beetle (Diabrotica speciosa), Bean Leaf Beetle (Cerotoma trifurcata), Bark beetle Beetle (Oulema melanopus), Root beetle (Aulacophora femoralis), Kibushi horn beetle (Phyllotreta striolata), Colorado potato beetle (De , Grapes colaspis (Colaspis brunnea), corn flare beetle (Chaetocnema pulicaria), potato flare beetle (Epitrix cucumeris), rice beetle (Dicladispa armigera) Grape Colaspis (Colaspis brunnea), southern beetles such as southern corn leaf beetle (Myochrous denticollis); Seedcorn beetle (Stenolophus lecontei), slender seedcorn beetle (Clivina impressifrons), etc .; , Anomala albopilosa, Bean squirrel (Popillia japonica), Nagachakogane (Heptophylla picea), European Chafer (Rhizotrogus majalis), Black marsh moth (Tomarus gibbosus), Holotrichia genus Weevil (Sitophilus zeamais), rice weevil (Echinocnemus squameus), rice weevil (Lissorhoptrus oryzophilus), white weevil (Rhabdoscelus lineatocollis), cotton weevil (Anthonomus grandophus scorpion) natus), Southern Corn Billbug (Sphenophorus callosus), Soybean stalk weevil (Sternechus S subsignatus), Sgarcane wiivil (Sphenophorus levis), Sabihyo weevil (Scepticus griseus), Toburo Weevil such as Coffee Berry Borer (Hypothenemus hampei); Long-horned beetles; leopard beetles; longhorn beetles (Anoplophora malasiaca), longhorn beetles such as Migdolus fryanus; Okinawa beetle (Melanotus okinawensis), Agriotes scous s), beetles such as Melanotusnotlegatus (Agriotes sp., Aelous sp., Anchastus sp., Melanotus sp., Limonius sp., Connoderus sp., Ctenicera sp.); Scallops.
直翅目害虫:トノサマバッタ(Locusta migratoria)、モロッコトビバッタ(Dociostaurus maroccanus)、オーストラリアトビバッタ(Chortoicetes terminifera)、アカトビバッタ(Nomadacris septemfasciata)、Brown Locust(Locustana pardalina)、Tree Locust (Anacridium melanorhodon)、Italian Locust (Calliptamus italicus)、Differential grasshopper(Melanoplus differentialis)、Two striped grasshopper(Melanoplus bivittatus)、Migratory grasshopper(Melanoplus sanguinipes)、Red-Legged grasshopper(Melanoplus femurrubrum)、Clearwinged grasshopper(Camnula pellucida)、サバクワタリバッタ(Schistocerca gregaria)、Yellow-winged locust (Gastrimargus musicus)、Spur-throated locust (Austracris guttulosa)、コバネイナゴ(Oxya yezoensis)、ハネナガイナゴ(Oxya japonica)、タイワンツチイナゴ(Patanga succincta)等のバッタ類;ケラ(Gryllotalpa africana)等のケラ類;ヨーロッパイエコオロギ(Acheta domesticus)、エンマコオロギ(Teleogryllus emma)等のコオロギ類;Mormon cricket (Anabrus simplex)等のキリギリス類。
Insect pests: Locusta migratoria, Moroccan grasshopper (Dociostaurus maroccanus), Australian grasshopper (Chortoicetes terminifera), red locust (Nomadacris septemfasciata), Brown Locust (Locustana parust Calliptamus italicus), Differential grasshopper (Melanoplus differentialis), Two striped grasshopper (Melanoplus bivittatus), Migratory grasshopper (Melanoplus sanguinipes), Red-Legged grasshopper (Melanoplus femurrubrum), Grasshoppers such as Yellow-winged locust (Gastrimargus musicus), Spur-throated locust (Austracris コ guttulosa), Cobaineago (Oxya yezoensis), Red-tailed hawk (Oxya japonica), Thai winged chinook (Patanga succincta); Kellys such as ryllotalpa africana); Crickets such as European crickets (Acheta domesticus) and Enma crickets (Teleogryllus emma); Grasshoppers such as Mormon cricket (Anabrus simplex).
膜翅目害虫:カブラハバチ(Athalia rosae)、ニホンカブラバチ(Athalia japonica)等のハバチ類;ファイアーアント類;Brown leaf-cutting ant (Atta capiguara)等のアリ類等。
ゴキブリ目害虫:チャバネゴキブリ(Blattella germanica)等のチャバネゴキブリ類;クロゴキブリ(Periplaneta fuliginosa)、ワモンゴキブリ(Periplaneta americana)、トビイロゴキブリ(Periplaneta brunnea)、トウヨウゴキブリ(Blatta orientalis)等のゴキブリ類等。 Hymenopteran pests: bees such as Athalia rosae and Athalia japonica; fire ants; ants such as Brown leaf-cutting ant (Atta capiguara)
Cockroach insects: German cockroaches such as the German cockroach (Blattella germanica); cockroaches such as the black cockroach (Periplaneta fuliginosa), the American cockroach (Periplaneta americana), the black cockroach (Periplaneta brunnea), and the American cockroach (Blatta orientalis).
ゴキブリ目害虫:チャバネゴキブリ(Blattella germanica)等のチャバネゴキブリ類;クロゴキブリ(Periplaneta fuliginosa)、ワモンゴキブリ(Periplaneta americana)、トビイロゴキブリ(Periplaneta brunnea)、トウヨウゴキブリ(Blatta orientalis)等のゴキブリ類等。 Hymenopteran pests: bees such as Athalia rosae and Athalia japonica; fire ants; ants such as Brown leaf-cutting ant (Atta capiguara)
Cockroach insects: German cockroaches such as the German cockroach (Blattella germanica); cockroaches such as the black cockroach (Periplaneta fuliginosa), the American cockroach (Periplaneta americana), the black cockroach (Periplaneta brunnea), and the American cockroach (Blatta orientalis).
シロアリ目害虫:ヤマトシロアリ(Reticulitermes speratus)、イエシロアリ(Coptotermes formosanus)、アメリカカンザイシロアリ(Incisitermes minor)、ダイコクシロアリ(Cryptotermes domesticus)、タイワンシロアリ(Odontotermes formosanus)、コウシュンシロアリ(Neotermes koshunensis)、サツマシロアリ(Glyptotermes satsumensis)、ナカジマシロアリ(Glyptotermes nakajimai)、カタンシロアリ(Glyptotermes fuscus)、オオシロアリ(Hodotermopsis sjostedti)、コウシュウイエシロアリ(Coptotermes guangzhouensis)、アマミシロアリ(Reticulitermes amamianus)、ミヤタケシロアリ(Reticulitermes miyatakei)、カンモンシロアリ(Reticulitermes kanmonensis)、タカサゴシロアリ(Nasutitermes takasagoensis)、ニトベシロアリ(Pericapritermes nitobei)、ムシャシロアリ(Sinocapritermes mushae)、Cornitermes cumulans等。
Termite pests: Yamato termites (Reticulitermes speratus), termites (Coptotermes formosanus), American ants termites (Incisitermes minor), stag termites (Cryptotermes domesticus), ants, termites (Odontotermes eoformosaterm), ants Glyptotermes Reticulitermes kanmonensis), Takasago termites (Nasutitermes takasagoensis), Nitobe termites (Pericapritermes nitobei), Mushy termites (Sinocapritermes mushae), Cornitermes cumulans like.
ダニ類:ナミハダニ(Tetranychus urticae)、カンザワハダニ(Tetranychus kanzawai)、ミカンハダニ(Panonychus citri)、リンゴハダニ(Panonychus ulmi)、オリゴニカス属等のハダニ類;ミカンサビダニ(Aculops pelekassi)、リュウキュウミカンサビダニ(Phyllocoptruta citri)、トマトサビダニ(Aculops lycopersici)、チャノサビダニ(Calacarus carinatus)、チャノナガサビダニ(Acaphylla theavagrans)、ニセナシサビダニ(Eriophyes chibaensis)、リンゴサビダニ(Aculus schlechtendali)等のフシダニ類;チャノホコリダニ(Polyphagotarsonemus latus)等のホコリダニ類;ミナミヒメハダニ(Brevipalpus phoenicis)等のヒメハダニ類;ケナガハダニ類;フタトゲチマダニ(Haemaphysalis longicornis)、キチマダニ(Haemaphysalis flava)、タイワンカクマダニ(Dermacentor taiwanensis)、アメリカイヌカクマダニ(Dermacentor variabilis)、ヤマトマダニ(Ixodes ovatus)、シュルツマダニ(Ixodes persulcatus)、ブラックレッグドチック(Ixodes scapularis)、アメリカキララマダニ(Amblyomma americanum)、オウシマダニ(Boophilus microplus)、クリイロコイタマダニ(Rhipicephalus sanguineus)等のマダニ類;ケナガコナダニ(Tyrophagus putrescentiae)、ホウレンソウケナガコナダニ(Tyrophagus similis)等のコナダニ類;コナヒョウヒダニ(Dermatophagoides farinae)、ヤケヒョウヒダニ(Dermatophagoides pteronyssinus)等のチリダニ類;ホソツメダニ(Cheyletus eruditus)、クワガタツメダニ(Cheyletus malaccensis)、ミナミツメダニ(Cheyletus moorei)、イヌツメダニ(Cheyletiella yasguri)等のツメダニ類;ミミヒゼンダニ(Otodectes cynotis)、ヒゼンダニ(Sarcoptes scabiei)等のヒゼンダニ類;イヌニキビダニ(Demodex canis)等のニキビダニ類;ズツキダニ類;イエササラダニ類;イエダニ(Ornithonyssus bacoti)、トリサシダニ(Ornithonyssus sylviarum)等のオオサシダニ類;ワクモ(Dermanyssus gallinae)等のワクモ類;アカツツガムシ(Leptotrombidium akamushi)等のツツガムシ類等。
クモ類:カバキコマチグモ(Cheiracanthium japonicum)等のコマチグモ類;セアカゴケグモ(Latrodectus hasseltii)等のヒメグモ類等。
唇脚綱類:ゲジ(Thereuonema hilgendorfi)等のゲジ類;トビズムカデ(Scolopendra subspinipes)等のオオムカデ類等。
倍脚綱類:ヤケヤスデ(Oxidus gracilis),アカヤスデ(Nedyopus tambanus)等のヤケヤスデ類等。
等脚目類:オカダンゴムシ(Armadillidium vulgare)等のダンゴムシ類等。
腹足綱類:チャコウラナメクジ(Limax marginatus)、キイロコウラナメクジ(Limax flavus)等のコウラナメクジ類; スクミリンゴガイ(Pomacea canaliculata)等のリンゴガイ類;ヒメモノアラガイ (Austropeplea ollula)等のモノアラガイ類等。 Mites: Spider mites (Tetranychus urticae), spider mites (Tetranychus kanzawai), red spider mites (Panonychus ulmi), apple spider mites (Panonychus ulmi), spider mites (Aculops pelekassi), red mite Pistrum (copper) Tomato rustic mites (Aculops lycopersici), Chinese radish mites (Calacarus carinatus), Chinese radish mites (Acaphylla theavagrans), Green rustic mites (Eriophyes chibaensis), Apple ticks (Aculus schlechtendali), etc .; Toad spider mites (Brevipalpus phoenicis) and other spider mites; Toxid spider mites (Haemaphysalis longicornis), tossed tick (Haemaphysalis flava), tortoise tick (Dermacentor taiwanensis), to the American cattle bear Dermacentor variabilis, Ixodes ovatus, Ixodes persulcatus, Black-legged tick (Ixodes scapularis), Amblyomma americanum, Boophilus microplus, R. Tick such as: Tyrophagus putrescentiae, spiny mite (Tyrophagus similis), etc .; mite mite (Dermatophagoides pteronyssinus); , Mites (Cheyletus moorei), crayfish mites (Cheyletiella yasguri); mite mites (Otodectes cynotis), mite mites (Sarcoptes scabiei), etc .; Acne mites such as emodex canis; Carp mites; House crabs; Hornets such as Ornithonyssus sylviarum; Etc.
Spiders: Common spiders such as Cheracanthium japonicum; Brown spiders such as Latrodectus hasseltii.
Lip and leg class: Geges such as Gezi (Thereuonema hilgendorfi); Barley pods such as Scolopendra subspinipes.
Double-legged class: zelkova (Oxidus gracilis), zelkova (Nedyopus tambanus), etc.
Isopods: Rubber beetles such as Armadillidium vulgare.
Gastropoda: Coleoptera such as Limax marginatus and Limax flavus; Apple mussels such as Pomacea canaliculata; Monoaragai such as Austropeplea ollula.
クモ類:カバキコマチグモ(Cheiracanthium japonicum)等のコマチグモ類;セアカゴケグモ(Latrodectus hasseltii)等のヒメグモ類等。
唇脚綱類:ゲジ(Thereuonema hilgendorfi)等のゲジ類;トビズムカデ(Scolopendra subspinipes)等のオオムカデ類等。
倍脚綱類:ヤケヤスデ(Oxidus gracilis),アカヤスデ(Nedyopus tambanus)等のヤケヤスデ類等。
等脚目類:オカダンゴムシ(Armadillidium vulgare)等のダンゴムシ類等。
腹足綱類:チャコウラナメクジ(Limax marginatus)、キイロコウラナメクジ(Limax flavus)等のコウラナメクジ類; スクミリンゴガイ(Pomacea canaliculata)等のリンゴガイ類;ヒメモノアラガイ (Austropeplea ollula)等のモノアラガイ類等。 Mites: Spider mites (Tetranychus urticae), spider mites (Tetranychus kanzawai), red spider mites (Panonychus ulmi), apple spider mites (Panonychus ulmi), spider mites (Aculops pelekassi), red mite Pistrum (copper) Tomato rustic mites (Aculops lycopersici), Chinese radish mites (Calacarus carinatus), Chinese radish mites (Acaphylla theavagrans), Green rustic mites (Eriophyes chibaensis), Apple ticks (Aculus schlechtendali), etc .; Toad spider mites (Brevipalpus phoenicis) and other spider mites; Toxid spider mites (Haemaphysalis longicornis), tossed tick (Haemaphysalis flava), tortoise tick (Dermacentor taiwanensis), to the American cattle bear Dermacentor variabilis, Ixodes ovatus, Ixodes persulcatus, Black-legged tick (Ixodes scapularis), Amblyomma americanum, Boophilus microplus, R. Tick such as: Tyrophagus putrescentiae, spiny mite (Tyrophagus similis), etc .; mite mite (Dermatophagoides pteronyssinus); , Mites (Cheyletus moorei), crayfish mites (Cheyletiella yasguri); mite mites (Otodectes cynotis), mite mites (Sarcoptes scabiei), etc .; Acne mites such as emodex canis; Carp mites; House crabs; Hornets such as Ornithonyssus sylviarum; Etc.
Spiders: Common spiders such as Cheracanthium japonicum; Brown spiders such as Latrodectus hasseltii.
Lip and leg class: Geges such as Gezi (Thereuonema hilgendorfi); Barley pods such as Scolopendra subspinipes.
Double-legged class: zelkova (Oxidus gracilis), zelkova (Nedyopus tambanus), etc.
Isopods: Rubber beetles such as Armadillidium vulgare.
Gastropoda: Coleoptera such as Limax marginatus and Limax flavus; Apple mussels such as Pomacea canaliculata; Monoaragai such as Austropeplea ollula.
線虫類:イネシンガレセンチュウ (Aphelenchoides besseyi)等のアフェレンコイデス類;ミナミネグサレセンチュウ (Pratylenchus coffeae)、Pratylenchus brachyurus、ムギネグサレセンチュウ (Pratylenchus neglectus)、ラドフォルス・シミリス (Radopholus similis)等のプラティレンクス類;ジャワネコブセンチュウ (Meloidogyne javanica)、サツマイモネコブセンチュウ (Meloidogyne incognita)、キタネコブセンチュウ (Meloidogyne hapla)、ダイズシストセンチュウ(Heterodera glycines)、ジャガイモシストセンチュウ (Globodera rostochiensis)、ジャガイモシロシストセンチュウ(Globodera pallida)等のヘテロデラ類;Rotylenchulus reniformis等のホプロライムス類;イチゴメセンチュウ(Nothotylenchus acris)、ジチレンクス・ジプサシ (Ditylenchus dipsaci)等のアングイナ類;チレンクルス・セミペネトランス (Tylenchulus semipenetrans)等のティレンクルス類;ブドウオオハリセン(Xiphinema index)等のロンギドルス類;トリコドルス類;マツノザイセンチュウ (Bursaphelenchus xylophilus)等のパラシタアフェレンクス類等。
Nematodes: Aphelenchoides besseyi, such as Aphelenchoides besseyi; Minaminegusaresenchu (Pratylenchus coffeae), Pratylenchus brachyurus, Pratylenchus neglectus 等, Radsimus Cucumber species: Javaloid nematode Me (Meloidogyne javanica), Sweet potato nematode Me (Meloidogyne incognita), Kitaenbu nematode Me (Meloidogyne hapla), soybean cyst nematode (Heterodera glycines), potato cyst nematode (Globodera Heterodera; Hopro-Rimes such as Rotylenchulus reniformis; Anguinas such as Nothotylenchus acris and Ditylenchus dipsaci; Tirenkurusu such as Luz Semi penetrometer transformer (Tylenchulus semipenetrans); Torikodorusu such; grape giant harisen (Xiphinema index) Rongidorusu such as para Sita affection Ren box such as pine wood nematode (Bursaphelenchus xylophilus), and the like.
対象の有害昆虫および有害ダニ類は、殺虫・殺ダニ剤に薬剤感受性の低下した、または薬剤抵抗性の発達した昆虫およびダニ類であってもよい。ただし、薬剤感受性が大幅に低下した、または薬剤抵抗性が大幅に発達した場合は、その対象となる殺虫・殺ダニ剤以外の殺虫・殺ダニ剤を含む本発明組成物の使用が望ましい。
The target harmful insects and harmful ticks may be insects and ticks that have reduced drug sensitivity to insecticides / acaricides or have developed drug resistance. However, when the drug sensitivity is greatly reduced or the drug resistance is greatly developed, it is desirable to use the composition of the present invention containing an insecticide / acaricide other than the target insecticide / acaricide.
本発明化合物は、昆虫媒介性ウイルスによる植物病害から植物を保護するためにも用いることができる。
The compounds of the present invention can also be used to protect plants from plant diseases caused by insect-borne viruses.
本発明化合物が防除効力を有する昆虫媒介性ウイルスによる植物病害としては、例えば次のものが挙げられる。
Examples of plant diseases caused by insect-borne viruses having the control effect of the compound of the present invention include the following.
イネわい化病 (Rice waika virus)、ツングロ病(Rice tungro spherical virus、Rice tungro bacilliform virus)、イネグラッシースタント病 (Rice grassy stunt virus)、イネラギッドスタント病 (Rice ragged stunt virus)、稲縞葉枯れ病(Rice stripe virus)、黒すじ委縮病(Rice black streaked dwarf virus)、イネ南方黒すじ委縮病(Southern rice black-streaked dwarf virus)、稲こぶ萎縮病(Rice gall dwarf virus)、稲葉枯れ病(Rice hoja blanca virus)、イネ白葉病(White leaf desease of rice)、黄化萎縮病(Yellow dwarf virus)、Red disease(Rice penyakit merah virus)、イネ黄葉病(Rice yellow stunt virus)、トランジトリーイエローイング病(Rice transitory yellowing virus)、イネ黄斑病(Rice Yellow Mottle Virus)、イネえそモザイクウイルス(Rice necrosis mosaic virus)、イネ萎縮病(Rice dwarf stunt virus)、ムギ北地モザイク病(Northern Cereal Mosaic Virus)、オオムギ黄化萎縮病(Barley Yellow Dwarf Virus)、コムギ黄葉病(Wheat yellow dwarf virus )、Oat sterile dwarf(Oat sterile dwarf virus)、Wheat streak mosaic(Wheat streak mosaic virus)
トウモロコシモザイク病(Maize dwarf mosaic virus)、Maize stripe disease(maize stripe tenuivirus)、Maize chlorotic dwarf(Maize chlorotic dwarf virus)、Maize chlorotic mottle(maize chlorotic mottle virus)、Maize rayado fino (maize rayado fino marafivirus)、Corn stunt(Corn stunt spiroplasma)、Maize bushy stunt(Maize bushy stunt phytoplasma)、サトウキビモザイク病 (Sugarcane mosaic virus)、
ダイズ微斑モザイク病(Soybean mild mosaic virus)、モザイク病(Alfalfa Mosaic Virus、Bean yellow―spot mosaic virus、Soybean mosaic virus、Bean yellow mosaic virus、 Cowpea severe mosaic virus)、ダイズウイルス病(Broad bean wilt virus、 Bean common mosaic virus、 Peanut stunt virus、Southern bean mosaic virus)、ダイズ矮化病(Soybean dwarf luteovirus、Milk-vetch dwarf luteovirus)、Bean-pod mottle(Bean-pod mottle virus)、Brazilian bud blight(Tobbaco streak virus)、Cowpea chlorotic mottle(Cowpea chlorotic mottle)、Mung bean yellow mosaic (Mung bean yellow mosaic virus)、Peanut stripe (Peanut stripe mottle)、Soybean crinkle leaf(Soybean crinkle leaf virus)、Soybean severe stunt(Soybean severe stunt virus) トマト帰化病(Tomato chlorosis virus)、トマト黄化えそ病(Tomato spotted wilt virus)、トマト黄化葉巻病(Tomato yellow leaf curl virus)、メロン黄化えそ病(Melon yellow spot virus)、カボチャモザイク病(Watermelon mosaic virus)、萎縮病(Cucumber mosaic virus)、ズッキーニ黄斑モザイク病(Zucchini yellow mosaic virus)、カブモザイク病 (Turnip mosaic virus)、ウリ類退緑黄化病(Cucurbit chlorotic yellows virus)、退緑斑紋病(Capsicum chlorosis virus)、キュウリ黄化病(Beet pseudo yellows virus)、キク茎えそ病(chrysanthemum stem necrosis virus)、インパチェンスネクロティックスポット病(Impatiens necrotic spot virus)、アイリスイエロースポット(Iris yellow spot virus)、サツマイモ斑紋モザイク病 (Sweet potato internal cork virus)、サツマイモ縮葉モザイク病(Sweet potato shukuyo mosaic virus)、Polymixa属またはOlpidium属等によって媒介される各種植物のモザイクウイルス病。
Rice dwarf disease (Rice waika virus), Tundra disease (Rice tungro spherical virus, Rice tungro bacilliform virus), Rice grassy stunt disease, Rice ragged stunt virus, Rice striped leaf blight Diseases (Rice stripe virus), rice black streaked dwarf virus, rice southern black-streaked dwarf virus, rice gall dwarf virus, rice leaf blight ( Rice hoja blanca virus), White leaf desease of rice, Yellow dwarf virus, Red disease (Rice penyakit merah virus), Rice yellow stunt virus, Transition yellowing Disease (Rice transitory yellowing virus), Rice yellow mottle virus, Rice necrosis mosaic virus, Rice dwarf stunt virus, North wheat mosaic disease Northern Cereal Mosaic Virus), barley yellowing atrophy disease (Barley Yellow Dwarf Virus), wheat yellow leaves disease (Wheat yellow dwarf virus), Oat sterile dwarf (Oat sterile dwarf virus), Wheat streak mosaic (Wheat streak mosaic virus)
Maize dwarf mosaic virus, Maize stripe disease (maize stripe tenuivirus), Maize chlorotic dwarf (Maize chlorotic dwarf virus), Maize chlorotic mottle (maize chlorotic mottle virus), Maize rayado fino (maize rayado fino marafivirus), Corn stunt (Corn stunt spiroplasma), Maize bushy stunt (Maize bushy stunt phytoplasma), sugarcane mosaic disease (Sugarcane mosaic virus),
Soybean mild mosaic virus, Mosaic disease (Alfalfa Mosaic Virus, Bean yellow-spot mosaic virus, Soybean mosaic virus, Bean yellow mosaic virus, Cowpea severe mosaic virus), Soybean virus disease (Broad bean wilt virus, Bean common mosaic virus, Peanut stunt virus, Southern bean mosaic virus), soybean dwarf luteovirus, Milk-vetch dwarf luteovirus, Bean-pod mottle (Bean-pod mottle virus), Brazilian bud blight (Tobbaco streak virus) ), Cowpea chlorotic mottle (Cowpea chlorotic mottle), Mung bean yellow mosaic (Mung bean yellow mosaic virus), Peanut stripe (Peanut stripe mottle), Soybean crinkle leaf (Soybean crinkle leaf virus), Soybean severe stunt (Soybean severe stunt virus) Tomato chlorosis virus, Tomato spotted wilt virus, Tomato yellow leaf curl virus, Melon yellow wilt (Melon) yellow spot virus), pumpkin mosaic disease, Cucumber mosaic virus, Zucchini yellow mosaic virus, turnip mosaic virus, cucurbit yellowing disease ( Cucurbit chlorotic yellows virus), Capsicum chlorosis virus, Beet pseudo yellows virus, Chrysanthemum stem necrosis virus, Impatiens necrotic spot virus , Iris yellow spot virus, Sweet potato internal cork virus, Sweet potato shukuyo mosaic virus, Polymixa or Olpidium genus Viral disease.
トウモロコシモザイク病(Maize dwarf mosaic virus)、Maize stripe disease(maize stripe tenuivirus)、Maize chlorotic dwarf(Maize chlorotic dwarf virus)、Maize chlorotic mottle(maize chlorotic mottle virus)、Maize rayado fino (maize rayado fino marafivirus)、Corn stunt(Corn stunt spiroplasma)、Maize bushy stunt(Maize bushy stunt phytoplasma)、サトウキビモザイク病 (Sugarcane mosaic virus)、
ダイズ微斑モザイク病(Soybean mild mosaic virus)、モザイク病(Alfalfa Mosaic Virus、Bean yellow―spot mosaic virus、Soybean mosaic virus、Bean yellow mosaic virus、 Cowpea severe mosaic virus)、ダイズウイルス病(Broad bean wilt virus、 Bean common mosaic virus、 Peanut stunt virus、Southern bean mosaic virus)、ダイズ矮化病(Soybean dwarf luteovirus、Milk-vetch dwarf luteovirus)、Bean-pod mottle(Bean-pod mottle virus)、Brazilian bud blight(Tobbaco streak virus)、Cowpea chlorotic mottle(Cowpea chlorotic mottle)、Mung bean yellow mosaic (Mung bean yellow mosaic virus)、Peanut stripe (Peanut stripe mottle)、Soybean crinkle leaf(Soybean crinkle leaf virus)、Soybean severe stunt(Soybean severe stunt virus) トマト帰化病(Tomato chlorosis virus)、トマト黄化えそ病(Tomato spotted wilt virus)、トマト黄化葉巻病(Tomato yellow leaf curl virus)、メロン黄化えそ病(Melon yellow spot virus)、カボチャモザイク病(Watermelon mosaic virus)、萎縮病(Cucumber mosaic virus)、ズッキーニ黄斑モザイク病(Zucchini yellow mosaic virus)、カブモザイク病 (Turnip mosaic virus)、ウリ類退緑黄化病(Cucurbit chlorotic yellows virus)、退緑斑紋病(Capsicum chlorosis virus)、キュウリ黄化病(Beet pseudo yellows virus)、キク茎えそ病(chrysanthemum stem necrosis virus)、インパチェンスネクロティックスポット病(Impatiens necrotic spot virus)、アイリスイエロースポット(Iris yellow spot virus)、サツマイモ斑紋モザイク病 (Sweet potato internal cork virus)、サツマイモ縮葉モザイク病(Sweet potato shukuyo mosaic virus)、Polymixa属またはOlpidium属等によって媒介される各種植物のモザイクウイルス病。
Rice dwarf disease (Rice waika virus), Tundra disease (Rice tungro spherical virus, Rice tungro bacilliform virus), Rice grassy stunt disease, Rice ragged stunt virus, Rice striped leaf blight Diseases (Rice stripe virus), rice black streaked dwarf virus, rice southern black-streaked dwarf virus, rice gall dwarf virus, rice leaf blight ( Rice hoja blanca virus), White leaf desease of rice, Yellow dwarf virus, Red disease (Rice penyakit merah virus), Rice yellow stunt virus, Transition yellowing Disease (Rice transitory yellowing virus), Rice yellow mottle virus, Rice necrosis mosaic virus, Rice dwarf stunt virus, North wheat mosaic disease Northern Cereal Mosaic Virus), barley yellowing atrophy disease (Barley Yellow Dwarf Virus), wheat yellow leaves disease (Wheat yellow dwarf virus), Oat sterile dwarf (Oat sterile dwarf virus), Wheat streak mosaic (Wheat streak mosaic virus)
Maize dwarf mosaic virus, Maize stripe disease (maize stripe tenuivirus), Maize chlorotic dwarf (Maize chlorotic dwarf virus), Maize chlorotic mottle (maize chlorotic mottle virus), Maize rayado fino (maize rayado fino marafivirus), Corn stunt (Corn stunt spiroplasma), Maize bushy stunt (Maize bushy stunt phytoplasma), sugarcane mosaic disease (Sugarcane mosaic virus),
Soybean mild mosaic virus, Mosaic disease (Alfalfa Mosaic Virus, Bean yellow-spot mosaic virus, Soybean mosaic virus, Bean yellow mosaic virus, Cowpea severe mosaic virus), Soybean virus disease (Broad bean wilt virus, Bean common mosaic virus, Peanut stunt virus, Southern bean mosaic virus), soybean dwarf luteovirus, Milk-vetch dwarf luteovirus, Bean-pod mottle (Bean-pod mottle virus), Brazilian bud blight (Tobbaco streak virus) ), Cowpea chlorotic mottle (Cowpea chlorotic mottle), Mung bean yellow mosaic (Mung bean yellow mosaic virus), Peanut stripe (Peanut stripe mottle), Soybean crinkle leaf (Soybean crinkle leaf virus), Soybean severe stunt (Soybean severe stunt virus) Tomato chlorosis virus, Tomato spotted wilt virus, Tomato yellow leaf curl virus, Melon yellow wilt (Melon) yellow spot virus), pumpkin mosaic disease, Cucumber mosaic virus, Zucchini yellow mosaic virus, turnip mosaic virus, cucurbit yellowing disease ( Cucurbit chlorotic yellows virus), Capsicum chlorosis virus, Beet pseudo yellows virus, Chrysanthemum stem necrosis virus, Impatiens necrotic spot virus , Iris yellow spot virus, Sweet potato internal cork virus, Sweet potato shukuyo mosaic virus, Polymixa or Olpidium genus Viral disease.
本発明の有害節足動物防除剤は、本発明化合物と不活性担体とを含有する。本発明の有害節足動物防除剤は、通常、本発明化合物と固体担体、液体担体、ガス状担体等の不活性担体とを混合し、必要に応じて界面活性剤、その他の製剤用補助剤を添加して、乳剤、油剤、粉剤、粒剤、水和剤、フロアブル剤、マイクロカプセル剤、エアゾール剤、燻煙剤、毒餌剤、樹脂製剤、シャンプー剤、ペースト状製剤、泡沫剤、炭酸ガス製剤、錠剤等に製剤化されている。これらの製剤は蚊取り線香、電気蚊取りマット、液体蚊取り製剤、燻煙剤、燻蒸剤、シート製剤、スポットオン剤、経口処理剤に加工されて、使用されることもある。また、本発明の有害節足動物防除剤は、他の殺虫剤、殺ダニ剤、殺線虫剤、殺菌剤、植物成長調節剤、除草剤及び共力剤と混用することもできる。
本発明の有害節足動物防除剤は、本発明化合物を通常0.01~95重量%含有する。 The harmful arthropod control agent of the present invention contains the compound of the present invention and an inert carrier. The harmful arthropod control agent of the present invention is usually a mixture of the compound of the present invention and an inert carrier such as a solid carrier, a liquid carrier, a gaseous carrier, etc., and if necessary, a surfactant and other adjuvants for formulation. Emulsions, oils, powders, granules, wettable powders, flowables, microcapsules, aerosols, smokers, poisonous baits, resin preparations, shampoos, pastes, foams, carbon dioxide It is formulated into preparations, tablets and the like. These preparations may be used after being processed into mosquito coils, electric mosquito mats, liquid mosquito traps, fumigants, fumigants, sheet preparations, spot-on agents, or oral treatments. Moreover, the harmful arthropod control agent of the present invention can be mixed with other insecticides, acaricides, nematicides, fungicides, plant growth regulators, herbicides and synergists.
The harmful arthropod control agent of the present invention usually contains 0.01 to 95% by weight of the compound of the present invention.
本発明の有害節足動物防除剤は、本発明化合物を通常0.01~95重量%含有する。 The harmful arthropod control agent of the present invention contains the compound of the present invention and an inert carrier. The harmful arthropod control agent of the present invention is usually a mixture of the compound of the present invention and an inert carrier such as a solid carrier, a liquid carrier, a gaseous carrier, etc., and if necessary, a surfactant and other adjuvants for formulation. Emulsions, oils, powders, granules, wettable powders, flowables, microcapsules, aerosols, smokers, poisonous baits, resin preparations, shampoos, pastes, foams, carbon dioxide It is formulated into preparations, tablets and the like. These preparations may be used after being processed into mosquito coils, electric mosquito mats, liquid mosquito traps, fumigants, fumigants, sheet preparations, spot-on agents, or oral treatments. Moreover, the harmful arthropod control agent of the present invention can be mixed with other insecticides, acaricides, nematicides, fungicides, plant growth regulators, herbicides and synergists.
The harmful arthropod control agent of the present invention usually contains 0.01 to 95% by weight of the compound of the present invention.
製剤化の際に用いられる固体担体としては、例えば粘土類(カオリンクレー、珪藻土、ベントナイト、フバサミクレー、酸性白土等)、合成含水酸化珪素、タルク、セラミック、その他の無機鉱物(セリサイト、石英、硫黄、活性炭、炭酸カルシウム、水和シリカ等)、化学肥料(硫安、燐安、硝安、尿素、塩安等)等の微粉末及び粒状物等、並びに合成樹脂(ポリプロピレン、ポリアクリロニトリル、ポリメタクリル酸メチル、ポリエチレンテレフタレート等のポリエステル樹脂、ナイロン-6、ナイロン-11、ナイロン-66等のナイロン樹脂、ポリアミド樹脂、ポリ塩化ビニル、ポリ塩化ビニリデン、塩化ビニル-プロピレン共重合体等)があげられる。
Examples of solid carriers used for formulation include clays (kaolin clay, diatomaceous earth, bentonite, fusami clay, acidic clay), synthetic hydrous silicon oxide, talc, ceramics, and other inorganic minerals (sericite, quartz, sulfur). , Activated carbon, calcium carbonate, hydrated silica, etc.), fine powders and granules of chemical fertilizers (ammonium sulfate, phosphorous acid, ammonium nitrate, urea, ammonium chloride, etc.), and synthetic resins (polypropylene, polyacrylonitrile, polymethyl methacrylate) Polyester resins such as polyethylene terephthalate, nylon resins such as nylon-6, nylon-11, and nylon-66, polyamide resins, polyvinyl chloride, polyvinylidene chloride, and vinyl chloride-propylene copolymers).
液体担体としては、例えば水、アルコール類(メタノール、エタノール、イソプロピルアルコール、ブタノール、ヘキサノール、ベンジルアルコール、エチレングリコール、プロピレングリコール、フェノキシエタノール等)、ケトン類(アセトン、メチルエチルケトン、シクロヘキサノン等)、芳香族炭化水素類(トルエン、キシレン、エチルベンゼン、ドデシルベンゼン、フェニルキシリルエタン、メチルナフタレン等)、脂肪族炭化水素類(ヘキサン、シクロヘキサン、灯油、軽油等)、エステル類(酢酸エチル、酢酸ブチル、ミリスチン酸イソプロピル、オレイン酸エチル、アジピン酸ジイソプロピル、アジピン酸ジイソブチル、プロピレングリコールモノメチルエーテルアセテート等)、ニトリル類(アセトニトリル、イソブチロニトリル等)、エーテル類(ジイソプロピルエーテル、1,4-ジオキサン、エチレングリコールジメチルエーテル、ジエチレングリコールジメチルエーテル、ジエチレングリコールモノメチルエーテル、プロピレングリコールモノメチルエーテル、ジプロピレングリコールモノメチルエーテル、3-メトキシ-3-メチル-1-ブタノール等)、酸アミド類(ジメチルホルムアミド(以下、DMFと記す)、ジメチルアセトアミド等)、ハロゲン化炭化水素類(ジクロロメタン、トリクロロエタン、四塩化炭素等)、スルホキシド類(ジメチルスルホキシド等)、炭酸プロピレン及び植物油(大豆油、綿実油等)が挙げられる。
Examples of the liquid carrier include water, alcohols (methanol, ethanol, isopropyl alcohol, butanol, hexanol, benzyl alcohol, ethylene glycol, propylene glycol, phenoxyethanol, etc.), ketones (acetone, methyl ethyl ketone, cyclohexanone, etc.), aromatic hydrocarbons (Toluene, xylene, ethylbenzene, dodecylbenzene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, kerosene, light oil, etc.), esters (ethyl acetate, butyl acetate, isopropyl myristate, Ethyl oleate, diisopropyl adipate, diisobutyl adipate, propylene glycol monomethyl ether acetate, etc.), nitriles (acetonitrile, isobutyrate) Nitriles), ethers (diisopropyl ether, 1,4-dioxane, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, diethylene glycol monomethyl ether, propylene glycol monomethyl ether, dipropylene glycol monomethyl ether, 3-methoxy-3-methyl-1-butanol, etc. ), Acid amides (dimethylformamide (hereinafter referred to as DMF), dimethylacetamide, etc.), halogenated hydrocarbons (dichloromethane, trichloroethane, carbon tetrachloride, etc.), sulfoxides (dimethylsulfoxide, etc.), propylene carbonate and vegetable oil ( Soybean oil, cottonseed oil, etc.).
ガス状担体としては、例えばフルオロカーボン、ブタンガス、LPG(液化石油ガス)、ジメチルエーテル及び炭酸ガスがあげられる。
Examples of the gaseous carrier include fluorocarbon, butane gas, LPG (liquefied petroleum gas), dimethyl ether, and carbon dioxide gas.
界面活性剤としては、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルアリールエーテル、ポリエチレングリコール脂肪酸エステル等の非イオン界面活性剤、及びアルキルスルホン酸塩、アルキルベンゼンスルホン酸塩、アルキル硫酸塩等の陰イオン界面活性剤が挙げられる。
Examples of the surfactant include nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene alkyl aryl ether, and polyethylene glycol fatty acid ester, and anions such as alkyl sulfonate, alkyl benzene sulfonate, and alkyl sulfate. Surfactant is mentioned.
その他の製剤用補助剤としては、固着剤、分散剤、着色剤及び安定剤等、具体的には例えばカゼイン、ゼラチン、糖類(でんぷん、アラビアガム、セルロース誘導体、アルギン酸等)、リグニン誘導体、ベントナイト、合成水溶性高分子(ポリビニルアルコール、ポリビニルピロリドン、ポリアクリル酸類等)、PAP(酸性りん酸イソプロピル)、BHT(2,6-ジ-tert-ブチル-4-メチルフェノール)、BHA(2-tert-ブチル-4-メトキシフェノールと3-tert-ブチル-4-メトキシフェノールとの混合物)が挙げられる。
Examples of other adjuvants for preparation include fixing agents, dispersants, colorants and stabilizers, such as casein, gelatin, saccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, bentonite, Synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), PAP (isopropyl acid phosphate), BHT (2,6-di-tert-butyl-4-methylphenol), BHA (2-tert- And a mixture of butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol).
樹脂製剤の基材としては、例えば塩化ビニル系重合体、ポリウレタン等を挙げることができ、これらの基材には必要によりフタル酸エステル類(フタル酸ジメチル、フタル酸ジオクチル等)、アジピン酸エステル類、ステアリン酸等の可塑剤が添加されていてもよい。樹脂製剤は該基材中に化合物を通常の混練装置を用いて混練した後、射出成型、押出成型、プレス成型等により成型することにより得られ、必要により更に成型、裁断等の工程を経て、板状、フィルム状、テープ状、網状、ひも状等の樹脂製剤に加工できる。これらの樹脂製剤は、例えば動物用首輪、動物用イヤータッグ、シート製剤、誘引ひも、園芸用支柱として加工される。
毒餌の基材としては、例えば穀物粉、植物油、糖、結晶セルロース等が挙げられ、更に必要に応じて、ジブチルヒドロキシトルエン、ノルジヒドログアイアレチン酸等の酸化防止剤、デヒドロ酢酸等の保存料、トウガラシ末等の子供やペットによる誤食防止剤、チーズ香料、タマネギ香料ピーナッツオイル等の害虫誘引性香料等が添加される。 Examples of the base material of the resin preparation include vinyl chloride polymers, polyurethanes, etc., and these base materials include phthalic acid esters (dimethyl phthalate, dioctyl phthalate, etc.) and adipic acid esters as necessary. Further, a plasticizer such as stearic acid may be added. The resin formulation is obtained by kneading the compound in the base material using a normal kneading apparatus, and then molding by injection molding, extrusion molding, press molding, etc., and if necessary, through steps such as molding, cutting, It can be processed into resin preparations such as plate, film, tape, net, and string. These resin preparations are processed, for example, as animal collars, animal ear tags, sheet preparations, attracting strings, or gardening supports.
Examples of the bait base include cereal flour, vegetable oil, sugar, crystalline cellulose and the like, and if necessary, antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid, and preservatives such as dehydroacetic acid. Additives for preventing accidental eating by children and pets such as pepper powder, pests such as cheese flavor, onion flavor and peanut oil are added.
毒餌の基材としては、例えば穀物粉、植物油、糖、結晶セルロース等が挙げられ、更に必要に応じて、ジブチルヒドロキシトルエン、ノルジヒドログアイアレチン酸等の酸化防止剤、デヒドロ酢酸等の保存料、トウガラシ末等の子供やペットによる誤食防止剤、チーズ香料、タマネギ香料ピーナッツオイル等の害虫誘引性香料等が添加される。 Examples of the base material of the resin preparation include vinyl chloride polymers, polyurethanes, etc., and these base materials include phthalic acid esters (dimethyl phthalate, dioctyl phthalate, etc.) and adipic acid esters as necessary. Further, a plasticizer such as stearic acid may be added. The resin formulation is obtained by kneading the compound in the base material using a normal kneading apparatus, and then molding by injection molding, extrusion molding, press molding, etc., and if necessary, through steps such as molding, cutting, It can be processed into resin preparations such as plate, film, tape, net, and string. These resin preparations are processed, for example, as animal collars, animal ear tags, sheet preparations, attracting strings, or gardening supports.
Examples of the bait base include cereal flour, vegetable oil, sugar, crystalline cellulose and the like, and if necessary, antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid, and preservatives such as dehydroacetic acid. Additives for preventing accidental eating by children and pets such as pepper powder, pests such as cheese flavor, onion flavor and peanut oil are added.
本発明の有害節足動物防除方法は、本発明化合物の有効量を有害節足動物に直接、及び/又は、有害節足動物の生息場所(植物、土壌、家屋内、動物体等)に施用することにより行われる。本発明の有害節足動物防除方法には、通常、本発明の有害節足動物防除剤の形態で用いられる。
In the method for controlling harmful arthropods of the present invention, an effective amount of the compound of the present invention is applied directly to harmful arthropods and / or to the place where the harmful arthropods live (plants, soil, households, animal bodies, etc.). Is done. The harmful arthropod control method of the present invention is usually used in the form of the harmful arthropod control agent of the present invention.
本発明の有害節足動物防除剤を農業分野の有害節足動物防除に用いる場合、その施用量は、10000m2あたりの本発明化合物量で通常1~10000gである。本発明の有害節足動物防除剤が乳剤、水和剤、フロアブル剤等に製剤化されている場合は、通常、本発明化合物の濃度が0.01~10000ppmとなるように水で希釈して施用し、粒剤、粉剤等は、通常、そのまま施用する。
When the harmful arthropod control agent of the present invention is used for controlling harmful arthropods in the agricultural field, the application amount is usually 1 to 10,000 g as the amount of the compound of the present invention per 10,000 m 2 . When the harmful arthropod control agent of the present invention is formulated into an emulsion, wettable powder, flowable agent, etc., it is usually diluted with water so that the concentration of the compound of the present invention becomes 0.01 to 10,000 ppm. Applied, granules, powders, etc. are usually applied as they are.
これらの製剤や製剤の水希釈液は、有害節足動物又は有害節足動物から保護すべき作物等の植物に直接散布処理してもよく、また耕作地の土壌に生息する有害節足動物を防除するために、該土壌に処理してもよい。
These preparations and water dilutions of these preparations may be sprayed directly on harmful arthropods or plants such as crops to be protected from harmful arthropods, and harmful arthropods that inhabit the soil of cultivated land. You may treat to this soil in order to control.
また、シート状やひも状に加工した樹脂製剤を作物に巻き付ける、作物近傍に張り渡す、株元土壌に敷く等の方法により処理することもできる。
Also, it can be treated by methods such as wrapping a resin preparation processed into a sheet or string around the crop, stretching it around the crop, or laying it on the stock soil.
本発明の有害節足動物防除剤を家屋内に生息する有害節足動物の防除に用いる場合、その施用量は、面上に処理する場合は処理面積1m2あたりの本発明化合物量で、通常、0.01~1000mgであり、空間に処理する場合は処理空間1m3あたりの本発明化合物量で、通常、0.01~500mgである。本発明の有害節足動物防除剤が乳剤、水和剤、フロアブル剤等に製剤化されている場合は、通常本発明化合物の濃度が0.1~10000ppmとなるように水で希釈して施用し、油剤、エアゾール剤、燻煙剤、毒餌剤等はそのまま施用する。
When the harmful arthropod control agent of the present invention is used for controlling harmful arthropods that live in the house, the amount applied is usually the amount of the compound of the present invention per 1 m 2 of treatment area when treated on the surface. 0.01 to 1000 mg, and when processing in a space, the amount of the compound of the present invention per 1 m 3 of the processing space is usually 0.01 to 500 mg. When the harmful arthropod control agent of the present invention is formulated into an emulsion, wettable powder, flowable agent, etc., it is usually diluted with water so that the concentration of the compound of the present invention is 0.1 to 10,000 ppm. Apply oils, aerosols, smoke, poison baits, etc. as they are.
本発明の有害節足動物防除剤をウシ、ウマ、ブタ、ヒツジ、ヤギ、ニワトリ用の家畜、イヌ、ネコ、ラット、マウス等の小動物の外部寄生虫防除に用いる場合は、獣医学的に公知の方法で動物に使用することができる。具体的な使用方法としては、全身抑制を目的にする場合には、例えば錠剤、飼料混入、坐薬、注射(筋肉内、皮下、静脈内、腹腔内等)により投与され、非全身的抑制を目的とする場合には、例えば油剤若しくは水性液剤を噴霧する、ポアオン処理若しくはスポットオン処理を行う、シャンプー製剤で動物を洗う又は樹脂製剤を首輪や耳札にして動物に付ける等の方法により用いられる。動物体に投与する場合の本発明化合物の量は、通常動物の体重1kgに対して、0.1~1000mgの範囲である。
When the harmful arthropod control agent of the present invention is used to control ectoparasites of cattle, horses, pigs, sheep, goats, chickens, small animals such as dogs, cats, rats, mice, etc., it is well known in veterinary medicine. Can be used on animals. As a specific method of use, for the purpose of systemic suppression, for example, administration by tablet, feed mixing, suppository, injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.) is intended for non-systemic suppression. In this case, for example, an oil agent or an aqueous liquid is sprayed, a pour-on treatment or a spot-on treatment is performed, the animal is washed with a shampoo preparation, or a resin preparation is attached to the animal with a collar or ear tag. The amount of the compound of the present invention when administered to an animal body is usually in the range of 0.1 to 1000 mg per 1 kg body weight of the animal.
以下に製造例、製剤例及び試験例を示して、本発明をより具体的に説明するが、本発明はこれらの例に限定されない。
実施例において、室温とは通常10~30℃を示す。1H NMRとはプロトン核磁気共鳴スペクトルを示し、内部標準としてテトラメチルシランを用い、ケミカルシフト(δ)をppmで表記した。 Hereinafter, the present invention will be described more specifically with reference to production examples, formulation examples, and test examples. However, the present invention is not limited to these examples.
In the examples, room temperature usually indicates 10 to 30 ° C. 1 H NMR represents a proton nuclear magnetic resonance spectrum, tetramethylsilane was used as an internal standard, and chemical shift (δ) was expressed in ppm.
実施例において、室温とは通常10~30℃を示す。1H NMRとはプロトン核磁気共鳴スペクトルを示し、内部標準としてテトラメチルシランを用い、ケミカルシフト(δ)をppmで表記した。 Hereinafter, the present invention will be described more specifically with reference to production examples, formulation examples, and test examples. However, the present invention is not limited to these examples.
In the examples, room temperature usually indicates 10 to 30 ° C. 1 H NMR represents a proton nuclear magnetic resonance spectrum, tetramethylsilane was used as an internal standard, and chemical shift (δ) was expressed in ppm.
製造例1(1)
4-ヒドロキシフェニル=トリフルオロメタンスルホナート10.5g及び酢酸35mLの混合物に、室温で65%硝酸4.2gをゆっくり加えた後、室温で1時間撹拌した。反応混合物に水を加え、酢酸エチルで抽出した。有機層を水洗し、無水硫酸マグネシウムで乾燥した後、有機層を減圧下濃縮し、次式で示される化合物(以下、中間体(1-1)と記す)10.99gを得た。
1H-NMR (CDCl3) δ: 10.60 (1H, s), 8.07 (1H, d), 7.53 (1H, dd), 7.29 (1H, d). Production Example 1 (1)
After slowly adding 4.2 g of 65% nitric acid at room temperature to a mixture of 10.5 g of 4-hydroxyphenyl = trifluoromethanesulfonate and 35 mL of acetic acid, the mixture was stirred at room temperature for 1 hour. Water was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and dried over anhydrous magnesium sulfate, and then the organic layer was concentrated under reduced pressure to obtain 10.99 g of a compound represented by the following formula (hereinafter referred to as intermediate (1-1)).
1 H-NMR (CDCl 3 ) δ: 10.60 (1H, s), 8.07 (1H, d), 7.53 (1H, dd), 7.29 (1H, d).
4-ヒドロキシフェニル=トリフルオロメタンスルホナート10.5g及び酢酸35mLの混合物に、室温で65%硝酸4.2gをゆっくり加えた後、室温で1時間撹拌した。反応混合物に水を加え、酢酸エチルで抽出した。有機層を水洗し、無水硫酸マグネシウムで乾燥した後、有機層を減圧下濃縮し、次式で示される化合物(以下、中間体(1-1)と記す)10.99gを得た。
1H-NMR (CDCl3) δ: 10.60 (1H, s), 8.07 (1H, d), 7.53 (1H, dd), 7.29 (1H, d). Production Example 1 (1)
After slowly adding 4.2 g of 65% nitric acid at room temperature to a mixture of 10.5 g of 4-hydroxyphenyl = trifluoromethanesulfonate and 35 mL of acetic acid, the mixture was stirred at room temperature for 1 hour. Water was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and dried over anhydrous magnesium sulfate, and then the organic layer was concentrated under reduced pressure to obtain 10.99 g of a compound represented by the following formula (hereinafter referred to as intermediate (1-1)).
1 H-NMR (CDCl 3 ) δ: 10.60 (1H, s), 8.07 (1H, d), 7.53 (1H, dd), 7.29 (1H, d).
製造例1(2)
中間体(1-1)5.44g、鉄粉6.09g、酢酸7mL、水7mL及び酢酸エチル21mLの混合物を還流下で1時間撹拌した。反応混合物をろ過した後、ろ液に水を加えて酢酸エチルで抽出した。有機層を水洗した後、無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣にn-ヘキサンとクロロホルムとを加えて、析出した固体をろ取し、次式で示される化合物(以下、中間体(1-2)と記す)3.53gを得た。
1H-NMR (CDCl3) δ: 6.71 (1H, d), 6.64 (1H, d), 6.54 (1H, dd), 4.95 (1H, br s), 3.90 (2H, br s). Production Example 1 (2)
A mixture of intermediate (1-1) 5.44 g, iron powder 6.09 g, acetic acid 7 mL, water 7 mL and ethyl acetate 21 mL was stirred under reflux for 1 hour. The reaction mixture was filtered, water was added to the filtrate, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. N-Hexane and chloroform were added to the obtained residue, and the precipitated solid was collected by filtration to obtain 3.53 g of a compound represented by the following formula (hereinafter referred to as intermediate (1-2)).
1 H-NMR (CDCl 3 ) δ: 6.71 (1H, d), 6.64 (1H, d), 6.54 (1H, dd), 4.95 (1H, br s), 3.90 (2H, br s).
中間体(1-1)5.44g、鉄粉6.09g、酢酸7mL、水7mL及び酢酸エチル21mLの混合物を還流下で1時間撹拌した。反応混合物をろ過した後、ろ液に水を加えて酢酸エチルで抽出した。有機層を水洗した後、無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣にn-ヘキサンとクロロホルムとを加えて、析出した固体をろ取し、次式で示される化合物(以下、中間体(1-2)と記す)3.53gを得た。
1H-NMR (CDCl3) δ: 6.71 (1H, d), 6.64 (1H, d), 6.54 (1H, dd), 4.95 (1H, br s), 3.90 (2H, br s). Production Example 1 (2)
A mixture of intermediate (1-1) 5.44 g, iron powder 6.09 g, acetic acid 7 mL, water 7 mL and ethyl acetate 21 mL was stirred under reflux for 1 hour. The reaction mixture was filtered, water was added to the filtrate, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. N-Hexane and chloroform were added to the obtained residue, and the precipitated solid was collected by filtration to obtain 3.53 g of a compound represented by the following formula (hereinafter referred to as intermediate (1-2)).
1 H-NMR (CDCl 3 ) δ: 6.71 (1H, d), 6.64 (1H, d), 6.54 (1H, dd), 4.95 (1H, br s), 3.90 (2H, br s).
製造例1(3)
2-(エチルスルファニル)-4-(トリフルオロメチル)安息香酸320mg、二塩化オキサリル0.16mL、DMF1滴及びクロロホルム5mLの混合物を室温で1時間撹拌し、減圧下濃縮した。得られた残渣とTHF5mLとの混合物を、中間体(1-2)329mgとTHF8mLとの混合物に氷冷下で加え、室温にした後室温で1時間撹拌した。反応混合物に飽和炭酸水素ナトリウム水溶液を加えて、酢酸エチルで抽出した。有機層を無水硫酸ナトリウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、中間体(1-3)と記す)316mgを得た。
1H-NMR (CDCl3) δ: 9.31 (1H, s), 8.15 (1H, s), 8.03 (1H, d), 7.74 (1H, s), 7.62 (1H, d), 7.41 (1H, s), 7.11-7.06 (2H, m), 3.05 (2H, q), 1.36 (3H, t). Production Example 1 (3)
A mixture of 320 mg of 2- (ethylsulfanyl) -4- (trifluoromethyl) benzoic acid, 0.16 mL of oxalyl dichloride, 1 drop of DMF and 5 mL of chloroform was stirred at room temperature for 1 hour and concentrated under reduced pressure. A mixture of the obtained residue and 5 mL of THF was added to a mixture of 329 mg of Intermediate (1-2) and 8 mL of THF under ice-cooling, and the mixture was brought to room temperature and stirred at room temperature for 1 hour. Saturated aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography, so as to obtain 316 mg of a compound represented by the following formula (hereinafter referred to as intermediate (1-3)).
1 H-NMR (CDCl 3 ) δ: 9.31 (1H, s), 8.15 (1H, s), 8.03 (1H, d), 7.74 (1H, s), 7.62 (1H, d), 7.41 (1H, s ), 7.11-7.06 (2H, m), 3.05 (2H, q), 1.36 (3H, t).
2-(エチルスルファニル)-4-(トリフルオロメチル)安息香酸320mg、二塩化オキサリル0.16mL、DMF1滴及びクロロホルム5mLの混合物を室温で1時間撹拌し、減圧下濃縮した。得られた残渣とTHF5mLとの混合物を、中間体(1-2)329mgとTHF8mLとの混合物に氷冷下で加え、室温にした後室温で1時間撹拌した。反応混合物に飽和炭酸水素ナトリウム水溶液を加えて、酢酸エチルで抽出した。有機層を無水硫酸ナトリウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、中間体(1-3)と記す)316mgを得た。
1H-NMR (CDCl3) δ: 9.31 (1H, s), 8.15 (1H, s), 8.03 (1H, d), 7.74 (1H, s), 7.62 (1H, d), 7.41 (1H, s), 7.11-7.06 (2H, m), 3.05 (2H, q), 1.36 (3H, t). Production Example 1 (3)
A mixture of 320 mg of 2- (ethylsulfanyl) -4- (trifluoromethyl) benzoic acid, 0.16 mL of oxalyl dichloride, 1 drop of DMF and 5 mL of chloroform was stirred at room temperature for 1 hour and concentrated under reduced pressure. A mixture of the obtained residue and 5 mL of THF was added to a mixture of 329 mg of Intermediate (1-2) and 8 mL of THF under ice-cooling, and the mixture was brought to room temperature and stirred at room temperature for 1 hour. Saturated aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography, so as to obtain 316 mg of a compound represented by the following formula (hereinafter referred to as intermediate (1-3)).
1 H-NMR (CDCl 3 ) δ: 9.31 (1H, s), 8.15 (1H, s), 8.03 (1H, d), 7.74 (1H, s), 7.62 (1H, d), 7.41 (1H, s ), 7.11-7.06 (2H, m), 3.05 (2H, q), 1.36 (3H, t).
製造例1(4)
中間体(1-3)を310mg、アゾジカルボン酸ビス(2-メトキシエチル)260mg、トリフェニルホスフィン282mg及びTHF8mLの混合物を室温で30分間撹拌した後、50℃で1時間撹拌した。反応混合物に飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。有機層を無水硫酸ナトリウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、化合物(2)と記す)を212mg得た。
1H-NMR (CDCl3) δ: 8.28 (1H, d), 7.84 (1H, d), 7.68 (1H, d), 7.62 (1H, s), 7.51 (1H, d), 7.35 (1H, dd), 3.11 (2H, q), 1.47 (3H, t). Production Example 1 (4)
A mixture of 310 mg of the intermediate (1-3), 260 mg of bis (2-methoxyethyl) azodicarboxylate, 282 mg of triphenylphosphine and 8 mL of THF was stirred at room temperature for 30 minutes, and then stirred at 50 ° C. for 1 hour. A saturated aqueous ammonium chloride solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 212 mg of a compound represented by the following formula (hereinafter referred to as compound (2)).
1 H-NMR (CDCl 3 ) δ: 8.28 (1H, d), 7.84 (1H, d), 7.68 (1H, d), 7.62 (1H, s), 7.51 (1H, d), 7.35 (1H, dd ), 3.11 (2H, q), 1.47 (3H, t).
中間体(1-3)を310mg、アゾジカルボン酸ビス(2-メトキシエチル)260mg、トリフェニルホスフィン282mg及びTHF8mLの混合物を室温で30分間撹拌した後、50℃で1時間撹拌した。反応混合物に飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。有機層を無水硫酸ナトリウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、化合物(2)と記す)を212mg得た。
1H-NMR (CDCl3) δ: 8.28 (1H, d), 7.84 (1H, d), 7.68 (1H, d), 7.62 (1H, s), 7.51 (1H, d), 7.35 (1H, dd), 3.11 (2H, q), 1.47 (3H, t). Production Example 1 (4)
A mixture of 310 mg of the intermediate (1-3), 260 mg of bis (2-methoxyethyl) azodicarboxylate, 282 mg of triphenylphosphine and 8 mL of THF was stirred at room temperature for 30 minutes, and then stirred at 50 ° C. for 1 hour. A saturated aqueous ammonium chloride solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 212 mg of a compound represented by the following formula (hereinafter referred to as compound (2)).
1 H-NMR (CDCl 3 ) δ: 8.28 (1H, d), 7.84 (1H, d), 7.68 (1H, d), 7.62 (1H, s), 7.51 (1H, d), 7.35 (1H, dd ), 3.11 (2H, q), 1.47 (3H, t).
製造例1(4)に記載の方法に準じて製造した化合物と、その物性値を以下に示す。
式(1-c)
で示される化合物において、A及びR4の組み合わせが[表1]で表される化合物。 The compounds produced according to the method described in Production Example 1 (4) and their physical properties are shown below.
Formula (1-c)
Wherein the combination of A and R 4 is represented by [Table 1].
式(1-c)
で示される化合物において、A及びR4の組み合わせが[表1]で表される化合物。 The compounds produced according to the method described in Production Example 1 (4) and their physical properties are shown below.
Formula (1-c)
Wherein the combination of A and R 4 is represented by [Table 1].
化合物(8):1H-NMR (CDCl3) δ: 8.80-8.77 (1H, m), 7.94 (1H, d), 7.90 (1H, d), 7.80-7.76 (1H, m), 7.40 (1H, dd), 3.11 (2H, q), 1.51 (3H, t).
Compound (8): 1 H-NMR (CDCl 3 ) δ: 8.80-8.77 (1H, m), 7.94 (1H, d), 7.90 (1H, d), 7.80-7.76 (1H, m), 7.40 (1H , dd), 3.11 (2H, q), 1.51 (3H, t).
式(1-d)
で示される化合物において、A及びR4の組み合わせが[表2]で表される化合物。 Formula (1-d)
Wherein the combination of A and R 4 is represented by [Table 2].
で示される化合物において、A及びR4の組み合わせが[表2]で表される化合物。 Formula (1-d)
Wherein the combination of A and R 4 is represented by [Table 2].
化合物(10):1H-NMR (CDCl3) δ: 9.28 (1H, s), 8.74 (1H, d), 8.30 (1H, d), 8.20 (1H, s), 7.83 (1H, d), 7.81-7.77 (1H, m), 7.45 (1H, dd), 3.97 (2H, q), 1.45 (3H, t).
Compound (10): 1 H-NMR (CDCl 3 ) δ: 9.28 (1H, s), 8.74 (1H, d), 8.30 (1H, d), 8.20 (1H, s), 7.83 (1H, d), 7.81-7.77 (1H, m), 7.45 (1H, dd), 3.97 (2H, q), 1.45 (3H, t).
製造例2
化合物(2)を212mg及びクロロホルム5mLの混合物に、氷冷下でmCPBA(純度65%以上)228mgを加え、室温で3時間撹拌した。反応混合物にチオ硫酸ナトリウム水溶液を加えて、クロロホルムで抽出した。有機層を飽和炭酸水素ナトリウム水溶液で洗浄し、無水硫酸ナトリウムで乾燥後、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、化合物(3)と記す)を208mg得た。
1H-NMR (CDCl3) δ: 8.53 (1H, d), 8.14 (1H, d), 8.08 (1H, dd), 7.79 (1H, d), 7.71 (1H, d), 7.40 (1H, dd), 3.89 (2H, q), 1.44 (3H, t). Production Example 2
To a mixture of 212 mg of compound (2) and 5 mL of chloroform, 228 mg of mCPBA (purity 65% or more) was added under ice cooling, and the mixture was stirred at room temperature for 3 hours. A sodium thiosulfate aqueous solution was added to the reaction mixture, and the mixture was extracted with chloroform. The organic layer was washed with a saturated aqueous sodium hydrogen carbonate solution and dried over anhydrous sodium sulfate, and then the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 208 mg of a compound represented by the following formula (hereinafter referred to as compound (3)).
1 H-NMR (CDCl 3 ) δ: 8.53 (1H, d), 8.14 (1H, d), 8.08 (1H, dd), 7.79 (1H, d), 7.71 (1H, d), 7.40 (1H, dd ), 3.89 (2H, q), 1.44 (3H, t).
化合物(2)を212mg及びクロロホルム5mLの混合物に、氷冷下でmCPBA(純度65%以上)228mgを加え、室温で3時間撹拌した。反応混合物にチオ硫酸ナトリウム水溶液を加えて、クロロホルムで抽出した。有機層を飽和炭酸水素ナトリウム水溶液で洗浄し、無水硫酸ナトリウムで乾燥後、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、化合物(3)と記す)を208mg得た。
1H-NMR (CDCl3) δ: 8.53 (1H, d), 8.14 (1H, d), 8.08 (1H, dd), 7.79 (1H, d), 7.71 (1H, d), 7.40 (1H, dd), 3.89 (2H, q), 1.44 (3H, t). Production Example 2
To a mixture of 212 mg of compound (2) and 5 mL of chloroform, 228 mg of mCPBA (purity 65% or more) was added under ice cooling, and the mixture was stirred at room temperature for 3 hours. A sodium thiosulfate aqueous solution was added to the reaction mixture, and the mixture was extracted with chloroform. The organic layer was washed with a saturated aqueous sodium hydrogen carbonate solution and dried over anhydrous sodium sulfate, and then the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 208 mg of a compound represented by the following formula (hereinafter referred to as compound (3)).
1 H-NMR (CDCl 3 ) δ: 8.53 (1H, d), 8.14 (1H, d), 8.08 (1H, dd), 7.79 (1H, d), 7.71 (1H, d), 7.40 (1H, dd ), 3.89 (2H, q), 1.44 (3H, t).
製造例2に記載の方法に準じて製造した化合物と、その物性値を以下に示す。
式(1-e)
で示される化合物において、A及びR4が[表3]で表される化合物。 The compounds produced according to the method described in Production Example 2 and their physical properties are shown below.
Formula (1-e)
A compound in which A and R 4 are represented by [Table 3].
式(1-e)
で示される化合物において、A及びR4が[表3]で表される化合物。 The compounds produced according to the method described in Production Example 2 and their physical properties are shown below.
Formula (1-e)
A compound in which A and R 4 are represented by [Table 3].
化合物(1):
1H-NMR (CDCl3) δ: 8.26 (1H, d), 7.94 (1H, d), 7.79 (1H, dd), 7.75 (1H, d), 7.68 (1H, d), 7.37 (1H, dd), 3.87 (2H, q), 1.43 (3H, t).
化合物(7):1H-NMR (CDCl3) δ: 8.41 (1H, d), 7.96 (1H, dd), 7.86 (1H, d), 7.75 (1H, d), 7.68 (1H, d), 7.37 (1H, dd), 3.87 (2H, q), 1.43 (3H, t).
化合物(9):1H-NMR (CDCl3) δ: 9.25 (1H, d), 8.84 (1H, d), 7.83 (1H, d), 7.79 (1H, d), 7.45 (1H, dd), 4.08 (2H, q), 1.47 (3H, t).
Compound (1):
1 H-NMR (CDCl 3 ) δ: 8.26 (1H, d), 7.94 (1H, d), 7.79 (1H, dd), 7.75 (1H, d), 7.68 (1H, d), 7.37 (1H, dd ), 3.87 (2H, q), 1.43 (3H, t).
Compound (7): 1 H-NMR (CDCl 3 ) δ: 8.41 (1H, d), 7.96 (1H, dd), 7.86 (1H, d), 7.75 (1H, d), 7.68 (1H, d), 7.37 (1H, dd), 3.87 (2H, q), 1.43 (3H, t).
Compound (9): 1 H-NMR (CDCl 3 ) δ: 9.25 (1H, d), 8.84 (1H, d), 7.83 (1H, d), 7.79 (1H, d), 7.45 (1H, dd), 4.08 (2H, q), 1.47 (3H, t).
式(1-f)
で示される化合物において、A及びR4が[表4]で表される化合物。 Formula (1-f)
A compound in which A and R 4 are represented by [Table 4].
で示される化合物において、A及びR4が[表4]で表される化合物。 Formula (1-f)
A compound in which A and R 4 are represented by [Table 4].
化合物(12):1H-NMR (CDCl3) δ: 9.03 (1H, dd), 8.60 (1H, dd), 7.91 (1H, d), 7.75 (1H, dd), 7.66 (1H, d), 7.39 (1H, dd), 4.00 (2H, q), 1.43 (3H, t).
Compound (12): 1 H-NMR (CDCl 3 ) δ: 9.03 (1H, dd), 8.60 (1H, dd), 7.91 (1H, d), 7.75 (1H, dd), 7.66 (1H, d), 7.39 (1H, dd), 4.00 (2H, q), 1.43 (3H, t).
製造例3(1)
4-ヒドロキシフェニル=トリフルオロメタンスルホナートの代わりに、3-ヒドロキシフェニル=トリフルオロメタンスルホナートを用い、製造例1(1)に記載の方法に準じて、次式で示される化合物(以下、中間体(3-1)と記す)を得た。
1H-NMR (CDCl3) δ: 10.73 (1H, s), 8.25 (1H, d), 7.13 (1H, d), 6.95 (1H, dd). Production Example 3 (1)
In place of 4-hydroxyphenyl = trifluoromethanesulfonate, 3-hydroxyphenyl = trifluoromethanesulfonate was used, and a compound represented by the following formula (hereinafter referred to as an intermediate) according to the method described in Production Example 1 (1) (Denoted as (3-1)).
1 H-NMR (CDCl 3 ) δ: 10.73 (1H, s), 8.25 (1H, d), 7.13 (1H, d), 6.95 (1H, dd).
4-ヒドロキシフェニル=トリフルオロメタンスルホナートの代わりに、3-ヒドロキシフェニル=トリフルオロメタンスルホナートを用い、製造例1(1)に記載の方法に準じて、次式で示される化合物(以下、中間体(3-1)と記す)を得た。
1H-NMR (CDCl3) δ: 10.73 (1H, s), 8.25 (1H, d), 7.13 (1H, d), 6.95 (1H, dd). Production Example 3 (1)
In place of 4-hydroxyphenyl = trifluoromethanesulfonate, 3-hydroxyphenyl = trifluoromethanesulfonate was used, and a compound represented by the following formula (hereinafter referred to as an intermediate) according to the method described in Production Example 1 (1) (Denoted as (3-1)).
1 H-NMR (CDCl 3 ) δ: 10.73 (1H, s), 8.25 (1H, d), 7.13 (1H, d), 6.95 (1H, dd).
製造例3(2)
中間体(1-1)の代わりに、中間体(3-1)を用い、製造例1(2)に記載の方法に準じて、次式で示される化合物(以下、中間体(3-2)と記す)を得た。
1H-NMR (CDCl3) δ: 6.76-6.67 (3H, m), 5.26 (1H, br s), 3.76 (2H, br s). Production Example 3 (2)
In place of intermediate (1-1), intermediate (3-1) was used, and a compound represented by the following formula (hereinafter referred to as intermediate (3-2) was prepared according to the method described in Production Example 1 (2). )).
1 H-NMR (CDCl 3 ) δ: 6.76-6.67 (3H, m), 5.26 (1H, br s), 3.76 (2H, br s).
中間体(1-1)の代わりに、中間体(3-1)を用い、製造例1(2)に記載の方法に準じて、次式で示される化合物(以下、中間体(3-2)と記す)を得た。
1H-NMR (CDCl3) δ: 6.76-6.67 (3H, m), 5.26 (1H, br s), 3.76 (2H, br s). Production Example 3 (2)
In place of intermediate (1-1), intermediate (3-1) was used, and a compound represented by the following formula (hereinafter referred to as intermediate (3-2) was prepared according to the method described in Production Example 1 (2). )).
1 H-NMR (CDCl 3 ) δ: 6.76-6.67 (3H, m), 5.26 (1H, br s), 3.76 (2H, br s).
製造例3(3)
2-ブロモ-3-フルオロピリジン25g、水素化ナトリウム(60%油性)6.25g及びDMF100mLの混合物に、氷冷下でエタンチオール10.5mLを1時間かけて加えて室温にした後、室温で一晩撹拌した。反応混合物を水に注ぎ、MTBEで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、中間体(3-3)と記す)を21.3g得た。
1H-NMR (CDCl3) δ: 8.13 (1H, dd), 7.46 (1H, dd), 7.23 (1H, dd), 2.96 (2H, q), 1.40 (3H, t). Production Example 3 (3)
To a mixture of 25 g of 2-bromo-3-fluoropyridine, 6.25 g of sodium hydride (60% oily) and 100 mL of DMF, 10.5 mL of ethanethiol was added over 1 hour under ice-cooling, and the mixture was brought to room temperature. Stir overnight. The reaction mixture was poured into water and extracted with MTBE. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 21.3 g of a compound represented by the following formula (hereinafter referred to as intermediate (3-3)).
1 H-NMR (CDCl 3 ) δ: 8.13 (1H, dd), 7.46 (1H, dd), 7.23 (1H, dd), 2.96 (2H, q), 1.40 (3H, t).
2-ブロモ-3-フルオロピリジン25g、水素化ナトリウム(60%油性)6.25g及びDMF100mLの混合物に、氷冷下でエタンチオール10.5mLを1時間かけて加えて室温にした後、室温で一晩撹拌した。反応混合物を水に注ぎ、MTBEで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、中間体(3-3)と記す)を21.3g得た。
1H-NMR (CDCl3) δ: 8.13 (1H, dd), 7.46 (1H, dd), 7.23 (1H, dd), 2.96 (2H, q), 1.40 (3H, t). Production Example 3 (3)
To a mixture of 25 g of 2-bromo-3-fluoropyridine, 6.25 g of sodium hydride (60% oily) and 100 mL of DMF, 10.5 mL of ethanethiol was added over 1 hour under ice-cooling, and the mixture was brought to room temperature. Stir overnight. The reaction mixture was poured into water and extracted with MTBE. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 21.3 g of a compound represented by the following formula (hereinafter referred to as intermediate (3-3)).
1 H-NMR (CDCl 3 ) δ: 8.13 (1H, dd), 7.46 (1H, dd), 7.23 (1H, dd), 2.96 (2H, q), 1.40 (3H, t).
製造例3(4)
中間体(3-3)を1.75g、THF10mL及びジエチルエーテル25mLの混合物に-78℃でn-ブチルリチウム(1.55M)5.7mLを加えて、-78℃で1時間撹拌した。反応混合物に-78℃でDMF0.41mLを加えて、-78℃で30分撹拌後、室温に昇温した。反応混合物に水を加え、MTBEで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、中間体(3-4)と記す)を941mg得た。
1H-NMR (CDCl3) δ: 10.18 (1H, s), 8.53 (1H, dd), 7.75-7.67 (1H, m), 7.41 (1H, dd), 2.98 (2H, q), 1.43 (3H, t). Production Example 3 (4)
To a mixture of 1.75 g of intermediate (3-3), 10 mL of THF and 25 mL of diethyl ether, 5.7 mL of n-butyllithium (1.55M) was added at −78 ° C., and the mixture was stirred at −78 ° C. for 1 hour. To the reaction mixture was added DMF 0.41 mL at −78 ° C., and the mixture was stirred at −78 ° C. for 30 minutes, and then warmed to room temperature. Water was added to the reaction mixture and extracted with MTBE. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography, so as to obtain 941 mg of a compound represented by the following formula (hereinafter, referred to as intermediate (3-4)).
1 H-NMR (CDCl 3 ) δ: 10.18 (1H, s), 8.53 (1H, dd), 7.75-7.67 (1H, m), 7.41 (1H, dd), 2.98 (2H, q), 1.43 (3H , t).
中間体(3-3)を1.75g、THF10mL及びジエチルエーテル25mLの混合物に-78℃でn-ブチルリチウム(1.55M)5.7mLを加えて、-78℃で1時間撹拌した。反応混合物に-78℃でDMF0.41mLを加えて、-78℃で30分撹拌後、室温に昇温した。反応混合物に水を加え、MTBEで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、中間体(3-4)と記す)を941mg得た。
1H-NMR (CDCl3) δ: 10.18 (1H, s), 8.53 (1H, dd), 7.75-7.67 (1H, m), 7.41 (1H, dd), 2.98 (2H, q), 1.43 (3H, t). Production Example 3 (4)
To a mixture of 1.75 g of intermediate (3-3), 10 mL of THF and 25 mL of diethyl ether, 5.7 mL of n-butyllithium (1.55M) was added at −78 ° C., and the mixture was stirred at −78 ° C. for 1 hour. To the reaction mixture was added DMF 0.41 mL at −78 ° C., and the mixture was stirred at −78 ° C. for 30 minutes, and then warmed to room temperature. Water was added to the reaction mixture and extracted with MTBE. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography, so as to obtain 941 mg of a compound represented by the following formula (hereinafter, referred to as intermediate (3-4)).
1 H-NMR (CDCl 3 ) δ: 10.18 (1H, s), 8.53 (1H, dd), 7.75-7.67 (1H, m), 7.41 (1H, dd), 2.98 (2H, q), 1.43 (3H , t).
製造例3(5)
中間体(3-2)を550mg、中間体(3-4)を357mg及びキシレン2.5mLの混合物を還流下で1時間撹拌した。反応混合物にヨウ素1gをさらに加えて、還流下で1時間撹拌した。反応混合物に10%チオ硫酸ナトリウム水溶液を加え、酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、化合物(11)と記す)を48mg得た。
1H-NMR (CDCl3) δ: 8.59 (1H, dd), 7.97 (1H, d), 7.79 (1H, dd), 7.64 (1H, d), 7.43 (1H, dd), 7.35 (1H, dd), 3.07 (2H, q), 1.47 (3H, t). Production Example 3 (5)
A mixture of 550 mg of intermediate (3-2), 357 mg of intermediate (3-4) and 2.5 mL of xylene was stirred under reflux for 1 hour. 1 g of iodine was further added to the reaction mixture, and the mixture was stirred for 1 hour under reflux. A 10% aqueous sodium thiosulfate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 48 mg of a compound represented by the following formula (hereinafter referred to as compound (11)).
1 H-NMR (CDCl 3 ) δ: 8.59 (1H, dd), 7.97 (1H, d), 7.79 (1H, dd), 7.64 (1H, d), 7.43 (1H, dd), 7.35 (1H, dd ), 3.07 (2H, q), 1.47 (3H, t).
中間体(3-2)を550mg、中間体(3-4)を357mg及びキシレン2.5mLの混合物を還流下で1時間撹拌した。反応混合物にヨウ素1gをさらに加えて、還流下で1時間撹拌した。反応混合物に10%チオ硫酸ナトリウム水溶液を加え、酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、化合物(11)と記す)を48mg得た。
1H-NMR (CDCl3) δ: 8.59 (1H, dd), 7.97 (1H, d), 7.79 (1H, dd), 7.64 (1H, d), 7.43 (1H, dd), 7.35 (1H, dd), 3.07 (2H, q), 1.47 (3H, t). Production Example 3 (5)
A mixture of 550 mg of intermediate (3-2), 357 mg of intermediate (3-4) and 2.5 mL of xylene was stirred under reflux for 1 hour. 1 g of iodine was further added to the reaction mixture, and the mixture was stirred for 1 hour under reflux. A 10% aqueous sodium thiosulfate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 48 mg of a compound represented by the following formula (hereinafter referred to as compound (11)).
1 H-NMR (CDCl 3 ) δ: 8.59 (1H, dd), 7.97 (1H, d), 7.79 (1H, dd), 7.64 (1H, d), 7.43 (1H, dd), 7.35 (1H, dd ), 3.07 (2H, q), 1.47 (3H, t).
製造例3(5)に記載の方法に準じて製造した化合物と、その物性値を以下に示す。
式(1-g)
で示される化合物において、A及びR4が[表5]で表される化合物。 The compounds produced according to the method described in Production Example 3 (5) and their physical properties are shown below.
Formula (1-g)
In which A and R 4 are represented by [Table 5].
式(1-g)
で示される化合物において、A及びR4が[表5]で表される化合物。 The compounds produced according to the method described in Production Example 3 (5) and their physical properties are shown below.
Formula (1-g)
In which A and R 4 are represented by [Table 5].
化合物(6):1H-NMR (CDCl3) δ: 8.03 (1H, d), 7.80 (1H, d), 7.64 (1H, d), 7.52 (1H, d), 7.41 (1H, dd), 7.32 (1H, dd), 3.06 (2H, q), 1.47 (3H, t).
Compound (6): 1 H-NMR (CDCl 3 ) δ: 8.03 (1H, d), 7.80 (1H, d), 7.64 (1H, d), 7.52 (1H, d), 7.41 (1H, dd), 7.32 (1H, dd), 3.06 (2H, q), 1.47 (3H, t).
製造例4(1)
3-エチルスルファニルピリジン-2-カルボン酸500mg、塩化チオニル0.5mL、DMF1滴及びトルエン5mLの混合物を100℃で2時間撹拌し、減圧下濃縮した。得られた残渣とTHF6mLとの混合物を、2-アミノ-4-メトキシフェノール380mgとTHF6mLとの混合物に氷冷下で加え、室温にした後室温で1時間撹拌した。反応混合物に飽和炭酸水素ナトリウム水溶液を加えて、酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をn-ヘキサン:酢酸エチル=3:1の混合液で洗浄し、次式で示される化合物(以下、中間体(4-1)と記す)650mgを得た。
1H-NMR (CDCl3) δ: 10.31 (1H, s), 8.35 (1H, dd), 8.09 (1H, s), 7.73 (1H, dd), 7.43 (1H, dd), 6.98 (1H, d), 6.87 (1H, d), 6.72 (1H, dd), 3.78 (3H, s), 2.95 (2H, q), 1.44 (3H, t). Production Example 4 (1)
A mixture of 500 mg of 3-ethylsulfanylpyridine-2-carboxylic acid, 0.5 mL of thionyl chloride, 1 drop of DMF and 5 mL of toluene was stirred at 100 ° C. for 2 hours and concentrated under reduced pressure. A mixture of the obtained residue and 6 mL of THF was added to a mixture of 380 mg of 2-amino-4-methoxyphenol and 6 mL of THF under ice-cooling, and the mixture was brought to room temperature and stirred at room temperature for 1 hour. Saturated aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was washed with a mixed solution of n-hexane: ethyl acetate = 3: 1 to obtain 650 mg of a compound represented by the following formula (hereinafter referred to as intermediate (4-1)).
1 H-NMR (CDCl 3 ) δ: 10.31 (1H, s), 8.35 (1H, dd), 8.09 (1H, s), 7.73 (1H, dd), 7.43 (1H, dd), 6.98 (1H, d ), 6.87 (1H, d), 6.72 (1H, dd), 3.78 (3H, s), 2.95 (2H, q), 1.44 (3H, t).
3-エチルスルファニルピリジン-2-カルボン酸500mg、塩化チオニル0.5mL、DMF1滴及びトルエン5mLの混合物を100℃で2時間撹拌し、減圧下濃縮した。得られた残渣とTHF6mLとの混合物を、2-アミノ-4-メトキシフェノール380mgとTHF6mLとの混合物に氷冷下で加え、室温にした後室温で1時間撹拌した。反応混合物に飽和炭酸水素ナトリウム水溶液を加えて、酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をn-ヘキサン:酢酸エチル=3:1の混合液で洗浄し、次式で示される化合物(以下、中間体(4-1)と記す)650mgを得た。
1H-NMR (CDCl3) δ: 10.31 (1H, s), 8.35 (1H, dd), 8.09 (1H, s), 7.73 (1H, dd), 7.43 (1H, dd), 6.98 (1H, d), 6.87 (1H, d), 6.72 (1H, dd), 3.78 (3H, s), 2.95 (2H, q), 1.44 (3H, t). Production Example 4 (1)
A mixture of 500 mg of 3-ethylsulfanylpyridine-2-carboxylic acid, 0.5 mL of thionyl chloride, 1 drop of DMF and 5 mL of toluene was stirred at 100 ° C. for 2 hours and concentrated under reduced pressure. A mixture of the obtained residue and 6 mL of THF was added to a mixture of 380 mg of 2-amino-4-methoxyphenol and 6 mL of THF under ice-cooling, and the mixture was brought to room temperature and stirred at room temperature for 1 hour. Saturated aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was washed with a mixed solution of n-hexane: ethyl acetate = 3: 1 to obtain 650 mg of a compound represented by the following formula (hereinafter referred to as intermediate (4-1)).
1 H-NMR (CDCl 3 ) δ: 10.31 (1H, s), 8.35 (1H, dd), 8.09 (1H, s), 7.73 (1H, dd), 7.43 (1H, dd), 6.98 (1H, d ), 6.87 (1H, d), 6.72 (1H, dd), 3.78 (3H, s), 2.95 (2H, q), 1.44 (3H, t).
製造例4(2)
中間体(4-1)を643mg、パラトルエンスルホン酸一水和物804mg及びキシレン10mLの混合物を還流下で2時間撹拌した。反応混合物に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、中間体(4-2)と記す)を261mg得た。
1H-NMR (CDCl3) δ: 8.57 (1H, dd), 7.76 (1H, dd), 7.58-7.54 (1H, m), 7.41 (1H, d), 7.38 (1H, dd), 7.02 (1H, dd), 3.88 (3H, s), 3.05 (2H, q), 1.47 (3H, t). Production Example 4 (2)
A mixture of 643 mg of the intermediate (4-1), 804 mg of paratoluenesulfonic acid monohydrate and 10 mL of xylene was stirred under reflux for 2 hours. A saturated aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography, so as to obtain 261 mg of a compound represented by the following formula (hereinafter referred to as intermediate (4-2)).
1 H-NMR (CDCl 3 ) δ: 8.57 (1H, dd), 7.76 (1H, dd), 7.58-7.54 (1H, m), 7.41 (1H, d), 7.38 (1H, dd), 7.02 (1H , dd), 3.88 (3H, s), 3.05 (2H, q), 1.47 (3H, t).
中間体(4-1)を643mg、パラトルエンスルホン酸一水和物804mg及びキシレン10mLの混合物を還流下で2時間撹拌した。反応混合物に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、中間体(4-2)と記す)を261mg得た。
1H-NMR (CDCl3) δ: 8.57 (1H, dd), 7.76 (1H, dd), 7.58-7.54 (1H, m), 7.41 (1H, d), 7.38 (1H, dd), 7.02 (1H, dd), 3.88 (3H, s), 3.05 (2H, q), 1.47 (3H, t). Production Example 4 (2)
A mixture of 643 mg of the intermediate (4-1), 804 mg of paratoluenesulfonic acid monohydrate and 10 mL of xylene was stirred under reflux for 2 hours. A saturated aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography, so as to obtain 261 mg of a compound represented by the following formula (hereinafter referred to as intermediate (4-2)).
1 H-NMR (CDCl 3 ) δ: 8.57 (1H, dd), 7.76 (1H, dd), 7.58-7.54 (1H, m), 7.41 (1H, d), 7.38 (1H, dd), 7.02 (1H , dd), 3.88 (3H, s), 3.05 (2H, q), 1.47 (3H, t).
製造例4(3)
化合物(2)の代わりに、中間体(4-2)を用い、製造例2に記載の方法に準じて、次式で示される化合物(以下、中間体(4-3)と記す)を得た。
1H-NMR (CDCl3) δ: 8.79-8.54 (2H, m), 7.87-7.53 (2H, m), 7.33-7.24 (1H, m), 7.12-7.02 (1H, m), 4.09 (2H, q), 3.90 (3H, s), 1.42 (3H, t) Production Example 4 (3)
Using the intermediate (4-2) instead of the compound (2), a compound represented by the following formula (hereinafter referred to as the intermediate (4-3)) is obtained according to the method described in Production Example 2. It was.
1 H-NMR (CDCl 3 ) δ: 8.79-8.54 (2H, m), 7.87-7.53 (2H, m), 7.33-7.24 (1H, m), 7.12-7.02 (1H, m), 4.09 (2H, q), 3.90 (3H, s), 1.42 (3H, t)
化合物(2)の代わりに、中間体(4-2)を用い、製造例2に記載の方法に準じて、次式で示される化合物(以下、中間体(4-3)と記す)を得た。
1H-NMR (CDCl3) δ: 8.79-8.54 (2H, m), 7.87-7.53 (2H, m), 7.33-7.24 (1H, m), 7.12-7.02 (1H, m), 4.09 (2H, q), 3.90 (3H, s), 1.42 (3H, t) Production Example 4 (3)
Using the intermediate (4-2) instead of the compound (2), a compound represented by the following formula (hereinafter referred to as the intermediate (4-3)) is obtained according to the method described in Production Example 2. It was.
1 H-NMR (CDCl 3 ) δ: 8.79-8.54 (2H, m), 7.87-7.53 (2H, m), 7.33-7.24 (1H, m), 7.12-7.02 (1H, m), 4.09 (2H, q), 3.90 (3H, s), 1.42 (3H, t)
製造例4(4)
中間体(4-3)を520mg、クロロトリメチルシラン1.04mL、ヨウ化ナトリウム1.23g及びアセトニトリル20mLの混合物を還流下で21時間撹拌した。反応混合物に10%チオ硫酸ナトリウム水溶液を加え、酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、中間体(4-4)と記す)を375mg得た。
1H-NMR (CDCl3) δ: 9.01 (1H, dd), 8.59 (1H, dd), 7.70 (1H, dd), 7.52 (1H, d), 7.25 (1H, d), 6.97 (1H, dd), 5.24 (1H, s), 4.06 (2H, q), 1.42 (3H, t). Production Example 4 (4)
A mixture of 520 mg of intermediate (4-3), 1.04 mL of chlorotrimethylsilane, 1.23 g of sodium iodide and 20 mL of acetonitrile was stirred under reflux for 21 hours. A 10% aqueous sodium thiosulfate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography, so as to obtain 375 mg of a compound represented by the following formula (hereinafter referred to as intermediate (4-4)).
1 H-NMR (CDCl 3 ) δ: 9.01 (1H, dd), 8.59 (1H, dd), 7.70 (1H, dd), 7.52 (1H, d), 7.25 (1H, d), 6.97 (1H, dd ), 5.24 (1H, s), 4.06 (2H, q), 1.42 (3H, t).
中間体(4-3)を520mg、クロロトリメチルシラン1.04mL、ヨウ化ナトリウム1.23g及びアセトニトリル20mLの混合物を還流下で21時間撹拌した。反応混合物に10%チオ硫酸ナトリウム水溶液を加え、酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、中間体(4-4)と記す)を375mg得た。
1H-NMR (CDCl3) δ: 9.01 (1H, dd), 8.59 (1H, dd), 7.70 (1H, dd), 7.52 (1H, d), 7.25 (1H, d), 6.97 (1H, dd), 5.24 (1H, s), 4.06 (2H, q), 1.42 (3H, t). Production Example 4 (4)
A mixture of 520 mg of intermediate (4-3), 1.04 mL of chlorotrimethylsilane, 1.23 g of sodium iodide and 20 mL of acetonitrile was stirred under reflux for 21 hours. A 10% aqueous sodium thiosulfate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography, so as to obtain 375 mg of a compound represented by the following formula (hereinafter referred to as intermediate (4-4)).
1 H-NMR (CDCl 3 ) δ: 9.01 (1H, dd), 8.59 (1H, dd), 7.70 (1H, dd), 7.52 (1H, d), 7.25 (1H, d), 6.97 (1H, dd ), 5.24 (1H, s), 4.06 (2H, q), 1.42 (3H, t).
製造例4(5)
中間体(4-4)195mg、ピリジン73μL及びクロロホルム3.5mLの混合物に、室温でトリフルオロメタンスルホン酸無水物140μLを加え、室温で2時間撹拌した。反応混合物に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、化合物(4)と記す)を190mg得た。
1H-NMR (CDCl3) δ: 9.03 (1H, dd), 8.60 (1H, dd), 7.80 (1H, d), 7.78-7.73 (2H, m), 7.41 (1H, dd), 4.01 (2H, q), 1.43 (3H, t). Production Example 4 (5)
To a mixture of 195 mg of Intermediate (4-4), 73 μL of pyridine and 3.5 mL of chloroform, 140 μL of trifluoromethanesulfonic anhydride was added at room temperature, and the mixture was stirred at room temperature for 2 hours. A saturated aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 190 mg of a compound represented by the following formula (hereinafter referred to as compound (4)).
1 H-NMR (CDCl 3 ) δ: 9.03 (1H, dd), 8.60 (1H, dd), 7.80 (1H, d), 7.78-7.73 (2H, m), 7.41 (1H, dd), 4.01 (2H , q), 1.43 (3H, t).
中間体(4-4)195mg、ピリジン73μL及びクロロホルム3.5mLの混合物に、室温でトリフルオロメタンスルホン酸無水物140μLを加え、室温で2時間撹拌した。反応混合物に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥し、有機層を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される化合物(以下、化合物(4)と記す)を190mg得た。
1H-NMR (CDCl3) δ: 9.03 (1H, dd), 8.60 (1H, dd), 7.80 (1H, d), 7.78-7.73 (2H, m), 7.41 (1H, dd), 4.01 (2H, q), 1.43 (3H, t). Production Example 4 (5)
To a mixture of 195 mg of Intermediate (4-4), 73 μL of pyridine and 3.5 mL of chloroform, 140 μL of trifluoromethanesulfonic anhydride was added at room temperature, and the mixture was stirred at room temperature for 2 hours. A saturated aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the organic layer was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 190 mg of a compound represented by the following formula (hereinafter referred to as compound (4)).
1 H-NMR (CDCl 3 ) δ: 9.03 (1H, dd), 8.60 (1H, dd), 7.80 (1H, d), 7.78-7.73 (2H, m), 7.41 (1H, dd), 4.01 (2H , q), 1.43 (3H, t).
製造例4(5)に記載の方法に準じて製造した化合物と、その物性値を以下に示す。
式(1-h)
で示される化合物において、A及びR4が[表6]で表される化合物。 The compounds produced according to the method described in Production Example 4 (5) and their physical properties are shown below.
Formula (1-h)
A compound in which A and R 4 are represented by [Table 6].
式(1-h)
で示される化合物において、A及びR4が[表6]で表される化合物。 The compounds produced according to the method described in Production Example 4 (5) and their physical properties are shown below.
Formula (1-h)
A compound in which A and R 4 are represented by [Table 6].
化合物(5):1H-NMR (CDCl3) δ: 8.29-8.23 (1H, m), 7.99-7.93 (1H, m), 7.86-7.77 (2H, m), 7.75 (1H, d), 7.67 (1H, d), 7.36 (1H, dd), 3.81 (2H, q), 1.40 (3H, t).
Compound (5): 1 H-NMR (CDCl 3 ) δ: 8.29-8.23 (1H, m), 7.99-7.93 (1H, m), 7.86-7.77 (2H, m), 7.75 (1H, d), 7.67 (1H, d), 7.36 (1H, dd), 3.81 (2H, q), 1.40 (3H, t).
次に製剤例を示す。なお、部は重量部を表す。
Next, formulation examples are shown. In addition, a part represents a weight part.
製剤例1
化合物1~12のいずれか1種 10部を、キシレン35部とDMF35部との混合物に溶解し、そこにポリオキシエチレンスチリルフェニルエーテル14部及びドデシルベンゼンスルホン酸カルシウム6部を加え、混合して各々の製剤を得る。 Formulation Example 1
10 parts of any one of compounds 1 to 12 are dissolved in a mixture of 35 parts of xylene and 35 parts of DMF, and 14 parts of polyoxyethylene styryl phenyl ether and 6 parts of calcium dodecylbenzenesulfonate are added and mixed. Each formulation is obtained.
化合物1~12のいずれか1種 10部を、キシレン35部とDMF35部との混合物に溶解し、そこにポリオキシエチレンスチリルフェニルエーテル14部及びドデシルベンゼンスルホン酸カルシウム6部を加え、混合して各々の製剤を得る。 Formulation Example 1
10 parts of any one of compounds 1 to 12 are dissolved in a mixture of 35 parts of xylene and 35 parts of DMF, and 14 parts of polyoxyethylene styryl phenyl ether and 6 parts of calcium dodecylbenzenesulfonate are added and mixed. Each formulation is obtained.
製剤例2
ラウリル硫酸ナトリウム4部、リグニンスルホン酸カルシウム2部、合成含水酸化珪素微粉末20部及び珪藻土54部を混合し、更に化合物1~12のいずれか1種 20部を加え、混合して各々の水和剤を得る。 Formulation Example 2
4 parts of sodium lauryl sulfate, 2 parts of calcium lignin sulfonate, 20 parts of synthetic silicon hydroxide fine powder and 54 parts of diatomaceous earth are added, and 20 parts of any one of compounds 1 to 12 are added and mixed to each water. Get a glaze.
ラウリル硫酸ナトリウム4部、リグニンスルホン酸カルシウム2部、合成含水酸化珪素微粉末20部及び珪藻土54部を混合し、更に化合物1~12のいずれか1種 20部を加え、混合して各々の水和剤を得る。 Formulation Example 2
4 parts of sodium lauryl sulfate, 2 parts of calcium lignin sulfonate, 20 parts of synthetic silicon hydroxide fine powder and 54 parts of diatomaceous earth are added, and 20 parts of any one of compounds 1 to 12 are added and mixed to each water. Get a glaze.
製剤例3
化合物1~12のいずれか1種 2部に、合成含水酸化珪素微粉末1部、リグニンスルホン酸カルシウム2部、ベントナイト30部及びカオリンクレー65部を加え混合する。ついで、この混合物に適当量の水を加え、さらに攪拌し、造粒機で造粒し、通風乾燥して各々の粒剤を得る。 Formulation Example 3
To 2 parts of any one of compounds 1 to 12, 1 part of a synthetic hydrous silicon oxide fine powder, 2 parts of calcium lignin sulfonate, 30 parts of bentonite and 65 parts of kaolin clay are added and mixed. Next, an appropriate amount of water is added to the mixture, and the mixture is further stirred, granulated by a granulator, and dried by ventilation to obtain each granule.
化合物1~12のいずれか1種 2部に、合成含水酸化珪素微粉末1部、リグニンスルホン酸カルシウム2部、ベントナイト30部及びカオリンクレー65部を加え混合する。ついで、この混合物に適当量の水を加え、さらに攪拌し、造粒機で造粒し、通風乾燥して各々の粒剤を得る。 Formulation Example 3
To 2 parts of any one of compounds 1 to 12, 1 part of a synthetic hydrous silicon oxide fine powder, 2 parts of calcium lignin sulfonate, 30 parts of bentonite and 65 parts of kaolin clay are added and mixed. Next, an appropriate amount of water is added to the mixture, and the mixture is further stirred, granulated by a granulator, and dried by ventilation to obtain each granule.
製剤例4
化合物1~12のいずれか1種 1部を適当量のアセトンに溶解し、これに合成含水酸化珪素微粉末5部、酸性りん酸イソプロピル0.3部及びフバサミクレー93.7部を加え、充分攪拌混合し、アセトンを蒸発除去して各々の粉剤を得る。 Formulation Example 4
1 part of any one of compounds 1 to 12 is dissolved in an appropriate amount of acetone, and 5 parts of a synthetic silicon hydroxide fine powder, 0.3 part of isopropyl acid phosphate and 93.7 parts of fusami clay are added to the resulting mixture and stirred sufficiently. Mix and evaporate off the acetone to obtain each powder.
化合物1~12のいずれか1種 1部を適当量のアセトンに溶解し、これに合成含水酸化珪素微粉末5部、酸性りん酸イソプロピル0.3部及びフバサミクレー93.7部を加え、充分攪拌混合し、アセトンを蒸発除去して各々の粉剤を得る。 Formulation Example 4
1 part of any one of compounds 1 to 12 is dissolved in an appropriate amount of acetone, and 5 parts of a synthetic silicon hydroxide fine powder, 0.3 part of isopropyl acid phosphate and 93.7 parts of fusami clay are added to the resulting mixture and stirred sufficiently. Mix and evaporate off the acetone to obtain each powder.
製剤例5
ポリオキシエチレンアルキルエーテルサルフェートアンモニウム塩及びホワイトカーボンの混合物(重量比1:1)35部と、化合物1~12のいずれか1種 10部と、水55部とを混合し、湿式粉砕法で微粉砕することにより、各々のフロアブル剤を得る。 Formulation Example 5
35 parts of a mixture of polyoxyethylene alkyl ether sulfate ammonium salt and white carbon (weight ratio 1: 1), 10 parts of any one of compounds 1 to 12, and 55 parts of water are mixed and finely divided by a wet grinding method. Each flowable agent is obtained by grinding.
ポリオキシエチレンアルキルエーテルサルフェートアンモニウム塩及びホワイトカーボンの混合物(重量比1:1)35部と、化合物1~12のいずれか1種 10部と、水55部とを混合し、湿式粉砕法で微粉砕することにより、各々のフロアブル剤を得る。 Formulation Example 5
35 parts of a mixture of polyoxyethylene alkyl ether sulfate ammonium salt and white carbon (weight ratio 1: 1), 10 parts of any one of compounds 1 to 12, and 55 parts of water are mixed and finely divided by a wet grinding method. Each flowable agent is obtained by grinding.
製剤例6
化合物1~12のいずれか1種 0.1部をキシレン5部及びトリクロロエタン5部の混合物に溶解し、これをケロシン89.9部に混合して各々の油剤を得る。 Formulation Example 6
0.1 part of any one of compounds 1 to 12 is dissolved in a mixture of 5 parts of xylene and 5 parts of trichloroethane, and this is mixed with 89.9 parts of kerosene to obtain each oil.
化合物1~12のいずれか1種 0.1部をキシレン5部及びトリクロロエタン5部の混合物に溶解し、これをケロシン89.9部に混合して各々の油剤を得る。 Formulation Example 6
0.1 part of any one of compounds 1 to 12 is dissolved in a mixture of 5 parts of xylene and 5 parts of trichloroethane, and this is mixed with 89.9 parts of kerosene to obtain each oil.
製剤例7
化合物1~12のいずれか1種 10mgをアセトン0.5mLに溶解し、この溶液を、動物用固形飼料粉末(飼育繁殖用固形飼料粉末CE-2、日本クレア株式会社商品)5gに滴下し、均一に混合する。ついでアセトンを蒸発乾燥させて各々の毒餌剤を得る。 Formulation Example 7
10 mg of any one of compounds 1 to 12 is dissolved in 0.5 mL of acetone, and this solution is added dropwise to 5 g of animal solid feed powder (bred breeding solid feed powder CE-2, Nippon Claire Co., Ltd.). Mix evenly. Then acetone is evaporated to dryness to obtain each poisonous bait.
化合物1~12のいずれか1種 10mgをアセトン0.5mLに溶解し、この溶液を、動物用固形飼料粉末(飼育繁殖用固形飼料粉末CE-2、日本クレア株式会社商品)5gに滴下し、均一に混合する。ついでアセトンを蒸発乾燥させて各々の毒餌剤を得る。 Formulation Example 7
10 mg of any one of compounds 1 to 12 is dissolved in 0.5 mL of acetone, and this solution is added dropwise to 5 g of animal solid feed powder (bred breeding solid feed powder CE-2, Nippon Claire Co., Ltd.). Mix evenly. Then acetone is evaporated to dryness to obtain each poisonous bait.
製剤例8
化合物1~12のいずれか1種 0.1部、及びネオチオゾール(中央化成株式会社製)49.9部をエアゾール缶に入れ、エアゾールバルブを装着した後、ジメチルエーテル25部、LPG25部を充填し振とうを加え、アクチュエータを装着することで油剤エアゾールを得る。 Formulation Example 8
0.1 part of any one of compounds 1 to 12 and 49.9 parts of neothiozole (manufactured by Chuo Kasei Co., Ltd.) are placed in an aerosol can, and after mounting an aerosol valve, 25 parts of dimethyl ether and 25 parts of LPG are filled and shaken. Finally, an oil aerosol is obtained by mounting the actuator.
化合物1~12のいずれか1種 0.1部、及びネオチオゾール(中央化成株式会社製)49.9部をエアゾール缶に入れ、エアゾールバルブを装着した後、ジメチルエーテル25部、LPG25部を充填し振とうを加え、アクチュエータを装着することで油剤エアゾールを得る。 Formulation Example 8
0.1 part of any one of compounds 1 to 12 and 49.9 parts of neothiozole (manufactured by Chuo Kasei Co., Ltd.) are placed in an aerosol can, and after mounting an aerosol valve, 25 parts of dimethyl ether and 25 parts of LPG are filled and shaken. Finally, an oil aerosol is obtained by mounting the actuator.
製剤例9
化合物1~12のいずれか1種 0.6部、BHT(2,6-ジ-tert-ブチル-4-メチルフェノール)0.01部、キシレン5部、ケロシン3.39部及び乳化剤{レオドールMO-60(花王株式会社製)}1部を混合したものと、蒸留水50部とをエアゾール容器に充填し、バルブを装着した後、該バルブを通じて噴射剤(LPG)40部を加圧充填して水性エアゾールを得る。 Formulation Example 9
0.6 part of any one of compounds 1 to 12, 0.01 part of BHT (2,6-di-tert-butyl-4-methylphenol), 5 parts of xylene, 3.39 parts of kerosene and an emulsifier {Rheidol MO -60 (manufactured by Kao Corporation)} 1 part mixed and 50 parts distilled water are filled into an aerosol container, and after the valve is mounted, 40 parts of propellant (LPG) is pressure filled through the valve. To obtain an aqueous aerosol.
化合物1~12のいずれか1種 0.6部、BHT(2,6-ジ-tert-ブチル-4-メチルフェノール)0.01部、キシレン5部、ケロシン3.39部及び乳化剤{レオドールMO-60(花王株式会社製)}1部を混合したものと、蒸留水50部とをエアゾール容器に充填し、バルブを装着した後、該バルブを通じて噴射剤(LPG)40部を加圧充填して水性エアゾールを得る。 Formulation Example 9
0.6 part of any one of compounds 1 to 12, 0.01 part of BHT (2,6-di-tert-butyl-4-methylphenol), 5 parts of xylene, 3.39 parts of kerosene and an emulsifier {Rheidol MO -60 (manufactured by Kao Corporation)} 1 part mixed and 50 parts distilled water are filled into an aerosol container, and after the valve is mounted, 40 parts of propellant (LPG) is pressure filled through the valve. To obtain an aqueous aerosol.
製剤例10
化合物1~12のいずれか1種 0.1gを、プロピレングリコール2mLに混合し、4.0×4.0cm、厚さ1.2cmの多孔セラミック板に含浸させて、加熱式くん煙剤を得る。 Formulation Example 10
0.1 g of any one of compounds 1 to 12 is mixed with 2 mL of propylene glycol and impregnated into a porous ceramic plate of 4.0 × 4.0 cm and a thickness of 1.2 cm to obtain a heating smoke. .
化合物1~12のいずれか1種 0.1gを、プロピレングリコール2mLに混合し、4.0×4.0cm、厚さ1.2cmの多孔セラミック板に含浸させて、加熱式くん煙剤を得る。 Formulation Example 10
0.1 g of any one of compounds 1 to 12 is mixed with 2 mL of propylene glycol and impregnated into a porous ceramic plate of 4.0 × 4.0 cm and a thickness of 1.2 cm to obtain a heating smoke. .
製剤例11
化合物1~12のいずれか1種 5部とエチレンーメタクリル酸メチル共重合体(共重合体中のメタクリル酸メチルの割合:10重量%、アクリフト(登録商標)WD301、住友化学製)95部を密閉式加圧ニーダー(森山製作所製)で溶融混練し、得られた混練物を押出し成型機から成型ダイスを介して押出し、長さ15cm、直径3mmの棒状成型体を得る。 Formulation Example 11
5 parts of any one of compounds 1 to 12 and 95 parts of ethylene-methyl methacrylate copolymer (ratio of methyl methacrylate in the copolymer: 10% by weight, ACRIFT (registered trademark) WD301, manufactured by Sumitomo Chemical Co., Ltd.) The mixture is melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is extruded from an extruder through a molding die to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.
化合物1~12のいずれか1種 5部とエチレンーメタクリル酸メチル共重合体(共重合体中のメタクリル酸メチルの割合:10重量%、アクリフト(登録商標)WD301、住友化学製)95部を密閉式加圧ニーダー(森山製作所製)で溶融混練し、得られた混練物を押出し成型機から成型ダイスを介して押出し、長さ15cm、直径3mmの棒状成型体を得る。 Formulation Example 11
5 parts of any one of compounds 1 to 12 and 95 parts of ethylene-methyl methacrylate copolymer (ratio of methyl methacrylate in the copolymer: 10% by weight, ACRIFT (registered trademark) WD301, manufactured by Sumitomo Chemical Co., Ltd.) The mixture is melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is extruded from an extruder through a molding die to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.
製剤例12
化合物1~12のいずれか1種 5部と軟質塩化ビニル樹脂95部を密閉式加圧ニーダー(森山製作所製)で溶融混練し、得られた混練物を押出し成型機から成型ダイスを介して押出し、長さ15cm、直径3mmの棒状成型体を得る。 Formulation Example 12
5 parts of any one of compounds 1 to 12 and 95 parts of a soft vinyl chloride resin are melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is extruded from an extrusion molding machine through a molding die. A rod-shaped molded body having a length of 15 cm and a diameter of 3 mm is obtained.
化合物1~12のいずれか1種 5部と軟質塩化ビニル樹脂95部を密閉式加圧ニーダー(森山製作所製)で溶融混練し、得られた混練物を押出し成型機から成型ダイスを介して押出し、長さ15cm、直径3mmの棒状成型体を得る。 Formulation Example 12
5 parts of any one of compounds 1 to 12 and 95 parts of a soft vinyl chloride resin are melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is extruded from an extrusion molding machine through a molding die. A rod-shaped molded body having a length of 15 cm and a diameter of 3 mm is obtained.
製剤例13
化合物1~12のいずれか1種 100mg、ラクトース68.75mg、トウモロコシデンプン237.5mg、微結晶性セルロース43.75mg、ポリビニルピロリドン18.75mg、ナトリウムカルボキシメチルデンプン28.75mg、及びステアリン酸マグネシウム2.5mgを混合し、得られた混合物を適切な大きさに圧縮して、錠剤を得る。 Formulation Example 13
Any one of Compounds 1-12 100 mg, lactose 68.75 mg, corn starch 237.5 mg, microcrystalline cellulose 43.75 mg, polyvinylpyrrolidone 18.75 mg, sodium carboxymethyl starch 28.75 mg, and magnesium stearate 5 mg is mixed and the resulting mixture is compressed to an appropriate size to obtain tablets.
化合物1~12のいずれか1種 100mg、ラクトース68.75mg、トウモロコシデンプン237.5mg、微結晶性セルロース43.75mg、ポリビニルピロリドン18.75mg、ナトリウムカルボキシメチルデンプン28.75mg、及びステアリン酸マグネシウム2.5mgを混合し、得られた混合物を適切な大きさに圧縮して、錠剤を得る。 Formulation Example 13
Any one of Compounds 1-12 100 mg, lactose 68.75 mg, corn starch 237.5 mg, microcrystalline cellulose 43.75 mg, polyvinylpyrrolidone 18.75 mg, sodium carboxymethyl starch 28.75 mg, and magnesium stearate 5 mg is mixed and the resulting mixture is compressed to an appropriate size to obtain tablets.
製剤例14
化合物1~12のいずれか1種 25mg、ラクトース60mg、トウモロコシデンプン25mg、カルメロースカルシウム6mg、及び5%ヒドロキシプロピルメチルセルロース適量を混合し、得られた混合物をハードシェルゼラチンカプセル又はヒドロキシプロピルメチルセルロースカプセルに充填し、カプセル剤を得る。 Formulation Example 14
Any one of compounds 1 to 12 25 mg, lactose 60 mg, corn starch 25 mg, carmellose calcium 6 mg, and 5% hydroxypropylmethylcellulose are mixed in an appropriate amount, and the resulting mixture is filled into a hard shell gelatin capsule or hydroxypropylmethylcellulose capsule And a capsule is obtained.
化合物1~12のいずれか1種 25mg、ラクトース60mg、トウモロコシデンプン25mg、カルメロースカルシウム6mg、及び5%ヒドロキシプロピルメチルセルロース適量を混合し、得られた混合物をハードシェルゼラチンカプセル又はヒドロキシプロピルメチルセルロースカプセルに充填し、カプセル剤を得る。 Formulation Example 14
Any one of compounds 1 to 12 25 mg, lactose 60 mg, corn starch 25 mg, carmellose calcium 6 mg, and 5% hydroxypropylmethylcellulose are mixed in an appropriate amount, and the resulting mixture is filled into a hard shell gelatin capsule or hydroxypropylmethylcellulose capsule And a capsule is obtained.
製剤例15
化合物1~12のいずれか1種 100mg、フマル酸500mg、塩化ナトリウム2000mg、メチルパラベン150mg、プロピルパラベン50mg、顆粒糖25000mg、ソルビトール(70%溶液)13000mg、VeegumK(VanderbiltCo.)100mg、香料35mg、及び着色料500mgに、最終容量が100mLとなるよう蒸留水を加え、混合して、経口投与用サスペンジョンを得る。 Formulation Example 15
Any one of Compounds 1-12 100 mg, fumaric acid 500 mg, sodium chloride 2000 mg, methylparaben 150 mg, propylparaben 50 mg, granule sugar 25000 mg, sorbitol (70% solution) 13000 mg, VeegumK (VanderbiltCo.) 100 mg, flavor 35 mg, and coloring Distilled water is added to 500 mg of the preparation so that the final volume becomes 100 mL, and mixed to obtain a suspension for oral administration.
化合物1~12のいずれか1種 100mg、フマル酸500mg、塩化ナトリウム2000mg、メチルパラベン150mg、プロピルパラベン50mg、顆粒糖25000mg、ソルビトール(70%溶液)13000mg、VeegumK(VanderbiltCo.)100mg、香料35mg、及び着色料500mgに、最終容量が100mLとなるよう蒸留水を加え、混合して、経口投与用サスペンジョンを得る。 Formulation Example 15
Any one of Compounds 1-12 100 mg, fumaric acid 500 mg, sodium chloride 2000 mg, methylparaben 150 mg, propylparaben 50 mg, granule sugar 25000 mg, sorbitol (70% solution) 13000 mg, VeegumK (VanderbiltCo.) 100 mg, flavor 35 mg, and coloring Distilled water is added to 500 mg of the preparation so that the final volume becomes 100 mL, and mixed to obtain a suspension for oral administration.
製剤例16
化合物1~12のいずれか1種 5重量%を、ポリソルベート85 5重量%、ベンジルアルコール3重量%、及びプロピレングリコール30重量%に溶解し、この溶液のpHが6.0~6.5となるようにリン酸塩緩衝液を加えた後、残部として水を加えて、経口投与用液剤を得る。 Formulation Example 16
5% by weight of any one of compounds 1 to 12 is dissolved in 5% by weight of polysorbate 85, 3% by weight of benzyl alcohol, and 30% by weight of propylene glycol, and the pH of this solution becomes 6.0 to 6.5. Thus, after adding a phosphate buffer solution, water is added as the remainder, and the liquid agent for oral administration is obtained.
化合物1~12のいずれか1種 5重量%を、ポリソルベート85 5重量%、ベンジルアルコール3重量%、及びプロピレングリコール30重量%に溶解し、この溶液のpHが6.0~6.5となるようにリン酸塩緩衝液を加えた後、残部として水を加えて、経口投与用液剤を得る。 Formulation Example 16
5% by weight of any one of compounds 1 to 12 is dissolved in 5% by weight of polysorbate 85, 3% by weight of benzyl alcohol, and 30% by weight of propylene glycol, and the pH of this solution becomes 6.0 to 6.5. Thus, after adding a phosphate buffer solution, water is added as the remainder, and the liquid agent for oral administration is obtained.
製剤例17
分留ヤシ油57重量%およびポリソルベート85 3重量%中にジステアリン酸アルミニウム5重量%を加え、加熱により分散させる。これを室温に冷却し、その油状ビヒクル中にサッカリン25重量%を分散させる。これに化合物1~12のいずれか1種 10重量%を配分し、経口投与用ペースト状製剤を得る。 Formulation Example 17
5% by weight of aluminum distearate in 57% by weight of fractionated coconut oil and 3% by weight of polysorbate 85 is added and dispersed by heating. This is cooled to room temperature and 25% by weight of saccharin is dispersed in the oily vehicle. To this, 10% by weight of any one of compounds 1 to 12 is allocated to obtain a paste preparation for oral administration.
分留ヤシ油57重量%およびポリソルベート85 3重量%中にジステアリン酸アルミニウム5重量%を加え、加熱により分散させる。これを室温に冷却し、その油状ビヒクル中にサッカリン25重量%を分散させる。これに化合物1~12のいずれか1種 10重量%を配分し、経口投与用ペースト状製剤を得る。 Formulation Example 17
5% by weight of aluminum distearate in 57% by weight of fractionated coconut oil and 3% by weight of polysorbate 85 is added and dispersed by heating. This is cooled to room temperature and 25% by weight of saccharin is dispersed in the oily vehicle. To this, 10% by weight of any one of compounds 1 to 12 is allocated to obtain a paste preparation for oral administration.
製剤例18
化合物1~12のいずれか1種 5重量%を石灰石粉95重量%と混合し、湿潤顆粒形成法を使用して経口投与用粒剤を得る。 Formulation Example 18
5% by weight of any one of compounds 1 to 12 is mixed with 95% by weight of limestone powder, and granules for oral administration are obtained using a wet granulation method.
化合物1~12のいずれか1種 5重量%を石灰石粉95重量%と混合し、湿潤顆粒形成法を使用して経口投与用粒剤を得る。 Formulation Example 18
5% by weight of any one of compounds 1 to 12 is mixed with 95% by weight of limestone powder, and granules for oral administration are obtained using a wet granulation method.
製剤例19
化合物1~12のいずれか1種 5部をジエチレングリコールモノエチルエーテル80部に溶解し、これに炭酸プロピレン15部を混合して、スポットオン液剤を得る。 Formulation Example 19
5 parts of any one of compounds 1 to 12 are dissolved in 80 parts of diethylene glycol monoethyl ether, and 15 parts of propylene carbonate are mixed with this to obtain a spot-on solution.
化合物1~12のいずれか1種 5部をジエチレングリコールモノエチルエーテル80部に溶解し、これに炭酸プロピレン15部を混合して、スポットオン液剤を得る。 Formulation Example 19
5 parts of any one of compounds 1 to 12 are dissolved in 80 parts of diethylene glycol monoethyl ether, and 15 parts of propylene carbonate are mixed with this to obtain a spot-on solution.
製剤例20
化合物1~12のいずれか1種 10部をジエチレングリコールモノエチルエーテル70部に溶解し、これに2-オクチルドデカノール20部を混合して、ポアオン液剤を得る。 Formulation Example 20
10 parts of any one of compounds 1 to 12 are dissolved in 70 parts of diethylene glycol monoethyl ether, and 20 parts of 2-octyldodecanol is mixed with it to obtain a pour-on solution.
化合物1~12のいずれか1種 10部をジエチレングリコールモノエチルエーテル70部に溶解し、これに2-オクチルドデカノール20部を混合して、ポアオン液剤を得る。 Formulation Example 20
10 parts of any one of compounds 1 to 12 are dissolved in 70 parts of diethylene glycol monoethyl ether, and 20 parts of 2-octyldodecanol is mixed with it to obtain a pour-on solution.
製剤例21
化合物1~12のいずれか1種 0.5部に、ニッコール(登録商標)TEALS-42(日光ケミカルズ・ラウリル硫酸トリエタノールアミンの42%水溶液)60部、プロピレングリコール20部を添加し、均一溶液になるまで充分撹拌混合した後、水19.5部を加えてさらに充分撹拌混合し、均一溶液のシャンプー剤を得る。 Formulation Example 21
To 0.5 parts of any one of compounds 1 to 12, 60 parts of Nikkor (registered trademark) TEALS-42 (42% aqueous solution of Nikko Chemicals lauryl sulfate triethanolamine) and 20 parts of propylene glycol were added to form a homogeneous solution. Then, 19.5 parts of water is added and further stirred and mixed to obtain a uniform solution shampoo agent.
化合物1~12のいずれか1種 0.5部に、ニッコール(登録商標)TEALS-42(日光ケミカルズ・ラウリル硫酸トリエタノールアミンの42%水溶液)60部、プロピレングリコール20部を添加し、均一溶液になるまで充分撹拌混合した後、水19.5部を加えてさらに充分撹拌混合し、均一溶液のシャンプー剤を得る。 Formulation Example 21
To 0.5 parts of any one of compounds 1 to 12, 60 parts of Nikkor (registered trademark) TEALS-42 (42% aqueous solution of Nikko Chemicals lauryl sulfate triethanolamine) and 20 parts of propylene glycol were added to form a homogeneous solution. Then, 19.5 parts of water is added and further stirred and mixed to obtain a uniform solution shampoo agent.
製剤例22
化合物1~12のいずれか1種 0.15重量%、動物飼料95重量%、並びに、第2リン酸カルシウム、珪藻土、Aerosil、及びカーボネート(又はチョーク)からなる混合物4.85重量%を十分攪拌混合し、動物用飼料プレミックスを得る。 Formulation Example 22
Any one of compounds 1 to 12 0.15% by weight, animal feed 95% by weight, and 4.85% by weight of a mixture composed of dicalcium phosphate, diatomaceous earth, Aerosil, and carbonate (or chalk) are sufficiently stirred and mixed. Obtain a premix for animal feed.
化合物1~12のいずれか1種 0.15重量%、動物飼料95重量%、並びに、第2リン酸カルシウム、珪藻土、Aerosil、及びカーボネート(又はチョーク)からなる混合物4.85重量%を十分攪拌混合し、動物用飼料プレミックスを得る。 Formulation Example 22
Any one of compounds 1 to 12 0.15% by weight, animal feed 95% by weight, and 4.85% by weight of a mixture composed of dicalcium phosphate, diatomaceous earth, Aerosil, and carbonate (or chalk) are sufficiently stirred and mixed. Obtain a premix for animal feed.
製剤例23
化合物1~12のいずれか1種 7.2g、及びホスコ(登録商標)S-55(丸石製薬株式会社製)92.8gを100℃で溶解混和し、坐剤形に注いで、冷却固化して、坐剤を得る。 Formulation Example 23
7.2 g of any one of compounds 1 to 12 and 92.8 g of Fosco (registered trademark) S-55 (manufactured by Maruishi Pharmaceutical Co., Ltd.) are dissolved and mixed at 100 ° C., poured into a suppository, and solidified by cooling. To obtain a suppository.
化合物1~12のいずれか1種 7.2g、及びホスコ(登録商標)S-55(丸石製薬株式会社製)92.8gを100℃で溶解混和し、坐剤形に注いで、冷却固化して、坐剤を得る。 Formulation Example 23
7.2 g of any one of compounds 1 to 12 and 92.8 g of Fosco (registered trademark) S-55 (manufactured by Maruishi Pharmaceutical Co., Ltd.) are dissolved and mixed at 100 ° C., poured into a suppository, and solidified by cooling. To obtain a suppository.
次に、本発明化合物の有害節足動物防除効力を試験例により示す。
Next, the harmful arthropod controlling efficacy of the compound of the present invention is shown by test examples.
試験例1
製剤例5により得られた化合物1、3、4、5、7、9、10又は12の製剤を、各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
一方、プラスチックカップに植えたキュウリ幼苗(第1本葉展開期)にワタアブラムシ(Aphis gossypii)(全ステージ)約30頭を接種し、1日間放置した後、この幼苗に、該希釈液20mLを散布した。
散布6日後に該キュウリの葉上に寄生したワタアブラムシ生存虫数を調査し、以下の式により防除価を求めた。
防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
Cb:無処理区の処理前の虫数
Cai:無処理区の観察時の寄生生存虫数
Tb:処理区の処理前の虫数
Tai:処理区の観察時の寄生生存虫数
ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した液を散布した区を意味する。
その結果、本発明化合物を供試したすべての処理区において、各々防除価90%以上を示した。 Test example 1
The preparation of Compound 1, 3, 4, 5, 7, 9, 10 or 12 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
On the other hand, about 30 Aphis gossypi (all stages) were inoculated into cucumber seedlings (first true leaf development stage) planted in plastic cups, and left for 1 day. Scattered.
Six days after spraying, the number of live cotton aphids that parasitized on the leaves of the cucumber was examined, and the control value was determined by the following formula.
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
Cb: number of insects before treatment in the untreated group Cai: number of live parasites when observed in the untreated group Tb: number of insects before treatment in the treated group Tai: number of live parasitic insects during observation of the treated group The group refers to a group in which a preparation diluted with the same amount of water as the treatment group was sprayed on the preparation not containing the compound of the present invention in Preparation Example 5.
As a result, the control value of 90% or more was exhibited in all the treatment sections where the compounds of the present invention were tested.
製剤例5により得られた化合物1、3、4、5、7、9、10又は12の製剤を、各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
一方、プラスチックカップに植えたキュウリ幼苗(第1本葉展開期)にワタアブラムシ(Aphis gossypii)(全ステージ)約30頭を接種し、1日間放置した後、この幼苗に、該希釈液20mLを散布した。
散布6日後に該キュウリの葉上に寄生したワタアブラムシ生存虫数を調査し、以下の式により防除価を求めた。
防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
Cb:無処理区の処理前の虫数
Cai:無処理区の観察時の寄生生存虫数
Tb:処理区の処理前の虫数
Tai:処理区の観察時の寄生生存虫数
ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した液を散布した区を意味する。
その結果、本発明化合物を供試したすべての処理区において、各々防除価90%以上を示した。 Test example 1
The preparation of Compound 1, 3, 4, 5, 7, 9, 10 or 12 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
On the other hand, about 30 Aphis gossypi (all stages) were inoculated into cucumber seedlings (first true leaf development stage) planted in plastic cups, and left for 1 day. Scattered.
Six days after spraying, the number of live cotton aphids that parasitized on the leaves of the cucumber was examined, and the control value was determined by the following formula.
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
Cb: number of insects before treatment in the untreated group Cai: number of live parasites when observed in the untreated group Tb: number of insects before treatment in the treated group Tai: number of live parasitic insects during observation of the treated group The group refers to a group in which a preparation diluted with the same amount of water as the treatment group was sprayed on the preparation not containing the compound of the present invention in Preparation Example 5.
As a result, the control value of 90% or more was exhibited in all the treatment sections where the compounds of the present invention were tested.
試験例2
製剤例5により得られた化合物4又は5の製剤を、各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
ポリエチレンカップに植えた第2葉展開期のイネ幼苗に、該希釈液10mLを散布した。風乾後、トビイロウンカ(Nilaparvata lugens)の3~4齢幼虫を20頭放して、25℃の温室内に保管した。6日後イネに寄生したトビイロウンカの数を調査し、以下の式により防除価を求めた。
防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
Cb:無処理区の処理前の虫数
Cai:無処理区の観察時の虫数
Tb:処理区の処理前の虫数
Tai:処理区の観察時の虫数
ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した液を散布した区を意味する。
その結果、本発明化合物を供試したすべての処理区において、各々防除価90%以上を示した。 Test example 2
The preparation of Compound 4 or 5 obtained in Preparation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
10 mL of the diluted solution was sprayed on rice seedlings in the second leaf development stage planted in a polyethylene cup. After air drying, 20 3-4 instar larvae of the green planthopper (Nilaparvata lugens) were released and stored in a greenhouse at 25 ° C. Six days later, the number of brown planthopper infested with rice was investigated, and the control value was determined by the following formula.
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
Cb: number of insects before treatment in the untreated group Cai: number of insects at the time of observation in the untreated group Tb: number of insects before the treatment in the treated group Tai: number of insects at the time of observation in the treated group In Formulation Example 5, this refers to a group in which a preparation containing no compound of the present invention was sprayed with a solution diluted with the same amount of water as the treatment group.
As a result, the control value of 90% or more was exhibited in all the treatment sections where the compounds of the present invention were tested.
製剤例5により得られた化合物4又は5の製剤を、各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
ポリエチレンカップに植えた第2葉展開期のイネ幼苗に、該希釈液10mLを散布した。風乾後、トビイロウンカ(Nilaparvata lugens)の3~4齢幼虫を20頭放して、25℃の温室内に保管した。6日後イネに寄生したトビイロウンカの数を調査し、以下の式により防除価を求めた。
防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
Cb:無処理区の処理前の虫数
Cai:無処理区の観察時の虫数
Tb:処理区の処理前の虫数
Tai:処理区の観察時の虫数
ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した液を散布した区を意味する。
その結果、本発明化合物を供試したすべての処理区において、各々防除価90%以上を示した。 Test example 2
The preparation of Compound 4 or 5 obtained in Preparation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
10 mL of the diluted solution was sprayed on rice seedlings in the second leaf development stage planted in a polyethylene cup. After air drying, 20 3-4 instar larvae of the green planthopper (Nilaparvata lugens) were released and stored in a greenhouse at 25 ° C. Six days later, the number of brown planthopper infested with rice was investigated, and the control value was determined by the following formula.
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
Cb: number of insects before treatment in the untreated group Cai: number of insects at the time of observation in the untreated group Tb: number of insects before the treatment in the treated group Tai: number of insects at the time of observation in the treated group In Formulation Example 5, this refers to a group in which a preparation containing no compound of the present invention was sprayed with a solution diluted with the same amount of water as the treatment group.
As a result, the control value of 90% or more was exhibited in all the treatment sections where the compounds of the present invention were tested.
試験例3
製剤例5により得られた化合物4の製剤を、化合物4の濃度が200ppmとなるように水で希釈し、希釈液を得た。
一方、プラスチックカップに植えたイネ幼苗(播種2週間後、第2葉展開期)に、該希釈液5mLを株元潅注し、7日間25℃温室内に保った。トビイロウンカ(Nilaparvata lugens)の3~4齢幼虫を20頭放して、更に6日該温室内に保った後に、該イネの葉上に寄生したトビイロウンカ生存虫数を調査し、以下の式により防除価を求めた。
防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
Cb:無処理区の処理前の虫数
Cai:無処理区の観察時の寄生生存虫数
Tb:処理区の処理前の虫数
Tai:処理区の観察時の寄生生存虫数
ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した液を散布した区を意味する。
その結果、化合物4を供試した処理区は、防除価100%を示した。 Test example 3
The formulation of Compound 4 obtained in Formulation Example 5 was diluted with water so that the concentration of Compound 4 was 200 ppm to obtain a diluted solution.
On the other hand, 5 mL of the diluted solution was irrigated to rice seedlings planted in plastic cups (2 weeks after sowing, the second leaf development stage) and kept in a 25 ° C. greenhouse for 7 days. After releasing 20 3-4 instar larvae of the green planthopper (Nilaparvata lugens) and keeping it in the greenhouse for another 6 days, the number of surviving insects parasitic on the rice leaves was investigated, and the control value was calculated by the following formula: Asked.
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
Cb: number of insects before treatment in the untreated group Cai: number of live parasites when observed in the untreated group Tb: number of insects before treatment in the treated group Tai: number of live parasitic insects during observation of the treated group The group refers to a group in which a preparation diluted with the same amount of water as the treatment group was sprayed on the preparation not containing the compound of the present invention in Preparation Example 5.
As a result, the treatment section in which Compound 4 was tested showed a control value of 100%.
製剤例5により得られた化合物4の製剤を、化合物4の濃度が200ppmとなるように水で希釈し、希釈液を得た。
一方、プラスチックカップに植えたイネ幼苗(播種2週間後、第2葉展開期)に、該希釈液5mLを株元潅注し、7日間25℃温室内に保った。トビイロウンカ(Nilaparvata lugens)の3~4齢幼虫を20頭放して、更に6日該温室内に保った後に、該イネの葉上に寄生したトビイロウンカ生存虫数を調査し、以下の式により防除価を求めた。
防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
Cb:無処理区の処理前の虫数
Cai:無処理区の観察時の寄生生存虫数
Tb:処理区の処理前の虫数
Tai:処理区の観察時の寄生生存虫数
ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した液を散布した区を意味する。
その結果、化合物4を供試した処理区は、防除価100%を示した。 Test example 3
The formulation of Compound 4 obtained in Formulation Example 5 was diluted with water so that the concentration of Compound 4 was 200 ppm to obtain a diluted solution.
On the other hand, 5 mL of the diluted solution was irrigated to rice seedlings planted in plastic cups (2 weeks after sowing, the second leaf development stage) and kept in a 25 ° C. greenhouse for 7 days. After releasing 20 3-4 instar larvae of the green planthopper (Nilaparvata lugens) and keeping it in the greenhouse for another 6 days, the number of surviving insects parasitic on the rice leaves was investigated, and the control value was calculated by the following formula: Asked.
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
Cb: number of insects before treatment in the untreated group Cai: number of live parasites when observed in the untreated group Tb: number of insects before treatment in the treated group Tai: number of live parasitic insects during observation of the treated group The group refers to a group in which a preparation diluted with the same amount of water as the treatment group was sprayed on the preparation not containing the compound of the present invention in Preparation Example 5.
As a result, the treatment section in which Compound 4 was tested showed a control value of 100%.
試験例4
製剤例5により得られた化合物1、3、4、5、7、9、10又は12の製剤を、各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
一方、ポリエチレンカップに植えた3葉期キャベツに、該希釈液を20mL/カップの割合で散布した。散布後植物を風乾し、茎葉部を切り取って50mLカップに収容し、コナガ(Plutella xylostella)2令幼虫5頭を放ち、蓋をした。25℃で保管し、5日後に死亡虫数を数え、次式より死虫率を求めた。
死虫率(%)=(死亡虫数/供試虫数)×100
その結果、本発明化合物を供試したすべての処理区において、各々死虫率80%以上を示した。 Test example 4
The preparation of Compound 1, 3, 4, 5, 7, 9, 10 or 12 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
On the other hand, the diluted solution was sprayed at a rate of 20 mL / cup on a three-leaf cabbage planted in a polyethylene cup. After spraying, the plants were air-dried, the stems and leaves were cut out and accommodated in a 50 mL cup, 5 larvae of Plutella xylostella were released and covered. After storing at 25 ° C., the number of dead insects was counted after 5 days, and the death rate was calculated from the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
製剤例5により得られた化合物1、3、4、5、7、9、10又は12の製剤を、各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
一方、ポリエチレンカップに植えた3葉期キャベツに、該希釈液を20mL/カップの割合で散布した。散布後植物を風乾し、茎葉部を切り取って50mLカップに収容し、コナガ(Plutella xylostella)2令幼虫5頭を放ち、蓋をした。25℃で保管し、5日後に死亡虫数を数え、次式より死虫率を求めた。
死虫率(%)=(死亡虫数/供試虫数)×100
その結果、本発明化合物を供試したすべての処理区において、各々死虫率80%以上を示した。 Test example 4
The preparation of Compound 1, 3, 4, 5, 7, 9, 10 or 12 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
On the other hand, the diluted solution was sprayed at a rate of 20 mL / cup on a three-leaf cabbage planted in a polyethylene cup. After spraying, the plants were air-dried, the stems and leaves were cut out and accommodated in a 50 mL cup, 5 larvae of Plutella xylostella were released and covered. After storing at 25 ° C., the number of dead insects was counted after 5 days, and the death rate was calculated from the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
試験例5
製剤例5により得られた化合物4の製剤を化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
直径5.5cmのポリエチレンカップの底に同大の濾紙を敷き、該希釈液0.7mLを濾紙上に滴下し、餌としてショ糖30mgを均一に入れた。該ポリエチレンカップ内にイエバエ(Musca domestica)雌成虫10頭を放ち、蓋をした。24時間後にイエバエの生死を調査し死亡虫数を数え、次式により死虫率を求めた。
死虫率(%)=(死亡虫数/供試虫数)×100
その結果、化合物4を供試した処理区は、死中率100%を示した。 Test Example 5
The formulation of Compound 4 obtained in Formulation Example 5 was diluted with water so that the concentration of the compound was 500 ppm to obtain a diluted solution.
A filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, and 0.7 mL of the diluted solution was dropped onto the filter paper, and 30 mg of sucrose was uniformly added as food. Ten female fly (Musca domestica) females were released into the polyethylene cup and capped. After 24 hours, the life and death of the house fly was investigated, the number of dead insects was counted, and the death rate was calculated by the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the treatment group in which Compound 4 was tested showed a death rate of 100%.
製剤例5により得られた化合物4の製剤を化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
直径5.5cmのポリエチレンカップの底に同大の濾紙を敷き、該希釈液0.7mLを濾紙上に滴下し、餌としてショ糖30mgを均一に入れた。該ポリエチレンカップ内にイエバエ(Musca domestica)雌成虫10頭を放ち、蓋をした。24時間後にイエバエの生死を調査し死亡虫数を数え、次式により死虫率を求めた。
死虫率(%)=(死亡虫数/供試虫数)×100
その結果、化合物4を供試した処理区は、死中率100%を示した。 Test Example 5
The formulation of Compound 4 obtained in Formulation Example 5 was diluted with water so that the concentration of the compound was 500 ppm to obtain a diluted solution.
A filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, and 0.7 mL of the diluted solution was dropped onto the filter paper, and 30 mg of sucrose was uniformly added as food. Ten female fly (Musca domestica) females were released into the polyethylene cup and capped. After 24 hours, the life and death of the house fly was investigated, the number of dead insects was counted, and the death rate was calculated by the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the treatment group in which Compound 4 was tested showed a death rate of 100%.
試験例6
製剤例5により得られた化合物3又は9の製剤を各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
直径5.5cmのポリエチレンカップの底に同大の濾紙を敷き、該希釈液0.7mLを濾紙上に滴下し、餌としてショ糖30mgを均一に入れた。該ポリエチレンカップ内にチャバネゴキブリ(Blattella germanica)雄成虫2頭を放ち、蓋をした。6日後にチャバネゴキブリの生死を調査し死亡虫数を数え、次式により死虫率を求めた。
死虫率(%)=(死亡虫数/供試虫数)×100
その結果、本発明化合物を供試したすべての処理区において、死虫率100%をした。 Test Example 6
The preparation of Compound 3 or 9 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
A filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, and 0.7 mL of the diluted solution was dropped onto the filter paper, and 30 mg of sucrose was uniformly added as food. Two adult male cockroaches (Blatella germanica) were released into the polyethylene cup and capped. Six days later, the death and death of German cockroaches were investigated, the number of dead insects was counted, and the death rate was calculated according to the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 100% in all treatments where the compounds of the present invention were tested.
製剤例5により得られた化合物3又は9の製剤を各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
直径5.5cmのポリエチレンカップの底に同大の濾紙を敷き、該希釈液0.7mLを濾紙上に滴下し、餌としてショ糖30mgを均一に入れた。該ポリエチレンカップ内にチャバネゴキブリ(Blattella germanica)雄成虫2頭を放ち、蓋をした。6日後にチャバネゴキブリの生死を調査し死亡虫数を数え、次式により死虫率を求めた。
死虫率(%)=(死亡虫数/供試虫数)×100
その結果、本発明化合物を供試したすべての処理区において、死虫率100%をした。 Test Example 6
The preparation of Compound 3 or 9 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
A filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, and 0.7 mL of the diluted solution was dropped onto the filter paper, and 30 mg of sucrose was uniformly added as food. Two adult male cockroaches (Blatella germanica) were released into the polyethylene cup and capped. Six days later, the death and death of German cockroaches were investigated, the number of dead insects was counted, and the death rate was calculated according to the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 100% in all treatments where the compounds of the present invention were tested.
試験例7
製剤例5により得られた化合物1、4、5、7、9又は10の製剤を各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
該希釈液0.7mlをイオン交換水100mLに加えた(濃度3.5ppm)。該液中にアカイエカ(Culex pipiens pallens)終令幼虫30頭を放ち、1日後にその生死を調査し死亡虫数を数え、死虫率を求めた。
死虫率(%)=(死亡虫数/供試虫数)×100
その結果、本発明化合物を供試したすべての処理区において、各々死虫率91%以上を示した。 Test Example 7
The preparation of Compound 1, 4, 5, 7, 9, or 10 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
0.7 ml of the diluted solution was added to 100 mL of ion exchange water (concentration: 3.5 ppm). 30 larvae of Culex pipiens parallels were released into the liquid, and after 1 day, the viability was investigated and the number of dead insects was counted to determine the death rate.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the mortality rate was 91% or more in all the treatment groups where the compounds of the present invention were tested.
製剤例5により得られた化合物1、4、5、7、9又は10の製剤を各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
該希釈液0.7mlをイオン交換水100mLに加えた(濃度3.5ppm)。該液中にアカイエカ(Culex pipiens pallens)終令幼虫30頭を放ち、1日後にその生死を調査し死亡虫数を数え、死虫率を求めた。
死虫率(%)=(死亡虫数/供試虫数)×100
その結果、本発明化合物を供試したすべての処理区において、各々死虫率91%以上を示した。 Test Example 7
The preparation of Compound 1, 4, 5, 7, 9, or 10 obtained in Formulation Example 5 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
0.7 ml of the diluted solution was added to 100 mL of ion exchange water (concentration: 3.5 ppm). 30 larvae of Culex pipiens parallels were released into the liquid, and after 1 day, the viability was investigated and the number of dead insects was counted to determine the death rate.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the mortality rate was 91% or more in all the treatment groups where the compounds of the present invention were tested.
試験例8
製剤例1により得られた化合物1、3、4、5、7、9、10又は12の製剤を、各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
一方、ポリエチレンカップに植えた3葉期キュウリに、該希釈液を30mL/カップの割合で散布した。散布後植物を風乾し、第2葉を切り取って200mLカップに収容し、ウリハムシ(Aulacophora femoralis)2令幼虫10頭を放ち、蓋をした。25℃で保管し、5日後に死亡虫数を数え、次式により死虫率を求めた。
死虫率(%)=(死亡虫数/供試虫数)×100
その結果、本発明化合物を供試したすべての処理区において、各々死虫率80%以上を示した。 Test Example 8
The preparation of Compound 1, 3, 4, 5, 7, 9, 10 or 12 obtained in Formulation Example 1 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
On the other hand, the diluted solution was sprayed at a rate of 30 mL / cup on the trilobal cucumber planted in a polyethylene cup. After spraying, the plants were air-dried, the second leaf was cut out and placed in a 200 mL cup, 10 larvae of Auricophora femorialis were released and capped. After storing at 25 ° C., the number of dead insects was counted after 5 days, and the death rate was calculated by the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
製剤例1により得られた化合物1、3、4、5、7、9、10又は12の製剤を、各化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
一方、ポリエチレンカップに植えた3葉期キュウリに、該希釈液を30mL/カップの割合で散布した。散布後植物を風乾し、第2葉を切り取って200mLカップに収容し、ウリハムシ(Aulacophora femoralis)2令幼虫10頭を放ち、蓋をした。25℃で保管し、5日後に死亡虫数を数え、次式により死虫率を求めた。
死虫率(%)=(死亡虫数/供試虫数)×100
その結果、本発明化合物を供試したすべての処理区において、各々死虫率80%以上を示した。 Test Example 8
The preparation of Compound 1, 3, 4, 5, 7, 9, 10 or 12 obtained in Formulation Example 1 was diluted with water so that the concentration of each compound was 500 ppm to obtain a diluted solution.
On the other hand, the diluted solution was sprayed at a rate of 30 mL / cup on the trilobal cucumber planted in a polyethylene cup. After spraying, the plants were air-dried, the second leaf was cut out and placed in a 200 mL cup, 10 larvae of Auricophora femorialis were released and capped. After storing at 25 ° C., the number of dead insects was counted after 5 days, and the death rate was calculated by the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
本発明化合物は、有害節足動物に対して防除効力を有し、有害節足動物防除剤の有効成分として有用である。
The compound of the present invention has a controlling effect on harmful arthropods and is useful as an active ingredient of a harmful arthropod controlling agent.
Claims (8)
- 式(I)
[式中、
Aは、窒素原子又はCR5を表し、
RA及びRBの一方は-OSO2CF3を表し、他方は水素原子を表し、
R1は、C1-C4アルキル基、シクロプロピル基又はシクロプロピルメチル基を表し、
R2及びR3は、それぞれ独立して、水素原子又はハロゲン原子を表し、
R4及びR5は、それぞれ独立して、水素原子、-S(O)mR6{mは、0、1、又は2を表す。}、1以上のハロゲン原子を有してもよいC3-C6シクロアルキル基、1以上のハロゲン原子を有してもよい(C1-C6アルコキシ)C1-C6アルキル基、1以上のハロゲン原子を有してもよい(C3-C6シクロアルキル)C1-C6アルキル基、-R7、-OR7、-NR8R9、-C(O)R10、-COOR10、-C(O)NR8R9、フェニル基、5~6員ヘテロアリール基{但し、該フェニル基、及び該5~6員へテロアリール基は、群Xから選ばれる1以上の原子又は置換基を有してもよく、2以上の原子もしくは置換基を有する場合、それらの原子及び置換基は同一でも異なっていてもよい。}、ニトロ基、シアノ基、ヒロドキシ基、スルファニル基、ハロゲン原子、-NR10C(O)R6、-NR10CO2R6、-NR10SO2R6、-NR10(OR6)、又は-N=S(O)pR6R11{pは、0又は1を表す。}を表し、
R6及びR11は、それぞれ独立して、1以上のハロゲン原子を有してもよいC1-C6アルキル基を表し、
R7は、1以上のハロゲン原子を有してもよいC1-C6鎖式炭化水素基を表し、
R8及びR9は、それぞれ独立して、水素原子又は1以上のハロゲン原子を有してもよいC1-C6鎖式炭化水素基を表すか、R8とR9とが結合して、1以上のハロゲン原子を有してもよいC2-C6アルカンジイル基を表し、
nは、0、1、又は2を表し、
群Xは-R6、-OR6、-S(O)mR6、-C(O)R6、-COOR6、-NR10R12、シアノ基、ニトロ基、及びハロゲン原子からなる群を表し、
R10及びR12は、それぞれ独立して、水素原子又は1以上のハロゲン原子を有してもよいC1-C6アルキル基を表す。]
で示されるベンゾオキサゾール化合物。 Formula (I)
[Where:
A represents a nitrogen atom or CR 5 ,
One of R A and R B represents —OSO 2 CF 3 , the other represents a hydrogen atom,
R 1 represents a C1-C4 alkyl group, a cyclopropyl group or a cyclopropylmethyl group,
R 2 and R 3 each independently represent a hydrogen atom or a halogen atom,
R 4 and R 5 each independently represents a hydrogen atom, —S (O) m R 6 {m represents 0, 1, or 2. } C3-C6 cycloalkyl group optionally having one or more halogen atoms, (C1-C6 alkoxy) optionally having one or more halogen atoms, C1-C6 alkyl group having one or more halogen atoms (C3-C6 cycloalkyl) C1-C6 alkyl group, —R 7 , —OR 7 , —NR 8 R 9 , —C (O) R 10 , —COOR 10 , —C (O) NR 8 R 9 , a phenyl group, a 5- to 6-membered heteroaryl group (provided that the phenyl group and the 5- to 6-membered heteroaryl group may have one or more atoms or substituents selected from group X; When it has two or more atoms or substituents, these atoms and substituents may be the same or different. }, Nitro group, cyano group, hydroxy group, sulfanyl group, halogen atom, —NR 10 C (O) R 6 , —NR 10 CO 2 R 6 , —NR 10 SO 2 R 6 , —NR 10 (OR 6 ) Or —N═S (O) p R 6 R 11 {p represents 0 or 1; },
R 6 and R 11 each independently represents a C1-C6 alkyl group which may have one or more halogen atoms,
R 7 represents a C1-C6 chain hydrocarbon group which may have one or more halogen atoms,
R 8 and R 9 each independently represents a hydrogen atom or a C1-C6 chain hydrocarbon group which may have one or more halogen atoms, or R 8 and R 9 are bonded to each other, Represents a C2-C6 alkanediyl group optionally having the above halogen atom,
n represents 0, 1, or 2;
Group X is a group consisting of —R 6 , —OR 6 , —S (O) m R 6 , —C (O) R 6 , —COOR 6 , —NR 10 R 12 , a cyano group, a nitro group, and a halogen atom. Represents
R 10 and R 12 each independently represents a hydrogen atom or a C1-C6 alkyl group which may have one or more halogen atoms. ]
A benzoxazole compound represented by: - R1が、C1-C3アルキル基であり、
R4及びR5が、それぞれ独立して、水素原子、-R6、-S(O)mR6、-OR6、-NR8R9、-COOR6、群Xから選ばれる1以上の原子もしくは置換基を有してもよい5~6員ヘテロアリール基、ハロゲン原子、-NR10C(O)R6、-NR10CO2R6、-NR10(OR6)、又は-N=S(O)pR6R11である請求項1に記載のベンゾオキサゾール化合物。 R 1 is a C1-C3 alkyl group,
R 4 and R 5 each independently represents one or more selected from a hydrogen atom, —R 6 , —S (O) m R 6 , —OR 6 , —NR 8 R 9 , —COOR 6 , group X An optionally substituted 5- to 6-membered heteroaryl group, a halogen atom, —NR 10 C (O) R 6 , —NR 10 CO 2 R 6 , —NR 10 (OR 6 ), or —N The benzoxazole compound according to claim 1, which is = S (O) p R 6 R 11 . - RAが-OSO2CF3であり、RBが水素原子である請求項1又は請求項2に記載のベンゾオキサゾール化合物。 The benzoxazole compound according to claim 1 or 2, wherein R A is -OSO 2 CF 3 and R B is a hydrogen atom.
- R1が、エチル基であり、
R2及びR3が、共に水素原子であり、
R4が、水素原子、ハロゲン原子、1以上のハロゲン原子を有してもよいC1-C3アルキル基、又は1以上のハロゲン原子を有してもよいC1-C3アルコキシ基であり、
R5が、水素原子又はハロゲン原子である請求項3に記載のベンゾオキサゾール化合物。 R 1 is an ethyl group,
R 2 and R 3 are both hydrogen atoms,
R 4 is a hydrogen atom, a halogen atom, a C1-C3 alkyl group that may have one or more halogen atoms, or a C1-C3 alkoxy group that may have one or more halogen atoms,
The benzoxazole compound according to claim 3, wherein R 5 is a hydrogen atom or a halogen atom. - Aが窒素原子である請求項1~請求項4のいずれかに記載のベンゾオキサゾール化合物。 The benzoxazole compound according to any one of claims 1 to 4, wherein A is a nitrogen atom.
- AがCR5である請求項1~請求項4のいずれかに記載のベンゾオキサゾール化合物。 The benzoxazole compound according to any one of claims 1 to 4, wherein A is CR 5 .
- 請求項1~請求項6のいずれかに記載のベンゾオキサゾール化合物と不活性担体とを含有する有害節足動物防除剤。 A harmful arthropod control agent comprising the benzoxazole compound according to any one of claims 1 to 6 and an inert carrier.
- 請求項1~請求項6のいずれかに記載のベンゾオキサゾール化合物の有効量を有害節足動物又はその生息場所に施用する有害節足動物の防除方法。 A method for controlling harmful arthropods, which comprises applying an effective amount of the benzoxazole compound according to any one of claims 1 to 6 to harmful arthropods or their habitats.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015019057 | 2015-02-03 | ||
JP2015-019057 | 2015-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016125622A1 true WO2016125622A1 (en) | 2016-08-11 |
Family
ID=56563973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2016/052091 WO2016125622A1 (en) | 2015-02-03 | 2016-01-26 | Benzoxazole compound, and use thereof for noxious arthropod control |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2016125622A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018065288A1 (en) | 2016-10-07 | 2018-04-12 | Bayer Cropscience Aktiengesellschaft | 2-[2-phenyl-1-(sulfonyl-methyl)-vinyl]-imidazo-[4,5-b] pyridine derivatives and related compounds as pesticides in plant protection |
WO2018065292A1 (en) | 2016-10-06 | 2018-04-12 | Bayer Cropscience Aktiengesellschaft | 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents |
WO2018130437A1 (en) | 2017-01-10 | 2018-07-19 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
WO2018130443A1 (en) | 2017-01-10 | 2018-07-19 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
WO2019065568A1 (en) * | 2017-09-26 | 2019-04-04 | 住友化学株式会社 | Heterocyclic compound and harmful arthropod-controlling agent containing same |
WO2020054790A1 (en) * | 2018-09-13 | 2020-03-19 | 住友化学株式会社 | Bipyridine compound and use thereof |
WO2022002818A1 (en) | 2020-07-02 | 2022-01-06 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
US11926623B2 (en) | 2018-06-26 | 2024-03-12 | Bayer Aktiengesellschaft | Heterocycle derivatives as pesticides |
WO2024189139A1 (en) | 2023-03-14 | 2024-09-19 | Syngenta Crop Protection Ag | Control of pests resistant to insecticides |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0656754A (en) * | 1992-04-23 | 1994-03-01 | Sumitomo Chem Co Ltd | Hydrazone compound, insecticide and miticide containing the compound as active component and its production intermediate |
WO1994005633A1 (en) * | 1992-09-01 | 1994-03-17 | Ciba-Geigy Ag | 3-cyano-4-halogeno-2-(subst.phenyl)-pyrroles as pesticides and fungicides |
JP2005505524A (en) * | 2001-07-27 | 2005-02-24 | シンジェンタ リミテッド | Azole derivatives useful as insecticides |
JP2011037824A (en) * | 2009-03-30 | 2011-02-24 | Sumitomo Chemical Co Ltd | Use of pyridazinone compound for control of harmful arthropod pest |
JP2011219420A (en) * | 2010-04-09 | 2011-11-04 | Otsuka Agritechno Co Ltd | New pyrazole compound, method for producing the same, and pest controlling agent |
WO2012086848A1 (en) * | 2010-12-24 | 2012-06-28 | Sumitomo Chemical Company, Limited | Fused heterocyclic compound and use for pest control thereof |
WO2013018928A1 (en) * | 2011-08-04 | 2013-02-07 | Sumitomo Chemical Company, Limited | Fused heterocyclic compound and use thereof for pest control |
WO2013163244A1 (en) * | 2012-04-26 | 2013-10-31 | Bristol-Myers Squibb Company | Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation |
JP2014024839A (en) * | 2012-06-21 | 2014-02-06 | Sumitomo Chemical Co Ltd | Pest-control composition and pest-control method |
WO2014037349A1 (en) * | 2012-09-05 | 2014-03-13 | Bayer Cropscience Ag | Use of substituted 2,3-dihydro-1-benzofuran-4-carboxylic acids or salts thereof as active substances against abiotic plant stress |
WO2015121136A1 (en) * | 2014-02-17 | 2015-08-20 | Bayer Cropscience Ag | 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents |
-
2016
- 2016-01-26 WO PCT/JP2016/052091 patent/WO2016125622A1/en active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0656754A (en) * | 1992-04-23 | 1994-03-01 | Sumitomo Chem Co Ltd | Hydrazone compound, insecticide and miticide containing the compound as active component and its production intermediate |
WO1994005633A1 (en) * | 1992-09-01 | 1994-03-17 | Ciba-Geigy Ag | 3-cyano-4-halogeno-2-(subst.phenyl)-pyrroles as pesticides and fungicides |
JP2005505524A (en) * | 2001-07-27 | 2005-02-24 | シンジェンタ リミテッド | Azole derivatives useful as insecticides |
JP2011037824A (en) * | 2009-03-30 | 2011-02-24 | Sumitomo Chemical Co Ltd | Use of pyridazinone compound for control of harmful arthropod pest |
JP2011219420A (en) * | 2010-04-09 | 2011-11-04 | Otsuka Agritechno Co Ltd | New pyrazole compound, method for producing the same, and pest controlling agent |
WO2012086848A1 (en) * | 2010-12-24 | 2012-06-28 | Sumitomo Chemical Company, Limited | Fused heterocyclic compound and use for pest control thereof |
WO2013018928A1 (en) * | 2011-08-04 | 2013-02-07 | Sumitomo Chemical Company, Limited | Fused heterocyclic compound and use thereof for pest control |
WO2013163244A1 (en) * | 2012-04-26 | 2013-10-31 | Bristol-Myers Squibb Company | Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation |
JP2014024839A (en) * | 2012-06-21 | 2014-02-06 | Sumitomo Chemical Co Ltd | Pest-control composition and pest-control method |
WO2014037349A1 (en) * | 2012-09-05 | 2014-03-13 | Bayer Cropscience Ag | Use of substituted 2,3-dihydro-1-benzofuran-4-carboxylic acids or salts thereof as active substances against abiotic plant stress |
WO2015121136A1 (en) * | 2014-02-17 | 2015-08-20 | Bayer Cropscience Ag | 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018065292A1 (en) | 2016-10-06 | 2018-04-12 | Bayer Cropscience Aktiengesellschaft | 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents |
US11339155B2 (en) | 2016-10-06 | 2022-05-24 | Bayer Cropscience Aktiengesellschaft | 2-(het)aryl-substituted fused bicyclic heterocycle derivatives as pesticides |
WO2018065288A1 (en) | 2016-10-07 | 2018-04-12 | Bayer Cropscience Aktiengesellschaft | 2-[2-phenyl-1-(sulfonyl-methyl)-vinyl]-imidazo-[4,5-b] pyridine derivatives and related compounds as pesticides in plant protection |
US11058115B2 (en) | 2017-01-10 | 2021-07-13 | Bayer Aktiengesellschaft | Heterocycle derivatives as pesticides |
WO2018130437A1 (en) | 2017-01-10 | 2018-07-19 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
WO2018130443A1 (en) | 2017-01-10 | 2018-07-19 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
US11083199B2 (en) | 2017-01-10 | 2021-08-10 | Bayer Aktiengesellschaft | Heterocycle derivatives as pesticides |
WO2019065568A1 (en) * | 2017-09-26 | 2019-04-04 | 住友化学株式会社 | Heterocyclic compound and harmful arthropod-controlling agent containing same |
US11926623B2 (en) | 2018-06-26 | 2024-03-12 | Bayer Aktiengesellschaft | Heterocycle derivatives as pesticides |
CN112673006A (en) * | 2018-09-13 | 2021-04-16 | 住友化学株式会社 | Bipyridine compound and use thereof |
JPWO2020054790A1 (en) * | 2018-09-13 | 2021-08-30 | 住友化学株式会社 | Bipyridine compounds and their uses |
WO2020054790A1 (en) * | 2018-09-13 | 2020-03-19 | 住友化学株式会社 | Bipyridine compound and use thereof |
JP7368368B2 (en) | 2018-09-13 | 2023-10-24 | 住友化学株式会社 | Bipyridine compounds and their uses |
TWI827660B (en) * | 2018-09-13 | 2024-01-01 | 日商住友化學股份有限公司 | Bipyridine compound and use thereof |
CN112673006B (en) * | 2018-09-13 | 2024-05-03 | 住友化学株式会社 | Bipyridine compound and use thereof |
WO2022002818A1 (en) | 2020-07-02 | 2022-01-06 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
WO2024189139A1 (en) | 2023-03-14 | 2024-09-19 | Syngenta Crop Protection Ag | Control of pests resistant to insecticides |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6649281B2 (en) | Bipyridine compounds and their use for controlling harmful arthropods | |
WO2016125621A1 (en) | Benzimidazole compound, and use thereof for noxious arthropod control | |
WO2016125622A1 (en) | Benzoxazole compound, and use thereof for noxious arthropod control | |
JP6763396B2 (en) | Condensed heterocyclic compound | |
WO2016121969A1 (en) | Bipyridine compound and use of same for noxious arthropod control | |
WO2016052455A1 (en) | Pyridazine compound | |
WO2016052247A1 (en) | Pyrimidinone compound | |
JP6809478B2 (en) | Pyridine compound | |
CN111902392B (en) | Alkyne compound and harmful arthropod control composition containing same | |
WO2017082132A1 (en) | Condensed heterocyclic compound | |
JP6816763B2 (en) | Heterocyclic compound | |
JP2018070512A (en) | Harmful arthropod control composition | |
JP6763380B2 (en) | Harmful arthropod control agent | |
WO2017188078A1 (en) | Heterocyclic compound | |
JP7281447B2 (en) | Cyclopropylethylene compound and harmful arthropod control composition containing the same | |
WO2016143652A1 (en) | 3-aminooxalylaminobenzamide compound and use for controlling harmful arthropod | |
WO2016163383A1 (en) | Oxalyl amide compound and use thereof for noxious arthropod control | |
WO2016143650A1 (en) | 3-aminooxalylaminobenzamide compound and use for controlling harmful arthropod | |
WO2016163379A1 (en) | Oxalyl amide compound and use thereof for noxious arthropod control |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16746453 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16746453 Country of ref document: EP Kind code of ref document: A1 |